| Description | Chemical ligand-receptor interactions curated by experts |
| Measurement | association by literature curation |
| Association | receptor-ligand (chemical) associations by expert curation |
| Category | physical interactions |
| Resource | Guide to Pharmacology |
| Citation(s) | |
| Last Updated | 2015 Apr 06 |
| Stats |
|
| API | |
| Script | |
| Downloads |
Gene Similarity
Attribute Similarity
Gene Attribute
4893 sets of receptors of ligands (chemical) from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
| Gene Set | Description |
|---|---|
| PETCM | |
| McN-A-343 | |
| betaxolol | A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure. |
| glucagon-(1-21) | |
| dimaprit | An imidothiocarbamic ester that has formula C6H15N3S. |
| T134 | |
| telmisartan | |
| compound 11c [PMID:17929793] | |
| 22R-hydroxycholesterol | |
| 2-hydroxyoctanoic acid | |
| nitrooleic acid | |
| argatroban | An alpha-N-substituted L-arginine that has formula C23H36N6O5S. |
| [<sup>3</sup>H]BWA868C | |
| methyltyrosine | |
| VUF 5207 | |
| compound 11q [PMID:19433355] | |
| ibodutant | |
| [<sup>18</sup>F]MK-1312 | |
| [<sup>3</sup>H]AZ11637326 | |
| VU0364739 | |
| NPY-(2-36) | |
| [D-Ala<sup>2</sup> F<sub>5</sub> Phe<sup>4</sup>]dynorphin-(1-13)-NH<sub>2</sub> | |
| PSB-10 | |
| (2R)-N-[(2S)-1-[(4-carbamimidoylphenyl)methylamino]-3-hydroxy-1-oxopropan-2-yl]-3-hydroxy-2-(phenylmethylsulfonylamino)propanamide | |
| lamotrigine | A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. |
| acetyldigitoxin | |
| MCL0129 | |
| UR-PG131A | |
| phenylacetylrinvanil | |
| idelalisib | A member of the class of quinazolines that is 5-fluoro-3-phenylquinazolin-4-one in which the hydrogen at position 2 is replaced by a (1S)-1-(3H-purin-6-ylamino)propyl group. used for for the treatment of refractory indolent non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukemia. |
| eGlu | |
| C2-NPY (pig) | |
| vincamine | |
| H-c[Cys-Phe-LAgl(N<sup>β</sup>Me benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH | |
| RS-504393 | |
| FPRL1-inhibitor protein | |
| Gue1654 | |
| demotate 2 | |
| [<sup>125</sup>I]KC-Tyr | |
| entinostat | |
| L-888 291 | |
| [<sup>3</sup>H]S-15535 | |
| slotoxin | |
| MEN 10376 | |
| [<sup>3</sup>H]SNAP-7941 | |
| (+)-S20 | |
| (3R 5R)-7-(5-{[(4-cyanophenyl)methyl]carbamoyl}-3-(4-fluorophenyl)-4-phenyl-1-(propan-2-yl)-1H-pyrrol-2-yl)-3 5-dihydroxyheptanoate | |
| [<sup>3</sup>H]resolvin E1 | |
| kurtoxin | |
| SR146131 | |
| immepip | A piperidine that has formula C9H15N3. |
| (E)-N-[(3E)-4 8-dimethylnona-3 7-dien-1-yl]-N-methyl-N'-[(2E 6E)-3 7 11-trimethyldodeca-2 6 10-trien-1-yl]methenimidamide | |
| [1-bromo-(3S)-hydrox-4-(palmitoyloxy)butyl]phosphate | |
| {[(3-{[(3E)-4 8-dimethylnona-3 7-dien-1-yl](methyl)amino}propoxy)(hydroxy)phosphoryl]oxy}phosphonic acid | |
| galanin(2-30) (human) | |
| PnTx-3-6 | |
| RO4988546 | |
| Z-VDVAD-FMK | |
| [Tyr<sup>34</sup>]PTH-(3-34)-NH<sub>2</sub> (human) | |
| RS 67333 | |
| Ro67-7476 | |
| (R)-NFPS | |
| JV-1-40 | |
| [<sup>11</sup>C]DTBZ | |
| afamelanotide | |
| methyl-piperidino-pyrazole | |
| cholesterol | |
| GR 125 743 | |
| [<sup>125</sup>I]EYF | |
| 3-N<sub>3</sub>-Phpa-LVA | |
| cyclorelix | |
| L-765314 | |
| imbutamine | |
| phenamil | |
| Lys-kallidin | |
| BEL | |
| BAY607550 | |
| L-748337 | |
| thio-BCTC | |
| 10 10-difluoro TXA<sub>2</sub> | |
| Flu-CCL3 | |
| compound 1754-31 | |
| lauric acid | A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil. |
| [<sup>125</sup>I]buserelin | |
| methyltrienolone | |
| ethopropazine | |
| P'-geranyl 3 5 8-trihydroxy-3-methyloctanate 8-diphosphate | |
| enalaprilat | |
| miglustat | |
| aminooxyacetic acid | |
| apicidin | |
| [<sup>3</sup>H]ICI-198615 | |
| d[Cha<sup>4</sup>]LVP | |
| ABT-491 | |
| compound 30 [PMID: 21757343] | |
| tedisamil | |
| AZD9668 | |
| (1S 3Z)-3-{2-[(1R 3aS 7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-octahydro-1H-inden-4-yl]ethylidene}-4 4-dimethylcyclohexan-1-ol | |
| rivastigmine | |
| (3R 5S 6E)-7-[2 4-bis(4-fluorophenyl)-5-(propan-2-yl)-1H-imidazol-1-yl]-3 5-dihydroxyhept-6-enoate | |
| LTE<sub>4</sub> | |
| [<sup>125</sup>I][Tyr<sup>8</sup>]bradykinin | |
| L-lactic acid | |
| [<sup>3</sup>H]SR142 801 | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Val<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| CyPPA | |
| Ins(3 4 5 6)P<sub>4</sub> | |
| fMet-Ile-Val-Ile-Leu | |
| AMI-1 | |
| palifermin | |
| linopirdine | An indole that has formula C26H21N3O. |
| [<sup>3</sup>H]RS 57639 | |
| RS 100235 | |
| [<sup>3</sup>H]NPC17731 | |
| darifenacin | |
| 15-deoxy-Δ<sup>12 14</sup>-PGD<sub>2</sub> | |
| SB-334867 | |
| astressin | A 30-membered homodetic cyclic peptide comprising the sequence D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 cyclised by an amide bridge, formed by condensation of the side-chain carboxy group of the Glu residue at position 19 and the side-chain amino group of the Lys residue at posoition 22. |
| cinacalcet | |
| WS-23 | |
| gefitinib | |
| 5-HT-moduline | |
| RS-17053 | |
| ZM-274773 | |
| 5-methyl-​5-(5-meth​ylthiophe​n-3-yl)-4​-oxo-4 5-​dihydrofu​ran-2-car​boxylic a​cid | |
| quadazocine | |
| E913 | |
| <i>N</i>-desmethylclozapine | |
| ethanol | A primary alcohol that is ethane in which one of the hydrogens is substituted by a hydroxy group. |
| SDZ SER-082 | |
| naproxen | A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes. |
| batrachotoxin | A steroid that has formula C31H42N2O6. |
| phlorizin | An aryl beta-D-glucoside that is phloretin attached to a beta-D-glucopyranosyl residue at position 2' via a glycosidic linkage. |
| ONO-AE1-329 | |
| [<sup>18</sup>F](R R)-quinuclidinyl-4-fluoromethyl-benzilate | |
| [<i><sup>t</sup></i>Bu-D-Gly<sup>5</sup>]NPS | |
| dihydroergotamine | Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension. |
| PTHrP-(1-20)/TIP-(23-39) (human) | |
| amiloride | A monocarboxylic acid amide that is N-carbamimidoylpyrazine-2-carboxamide substituted by amino groups at positions 3 and 5 and a chloro group at position 6. |
| phenelzine | |
| xylometazoline | |
| phosphatidylserine | |
| [<sup>32</sup>P]MRS2500 | |
| macitentan | A member of the class of sulfamides in which the two amino groups of sulfonamide are substituted by 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl and propyl groups. An orphan drug used for the treatment of pulmonary arterial hypertension. |
| adalimumab | |
| iodophenpropit | |
| [<sup>125</sup>I]glucagon (human mouse rat) | |
| ABT-384 | |
| norzotepine | |
| fMet-Leu-Phe-Glu | |
| BRL 44408 | |
| {5-[(4-phenyl-1 2 5-oxadiazol-3-yl)oxy]-1-phosphonopentyl}phosphonic acid | |
| SB269970 | |
| tonapofylline | |
| 5-benzyloxytryptamine | |
| PTH-(1-34) (rat) | |
| vestipitant | |
| (1S 2S 3S 5R)-1-(carboxymethyl)-3 5-bis({[(4-phenoxyphenyl)methyl](propyl)carbamoyl})cyclopentane-1 2-dicarboxylic acid | |
| compound 42 [PMID:22545772] | |
| quinidine | A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. |
| azathioprine | A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS. |
| AB-NECA | |
| 3-bicyclo[2.2.1]hept-2-yl-benzene-1 2-diol | |
| taprostene | |
| 3-phenyl-CPP | |
| (+)-JQ1 | |
| [<sup>3</sup>H]clidinium | |
| [His<sup>4</sup> Tyr<sup>5</sup> Trp<sup>6</sup> His<sup>7</sup>]TIP39 (human) | |
| PBMC | |
| [D-Trp<sup>32</sup>]NPY | |
| ivabradine | |
| MMPIP | |
| farnesyl thiodiphosphate | |
| Ro-70-0004 | |
| [<sup>18</sup>F]fluoroethylflumazenil | |
| sermorelin | |
| GIP-(6-30)-amide | |
| farnesyl monophosphate | |
| (-)-(<i>R</i>)-efonidipine | |
| [Sar<sup>1</sup> D-Ala<sup>12</sup>]galanin(1-16) | |
| HU-210 | |
| AH6809 | |
| fenoldopam | A benzazepine that has formula C16H16ClNO3. |
| Gal-B2-C<sub>12</sub> | |
| [<sup>3</sup>H]PAF | |
| DW13.3 | |
| NS11757 | |
| [<sup>125</sup>I]CNP (human) | |
| meloxicam | |
| TUG-424 | |
| DIDS | |
| <i>N</i>-α-Ac-PYY-(22-36) (rat) | |
| histrelin | |
| chlorthalidone | An isoindole that has formula C14H11ClN2O4S. |
| PD136450 | |
| Mg<sup>2+</sup> | |
| GW4064 | A stilbenoid that has formula C28H22Cl3NO4. |
| <i>N</i>-methyl-Phe-Lys-Pro-<small>D</small>-Cha-Cha-<small>D</small>-Arg-CO<sub>2</sub>H | |
| ciprofibrate | |
| chlorpromazine | A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety. |
| KT 5720 | |
| SB 699551 | |
| GV196771A | |
| dynorphin-(1-17)-NH<sub>2</sub> | |
| (3S 5R)-7-[(1S 2S 6R 8R)-2 6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1 2 6 7 8 8a-hexahydronaphthalen-1-yl]-3 5-dihydroxyheptanoate | |
| metolazone | |
| arecoline | A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine. |
| digeranyl bisphosphonate | |
| (1S 2S 3S 4S)-3 4-bis[(2-methylpropyl)[(4-phenoxyphenyl)methyl]carbamoyl]cyclobutane-1 2-dicarboxylic acid | |
| compound 23c [PMID:17929793] | |
| TC-2559 | |
| rifampicin | A rifamycin that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei) |
| ambrisentan | |
| dioleoylphosphatidic acid | A phosphatidic acid in which the phosphatidyl acyl groups are both oleoyl. |
| tegaserod | |
| SSR125543A | |
| bantag-1 | |
| SLIGRL-NH<sub>2</sub> | |
| NNC-711 | |
| kisspeptin-28 | |
| [<sup>3</sup>H]NGD941 | |
| SNAP-5114 | |
| AL-37350A | |
| [Leu<sup>9</sup> des-Arg<sup>10</sup>]kallidin | |
| chlorzoxazone | A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm. |
| (4R 6S)-6-[(E)-2-[6-chloro-4-(4-fluorophenyl)-2-(propan-2-yl)quinolin-3-yl]ethenyl]-4-hydroxyoxan-2-one | |
| UCCF-853 | |
| T-0632 | |
| acetylcholine | |
| capsaicin | A capsaicinoid that has formula C18H27NO3. |
| des-His<sup>1</sup>-[Leu<sup>4</sup>-Glu<sup>9</sup>]glucagon-NH<sub>2</sub> | |
| RO330-0802/001 | |
| ω-phonetoxin-IIA | |
| DAU 6285 | |
| (3R)-4-{[(E)-2-[5-ethyl-4-(4-fluorophenyl)-6-phenyl-2-(propan-2-yl)pyridin-3-yl]ethenyl]phosphinato}-3-hydroxybutanoate | |
| tivozanib | |
| OPC-51803 | |
| fludarabine | |
| quetiapine | A dibenzothiazepine that has formula C21H25N3O2S. |
| DPC | |
| 4-DAMP | |
| indoramin | |
| fMet-Leu-Phe | |
| VU0404251 | |
| prunetin | A hydroxyisoflavone that is genistein in which the hydroxy group at position 7 is replaced by a methoxy group. |
| LSP1-2111 | |
| Des-AA<sup>5</sup>-[D-Trp<sup>8</sup>]SRIF | |
| L-759 633 | |
| CYM5181 | |
| [<sup>125</sup>I]tertiapin Y1/K12/Q13 | |
| JNJ-10311795 | |
| SNX482 | |
| perphenazine | A member of the class of phenothiazines that is phenothiazine having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position. |
| α-ergocryptine | Ergotaman bearing hydroxy, isopropyl, and 2-methylpropyl groups at the 12', 2' and 5' positions, respectively, and oxo groups at positions 3', 6', and 18. It is a natural ergot alkaloid. Ergocryptine discussed in the literature prior to 1967, when beta-ergocryptine was separated from alpha-ergocryptine, is now referred to as alpha-ergocryptine. |
| [Tyr<sup>34</sup>]GLP-2 (human) | |
| saxitoxin | An alkaloid isolated from the marine dinoflagellates and cyanobacteria that causes paralytic shellfish poisoning. |
| [<sup>3</sup>H]QNB | |
| pCMPS | |
| [Leu<sup>14</sup> ψ 13-14)]bombesin | |
| propafenone | An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias. |
| compound 26 [PMID:16190743] | |
| roxithromycin | |
| d[Leu<sup>4</sup>]AVP | |
| FAUC213 | |
| seocalcitol | |
| apamin | |
| GSK-J1 | |
| GSK4716 | A monoterpenoid that has formula C17H18N2O2. |
| GlyH-101 | |
| galanin(5-29) (rat/mouse) | |
| [<sup>3</sup>H]NECA | |
| [<sup>125</sup>I]1DMe | |
| ErgTx-1 | |
| succinylcholine | A quaternary ammonium ion that is the bis-choline ester of succinic acid. |
| burimamide | An imidazole that has formula C9H16N4S. |
| pralnacasan | |
| 5-MPEP | |
| [<sup>125</sup>I]Tyr<sup>10</sup>NPS (human) | |
| (3R 6E)-7-[6-tert-butyl-4-(4-fluorophenyl)-2-(propan-2-yl)pyridin-3-yl]-3 5-dihydroxyhept-6-enoate | |
| alcuronium | |
| compound 12e [PMID: 22266036] | |
| Δ<sup>9</sup>-tetrahydrocannabinol | |
| 2 4 diahexanxoylphloroglucinol | |
| aliskiren | |
| camostat | |
| vCXCL-1 | |
| vMIP-II | |
| [<sup>125</sup>I]CHIPS | |
| compound 26a [PMID: 16242323] | |
| methyl (3R 5S 6E)-7-[3-bromo-4 5-bis(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-1-yl]-3 5-dihydroxyhept-6-enoate | |
| 5-oxo-ETE | An oxoicosatetraenoic acid having a 5-oxo group; and (6E)-, (8Z), (11Z)- and (14Z)-double bonds. |
| [Thi<sup>5 8</sup> D-Phe<sup>7</sup>]bradykinin | |
| JMV457 | |
| CCPA | |
| [<sup>125</sup>I][Tyr<sup>5</sup> DAla<sup>6</sup> NMeLeu<sup>7</sup> Pro<sup>9</sup>-NEt]GnRH | |
| CHIPS-(28-149) | |
| kassinin | |
| CITCO | |
| R-715 | |
| CHPG | |
| 3-hydroxy capric acid | |
| impentamine | |
| L-alanine | The L-enantiomer of alanine. |
| taprenepag | |
| IN-3 | |
| letrozole | A triazole that has formula C17H11N5. |
| [<sup>3</sup>H]flunitrazepam | |
| SCH 58261 | |
| pirinixic acid | An aryl sulfide that has formula C14H14ClN3O2S. |
| PIP<sub>2</sub> | |
| tyramine | |
| compound 8 [PMID: 15482908] | |
| MRK016 | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-6-{[(decyloxy)carbonyl]oxy}-4 7-dihydroxy-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| (3R)-3-hydroxy-5-oxo-7-phenylheptanoic acid | |
| pargyline | |
| zaprinast | |
| CP734432 | |
| ATLa2 | |
| 2-hydroxy-saclofen | |
| noxiustoxin | |
| <i>N</i>-1-isopropyltryptamine | |
| chemerin C-terminal peptide | |
| sibutramine | |
| 4-{[3-({[(2E)-6 6-dimethylhept-2-en-4-yn-1-yl](ethyl)amino}methyl)phenoxymethyl]dimethylsilyl}benzonitrile | |
| CXCL12-(1-17) | |
| [<sup>125</sup>I]CCL11 (human) | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14 </sup>Arg<sup>19</sup>]PTH-(1-21)-NH2 (human) | |
| [<sup>14</sup>C]TEA | |
| BIM 23056 | |
| ONO-AE5-599 | |
| Br-5MPEPy | |
| TAK-652 | |
| BIM 23068 | |
| BIM 23059 | |
| compound 1 [PMID: 22465637] | |
| (4R)-6-{2-[2-ethyl-4-(4-fluorophenyl)-6-phenylpyridin-3-yl]ethyl}-4-hydroxyoxan-2-one | |
| L-368 899 | |
| NS1738 | |
| BIM 23060 | |
| (-)-menthol | |
| [<sup>3</sup>H]CGP61594 | |
| quinpirole | A pyrazoloquinoline that is (4aR,8aR)-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline substituted by a propyl group at position 5. It acts as a dopamine agonist. |
| BIM 23066 | |
| DAVP | |
| benzolamide | |
| mequinol | |
| vatalanib | |
| desmopressin | A synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function. |
| [<sup>3</sup>H]M-MPEP | |
| BMS641 | |
| LY-288513 | |
| t-Boc-FLFLF | |
| IBMX | An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively. |
| metrifudil | |
| [<sup>125</sup>I]CCL7 (human) | |
| [<sup>125</sup>I]α-DTX | |
| Ro4491533 | |
| celecoxib | |
| MZ-5-78 | |
| MRS2927 | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Orn<sup>8</sup> Tyr-NH<sub>2</sub><sup>9</sup>]OVT | |
| 4-oxo-nonenal | |
| [<sup>3</sup>H]CGS23131 | |
| acetic acid | A simple monocarboxylic acid containing two carbons. |
| oxazine 89 | |
| VU0361737 | |
| 5-Me-IAA | |
| 3-[(E)-2-(4-phenylphenyl)ethenyl]-1-azabicyclo[2.2.2]octane | |
| gentamicin | |
| 4-[3-(dodeca-1 3-diyn-1-yl)oxiran-2-yl]butanoic acid | |
| ECDCA | |
| 4-MPPTS | |
| SIB-1757 | |
| Ro15-4513 | |
| pipamperone | |
| [Ac-His<sup>1</sup>]PACAP-27 | |
| SKF-83556 | |
| L-367 773 | |
| ZK-158252 | |
| [<sup>3</sup>H]methyllycaconitine | |
| [<sup>3</sup>H]taurocholic acid | |
| aspirin triggered lipoxin A4 | |
| UDP-glucose | |
| 3-hydroxyoctanoic acid | An 8-carbon, beta-hydroxy fatty acid which may be a marker for primary defects of beta-hydroxy fatty acid metabolism. Repeating unit of poly(3-hydroxyoctanoic acid), a biopolymer used by numerous bacterial species as carbon and energy reserves. |
| MK-2894 | |
| cetirizine | A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively. |
| galanin(9-29) (rat/mouse) | |
| [<sup>125</sup>I]CRF (ovine) | |
| allyl isothiocyanate | An isothiocyanate with the formula CH2=CHCH2N=C=S. A colorless oil with boiling point 152degreeC, it is responsible for the pungent taste of mustard, horseradish, and wasabi. |
| 2-arachidonoylglycerol | An endocannabinoid and an endogenous agonist of the cannabinoid receptors (CB1 and CB2). It is an ester formed from omega-6-arachidonic acid and glycerol. |
| [<sup>3</sup>H]gabazine | |
| Lu AF21934 | |
| compound 34 [PMID: 20409708] | |
| [βAla<sup>8</sup>]neurokinin A-(4-10) | |
| Rec 15/3079 | |
| brucine <i>N</i>-oxide | |
| strychnine | |
| Cl-IB-MECA | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(3-36) (human) | |
| dipropyl-5-CT | |
| Rb<sup>+</sup> | |
| DOTA-BASS | |
| (3R)-6-{[2-(4-fluorophenyl)-4-(propan-2-yl)quinolin-3-yl]oxy}-3 5-dihydroxyhexanoate | |
| [Arg<sup>14</sup>Lys<sup>15</sup>]N/OFQ | |
| dimethylethylamine | |
| CGP 20712A | |
| meclizine | |
| {2-[3-(decyloxy)phenyl]-1-hydroxy-1-phosphonoethyl}phosphonic acid | |
| R-138727 | |
| [D-Arg<sup>1</sup> D-Trp<sup>7 9</sup> Leu<sup>11</sup>]substance P | |
| L-054 522 | |
| [Tyr<sup>8</sup>]bradykinin | |
| HMA | |
| 1 2 3-benzenetricarboxylic acid | |
| INS50589 | |
| FK-453 | |
| gingerol | A beta-hydroxy ketone that is 5-hydroxydecan-3-one substituted by a 4-hydroxy-3-methoxyphenyl moiety at position 1; believed to inhibit adipogenesis. It is a constituent of fresh ginger. |
| azacitidine | |
| LY404187 | |
| MRS2768 | |
| L-ornithine | An optically active form of ornithine having L-configuration. |
| esmolol | A carboxylic ester that is methyl 3-(4-hydroxyphenyl)propanoate in which the hydrogen attached to the phenoic hydroxy group is substituted by a 2-hydroxy-3-(isopropylamino)propyl group. A cardioselective and short-acting beta1 receptor blocker with rapid onset but lacking intrinsic sympathomimetic and membrane-stabilising properties, it is used as the hydrochloride salt in the management of supraventricular arrhythmias, and for the control of hypertension and tachycardia during surgery. |
| metoclopramide | A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine. |
| halothane | A haloalkane comprising ethane having three flouro substituents at the 1-position as well as bromo- and chloro substituents at the 2-position. |
| 5-oxo-ODE | |
| MRE 3010F20 | |
| [Ala<sup>6</sup> D-Trp<sup>8</sup>]galanin-(1-15)-ol | |
| ML169 | |
| (±)-<i>trans</i>-H<sub>2</sub>-PAT | |
| PCA 4248 | |
| dodecylphosphate | |
| 2MeSADP | |
| RHC80267 | |
| SQ-34919 | |
| T<sub>3</sub> | |
| FMS586 | |
| XCC | |
| PS020990 | |
| S24014 | |
| (S)-3-hydroxy-3-methylglutaryl-CoA | An acyl-CoA oxoanion that results from the removal of all five protons from the phosphate and carboxylic acid groups of (3S)-3-hydroxy-3-methylglutaryl-CoA. |
| [<sup>125</sup>I]ANP | |
| alkyl glycerol phosphate 18:1 | |
| [<sup>3</sup>H]maraviroc | |
| AGN194204 | |
| [<sup>3</sup>H]2MeSADP | |
| <i>N</i>-α-methylhistamine | |
| ONO-AE2-227 | |
| UVI3003 | |
| ezlopitant | |
| gevokizumab | |
| uPar fragment | |
| ischemin | |
| o-hydroxyatorvastatin | |
| zaleplon | A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position. |
| J20 (galanin analogue) | |
| TCPA | |
| PSN375963 | |
| ZK93426 | |
| CT-(8-32) (salmon) | |
| succinic acid | |
| MRS2500 | |
| [Leu<sup>31</sup> Pro<sup>34</sup>]NPY | |
| CPI-203 | |
| [<sup>11</sup>C]SB207145 | |
| PD168 077 | |
| lexacalcitol | |
| M242 | |
| MRS2690 | |
| VUF5574 | |
| bilobalide | A terpenoid trilactone found in extracts of Ginkgo biloba. |
| clomipramine | A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias. |
| MM54 | |
| A804598 | |
| AD5075 | |
| fluvoxamine | A 5-methoxyvalerophenone O-(2-aminoethyl)oxime that has formula C15H21F3N2O2. |
| [<sup>125</sup>I]VIP | |
| ρ-Da1a | |
| L-βγ-meATP | |
| 5-(2-ethoxyethyl)-5-[4-(4-fluorophenoxy)phenoxy]-1 3-diazinane-2 4 6-trione | |
| galanin(2–29) (rat/mouse) | |
| HEMADO | |
| BIM 23027 | |
| ergometrine | A monocarboxylic acid amide that is lysergamide in which one of the hydrogens attached to the amide nitrogen is substituted by a 1-hydroxypropan-2-yl group (S-configuration). An ergot alkaloid that has a particularly powerful action on the uterus, its maleate (and formerly tartrate) salt is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced. |
| NNC 11-1607 | |
| [<sup>3</sup>H]5-oxo-ETE | |
| [<sup>125</sup>I]CXCL10 | |
| 6-hydroxymelatonin | A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6. |
| aminoguanidine | A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide. |
| gemfibrozil | An aromatic ether that has formula C15H22O3. |
| [<sup>125</sup>I]CXCL11 | |
| 3 5-dihydroxybenzoic acid | A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 5. |
| compound 41 [PMID: 23434029] | |
| H-c[Cys-Phe-LAgl(N<sup>β</sup>Me benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH | |
| ALX40-4C | |
| (1-phosphonato-4-{4-[4-(trifluoromethyl)phenyl]phenyl}butyl)phosphonate | |
| risperidone | A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2. |
| [D-Tyr<sup>8</sup>]CYN 154806 | |
| SQ 26655 | |
| meclinertant | |
| goserelin | |
| (+)-ADTN | |
| MZ-4-181 | |
| cinnamic acid | A monocarboxylic acid that consists of acrylic acid bearing a phenyl substituent at the 3-position. It is found in Cinnamomum cassia. |
| [<sup>125</sup>I]CT (salmon) | |
| CV-1808 | |
| [Leu<sup>31</sup> Pro<sup>34</sup>]NPY (pig) | |
| (3R 5R)-7-[(1S 2S 3R 6S)-2-{[(2 2-dimethylbutanoyl)oxy]methyl}-6-methyl-3-propylcyclohexyl]-3 5-dihydroxyheptanoic acid | |
| AZD9272 | |
| compound 22 [PMID: 17276684] | |
| GW0742X | |
| compound 9 (PMID: 23517011) | |
| group E 1682-2106 [PMID:16118363] | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-[(11-phenoxyundecyl)oxy]-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| mitotane | |
| (+)-aceclidine | |
| dATP | A purine 2'-deoxyribonucleoside 5'-triphosphate having adenine as the nucleobase. |
| methocarbamol | |
| meso-DAP | |
| VU0424465 | |
| compound 10 [PMID: 22533316] | |
| A425619 | |
| VPC32183 | |
| GSK1331268 | |
| [<sup>125</sup>I]CT (human) | |
| methyl isocyanate | Methane modified by a single isocyanato substituent. |
| compound 26b [PMID: 16242323] | |
| 5 7-dichlorokynurenic acid | |
| PD-135666 | |
| 7β 25-dihydroxycholesterol | |
| SC-50998 | |
| paxilline | An organooxygen compound that has formula C27H33NO4. |
| morphanthridine | |
| A-803467 | |
| compound 20o [PMID:22984835] | |
| L-362 823 | |
| <i>N</i>-[<sup>3</sup>H]methylhistamine | |
| PGD<sub>3</sub> | |
| compound 22 [PMID: 19289283] | |
| S 16924 | |
| α-conotoxin MII | |
| picrotin | A furopyran that has formula C15H18O7. |
| 2MD | |
| [<sup>3</sup>H]darifenacin | |
| HC067047 | |
| [Phe<sup>8</sup> <i>ψ</i>(CH<sub>2</sub>-NH)Arg<sup>9</sup>]BK | |
| ELND006 | |
| A134974 | |
| zoledronic acid | |
| 1-oleoyl glycerol | A 1-monoglyceride where the acyl group is oleoyl. |
| pergolide | A diamine that is ergoline in which the beta-hydrogen at position 8 is replaced by a (methylthio)methyl group and the hydrogen attached to the piperidine nitrogen (position 6) is replaced by a propyl group. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used as the mesylate salt in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction. |
| [<sup>3</sup>H]spiperone | |
| 3-[4-(thiophen-2-yl)phenyl]-octahydropyrido[2 1-c]morpholin-3-ol | |
| spantide I | |
| R3-B1-22R | |
| A740003 | |
| hexocyclium | |
| isoamylamine | |
| [Trp<sup>7</sup> β-Ala<sup>8</sup>] neurokinin A-(4-10) | |
| lintitript | |
| phencyclidine | A member of the class of piperidines that is piperidine in which the nitrogen is substituted with a 1-phenylcyclohexyl group. Formerly used as an anaesthetic agent, it exhibits both hallucinogenic and neurotoxic effects. |
| VU0364770 | |
| EISAI-1 | |
| [Leu<sup>31</sup> Pro<sup>34</sup>]PYY (pig) | |
| galmic | |
| bumetanide | A member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated with congestive heart failure, hepatic and renal disease. |
| VUF8504 | |
| CGP 71872 | |
| L 755507 | |
| DC-EBIO | A dichlorobenzene that has formula C9H8Cl2N2O. |
| upamostat | |
| ginkgolide C | A diterpene lactone that has formula C20H24O11. |
| ginkgolide B | A diterpene lactone that has formula C20H24O10. |
| ginkgolide A | A diterpene lactone that has formula C20H24O9. |
| compound 24d [PMID: 23357634] | |
| clonazepam | 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation. |
| 12-epi LTB<sub>4</sub> | |
| methylphenidate | A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy. |
| sotalol | A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is sustituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. |
| MZ-5-192 | |
| pregnenolone sulphate | |
| 9-anthroic acid | An anthroic acid carrying the carboxy substituent at position 9. |
| SKF-76783 | |
| jingzhaotoxin-XI | |
| farnesyl diphosphate | A farnesyl phosphate that has formula C15H28O7P2. |
| rivenprost | |
| [<sup>3</sup>H]pemetrexed | |
| compound 23h [PMID:17929793] | |
| acetaldehyde | The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke. |
| RO4938581 | |
| dendrotoxin-1 | |
| abnormal cannabidiol | |
| ginkgolide X | |
| 2-arachidonyl glyceryl ether | |
| (R)-flurocarazolol | |
| PF-4840154 | |
| linifanib | |
| 2'-Me-CCPA | |
| (+)-MCPG | |
| (+)-butaclamol | An organic heteropentacyclic compound that is 2,3,4,4a,8,9,13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinoline substituted at position 3 by both hydroxy and tert-butyl groups. |
| SP203 | |
| resminostat | |
| polyIC | A mismatched double-stranded RNA with one strand being a polymer of inosinic acid, the other a polymer of cytidylic acid. |
| CH 275 | |
| 8S-HETE | A HETE having an (8S)-hydroxy group and (5Z)-, (9E)-, (11Z)- and (14Z)-double bonds. |
| BAY-73-1449 | |
| SNAP 398299 | |
| tafluprost | |
| d[Cha<sup>4</sup> Dab<sup>8</sup>]VP | |
| para-coumaric acid | |
| D-Nal Cys Tyr D-Trp Orn Val Cys Nal-NH<sub>2 </sub> | |
| compound 3 [PMID: 12470711] | |
| 2-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the 2 position on the ring. |
| SB 242084 | |
| L-165041 | |
| [Ile<sup>31</sup> Gln<sup>34</sup>]PP (human) | |
| PP-(20-36) (human) | |
| glemanserin | |
| N<sup>ω</sup>propyl-L-arginine | |
| A-349821 | |
| compound 18 [PMID: 21927650] | |
| TPI 1361-17 | |
| relcovaptan | |
| cicloprolol | |
| sufinpyrazone | |
| FUB 349 | |
| R-L3 | A benzodiazepine that has formula C25H20FN3O. |
| chenodeoxycholic acid | A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 7 respectively. |
| eburnamonine | An alkaloid that has formula C19H22N2O. |
| [<sup>3</sup>H]PSB-0413 | |
| [<sup>3</sup>H]rauwolscine | |
| SB236057 | |
| (-)-N-porphynorapomorphine | |
| LY379268 | |
| AZ505 | |
| (<i>S</i>)-cetirizine | |
| AS16 | |
| [<sup>3</sup>H]tiotidine | |
| L-779 976 | |
| MRS1505 | |
| PIP<sub>3</sub> | |
| ONO-AE3-240 | |
| CP-293019 | |
| sauvagine | |
| rosuvastatin | |
| cinnamaldehyde | The E (trans) stereoisomer of cinnamaldehyde, the parent of the class of cinnamaldehydes. |
| WIN 64338 | |
| R3(BΔ23-27)R/I5 chimeric peptide | |
| (+)-LSD | |
| BIM 23127 | |
| histaprodifen | |
| WAY-163909 | |
| TNP-ATP | A sprioketal resulting from the formal condensation of the 2'- and 3'- hydroxy groups of ATP with picric acid. |
| PF3845 | |
| norethisterone | A 17beta-hydroxy steroid that is testosterone in which the hydrogen at position 17 is replaced by an ethynyl group and in which the methyl group attached to position 10 is replaced by hydrogen. |
| eucalyptol | |
| daglutril | |
| H3-CoA-20 | |
| BAY 55-9837 | |
| OPC 4392 | |
| SQ-29548 | |
| pancuronium | A steroid ester in which a 5alpha-androstane skeleton is C-3alpha- and C-17beta-disubstituted with acetoxy groups and 2beta- and 16beta-disubstituted with 1-methylpiperidinium-1-yl groups. It is a non-depolarizing curare-mimetic muscle relaxant. |
| sufugolix | |
| [<sup>3</sup>H](Pyr<sup>1</sup>)[Met(0)11]-apelin-13 | |
| TAK-070 | |
| diethylstilbestrol | |
| RN1734 | |
| 6-Cl-MLT | |
| 3-MPPTS | |
| [<sup>3</sup>H]LTC<sub>4</sub> | |
| vincristine | A vinca alkaloid that has formula C46H56N4O10. |
| d[Cha<sup>4</sup>]AVP | |
| [<sup>125</sup>I]antisauvagine | |
| U75302 | |
| SIB-1893 | |
| formalin | |
| immethridine | |
| (4R)-6-{2-[4-(4-fluorophenyl)-6-phenyl-2-(propan-2-yl)pyridin-3-yl]ethyl}-4-hydroxyoxan-2-one | |
| d[Pen<sup>1</sup> Tyr(Me)<sup>2</sup>]AVP | |
| [D-Ala<sup>7</sup>]-angiotensin(1-7) | |
| RO5101576 | |
| LS-192629 | |
| compound 7 [PMID: 22533316] | |
| TAK 044 | |
| ximelagatran | A member of the class of azetidines that is melagatran in which the carboxylic acid group has been converted to the corresponding ethyl ester and in which the amidine group has been converted to the corresponding amidoxime. A prodrug for melagatran, ximelagatran was the first orally available direct thrombin inhibitor to be brought to market as an anticoagulant, but was withdrawn in 2006 following reports of it causing liver damage. |
| GW841819X | |
| GSK2210875 | |
| probenecid | |
| 7-epi-ginkgolide C | |
| tetrahydrodeoxycorticosterone | |
| lepirudin | |
| EP 171 | |
| NQN-1 | |
| [<sup>125</sup>I]DTyr-Gly-[(Nle28 31)CCK-26-33 | |
| naringin | |
| [<sup>3</sup>H]GlySar | |
| carveol | A limonene monoterpenoid that is cyclohex-2-en-1-ol substituted by a methyl group at position 2 and a prop-1-en-2-yl group at position 5. |
| isonipecotic acid | |
| salvinorin A | An organooxygen compound that has formula C23H28O8. |
| Pfizer compound 67 [PMID:18445527] | |
| diphenyltetrahydrofuran | |
| (-)-pindolol | A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol. |
| imipramine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom. |
| givinostat | |
| MRS1476 | |
| BOMA | |
| omeprazole | A racemate comprising equimolar amounts of (R)- and (S)-omeprazole. |
| [<sup>125</sup>I]kisspeptin-13 (human) | |
| selfotel | An alpha-amino acid that has formula C7H14NO5P. |
| M15 | |
| methoctramine | A tetramine that is N,N'-bis(6-aminohexyl)octane-1,8-diamine where the primary amino groups both carry 2-methoxybenzyl substituents. |
| [<sup>3</sup>H]melatonin | |
| compound 8g [PMID:21444206] | |
| spantide II | |
| netoglitazone | |
| MEL57A | |
| 5S-HPETE | An icosatetraenoic acid in which the double bonds are located at the 6-7, 8-9, 11-12, and 14-15 positions and have E, Z, Z, and Z geometry, respectively, and in which the pro-S hydrogen is substituted by a hydroperoxy group. |
| PKR-A | |
| compound 16 [PMID: 16242323] | |
| calcitonin (salmon recombinant) | |
| [<sup>125</sup>I][Phe<sup>13</sup> Tyr<sup>19</sup>]MCH | |
| ED-71 | |
| liraglutide | |
| 2-arachidonoylglycerolphosphoinositol | |
| SCH 57790 | |
| inositol 2 4 5-trisphosphate | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-LAN | |
| <i>N</i>-desalkylquetiapine | |
| beta-ergocriptine | |
| BRD9539 | |
| banyu (I) | |
| <i>N</i>-ethylhistamine | |
| BWA868C | |
| miconazole | A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes. |
| [<sup>18</sup>F]ET-1 | |
| [<sup>3</sup>H]mesulergine | |
| [<sup>125</sup>I]H3-B/INSL5 A chimera | |
| dVDAVP | |
| BgK | |
| L-764406 | |
| [<sup>11</sup>C]flumazenil | |
| EFWSLAAPQRF-NH<sub>2</sub> | |
| clidinium | The ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. |
| [<sup>3</sup>H]SCH-23390 | |
| (12E 20Z 18S)-8-hydroxyvariabilin | |
| allopurinol | A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring. |
| D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH<sub>2</sub> | |
| ATL802 | |
| ranatensin | |
| PHA-709829 | |
| AS94 | |
| [<sup>125</sup>I]Tyr<sup>10</sup>-CST14 | |
| [<sup>125</sup>I]iodophenpropit | |
| galanin(9-25) (rat/mouse) | |
| 2-hydroxy capric acid | |
| NE58062 | |
| SLIGKV-NH<sub>2</sub> | |
| eribulin | |
| RGFP966 | |
| μ-conotoxin PIIIA | |
| phenylephrine | A member of the class of the class of phenylethanolamines that is 2-(methylamino)ethanol substituted by a 3-hydroxyphenyl group at position 1. |
| [<sup>125</sup>I]CGP 23996 | |
| GaTx1 | |
| roxindole | A ring assembly that has formula C23H26N2O. |
| GaTx2 | |
| chlorpheniramine | |
| AR-C67085 | |
| OH-LVA | |
| lysophosphatidylserine | An acylglycerophosphoserine resulting from partial hydrolysis of a phosphatidylserine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl. |
| triptorelin | |
| vMIP-I | |
| palonosetron | |
| MCH (salmon) | |
| lorcaserin | |
| SB705498 | |
| N N`-bis-alkyl butylimmidazole 12b | |
| FR167344 | |
| GR 63799 | |
| [<sup>3</sup>H]SR48 968 | |
| PFI-1 | |
| NPY-(13-36) (human) | |
| xamoterol | |
| [<sup>3</sup>H]LTB4 | |
| econazole | A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. |
| GR64349 | |
| prinomastat | |
| ML221 | |
| naltrindole | An isoquinoline that has formula C26H26N2O3. |
| HmTx2 | |
| FG-5893 | |
| compound 2b-1 [PMID: 12614873] | |
| HmTx1 | |
| phenytoin | A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5. |
| ibotenate | |
| EIPA | |
| N<sup>4</sup>-phenylethoxycytidine-5′-triphosphate | |
| 7α-NHEt-ginkgolide B | |
| pimozide | |
| CP 99994 | |
| compound 3 [PMID: 9003518] | |
| NE97221 | |
| PD123319 | An imidazopyridine consisting of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine having 4-(dimethylamino)-3-methylbenzyl, diphenylacetyl and carboxy and groups at positions 1, 5 and 6 respectively |
| CPPZ | |
| BRL 37344 | |
| (R)-EF-1520 | |
| CPPG | |
| [<sup>111</sup>In]DOTA-NOC-ATE | |
| cyclo apelin-12 (1-12) | |
| phenobarbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups. |
| PRL-2915 | |
| methazolamide | |
| buprenorphine | A morphinane alkaloid that is 7,8-dihydromorphine 6-O-methyl ether in which positions 6 and 14 are joined by a -CH2CH2- bridge, one of the hydrogens of the N-methyl group is substituted by cyclopropyl, and a hydrogen at position 7 is substituted by a 2-hydroxy-3,3-dimethylbutan-2-yl group. |
| prostaglandin A2 | A prostaglandins A that has formula C20H30O4. |
| (1S 3R 4R 4aR 7S 8S)-4-[(benzylcarbamoyl)oxy]-8-{2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3 7-dimethyl-decahydronaphthalen-1-yl 2 2-dimethylbutanoate | |
| [<sup>19</sup>Lys <sup>26</sup>Leu]-galparan | |
| compound 15 [PMID:18178086] | |
| tropisetron | |
| zofenopril | |
| MK-0493 | |
| piretanide | |
| N-palmitoylethanolamine | |
| LAS38096 | |
| [<sup>125</sup>I]exendin | |
| sBmTX 3 | |
| perindopril | An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline |
| CP94253 | |
| compound 36 [PMID: 17936624] | |
| desloratadine | Loratadine in which the ethoxycarbonyl group attached to the piperidine ring is replaced by hydrogen. The major metabolite of loratidine, desloratadine is an antihistamine which is used for the symptomatic relief of allergic conditions including rhinitis and chronic urticaria. It does not readily enter the central nervous system, so does not cause drowsiness. |
| TCS 2510 | |
| N-stearyl-[Nle<sup>17</sup>]VIP | |
| enzastaurin | |
| LY-518674 | |
| UAMC00039 | |
| compound 16 (PMID:20947351) | |
| amisulpride | |
| sCKβ8-1 | |
| etidocaine | |
| [<sup>3</sup>H]rimonabant | |
| analog 3 | |
| trabectedin | A tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer. |
| RS 57639 | |
| LY2365109 | |
| VU0357121 | |
| GW848687X | |
| [D-Phe<sup>6</sup> β-Ala<sup>11</sup> Phe<sup>13</sup> Nle<sup>14</sup>]bombesin-(6-14) | |
| [<sup>3</sup>H]2-furoyl-LIGRL-NH<sub>2</sub> | |
| SEW2871 | |
| ML 10302 | |
| [des-Arg<sup>10</sup>]icatibant | |
| NPY-(22-36) (pig) | |
| (3R 5S 6E)-7-[5-(4-fluorophenyl)-2-(propan-2-yl)-4-(pyridin-3-yl)-1H-imidazol-1-yl]-3 5-dihydroxyhept-6-enoate | |
| 15(<i>S</i>)-15-methyl-PGD<sub>2</sub> | |
| curcumin | A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa. |
| captopril | A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug. |
| GHRH-(1-29)-OH (human) | |
| procaine | A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol. |
| [Leu<sup>31</sup> Pro<sup>34</sup>]PYY (human) | |
| butyric acid | A four-carbon straight-chain saturated fatty acid. |
| 15(<i>R</i>)-15-methyl-PGD<sub>2</sub> | |
| nefazodone | A triazole that has formula C25H32ClN5O2. |
| WAY-100635 | |
| compound 7 [PMID:20638279] | |
| NE58018 | |
| compound 15 (Hay <i>et al</i> 2013) | |
| neuromedin C (pig) | |
| NGB 2904 | |
| 2 2 2-TEMPS | |
| flupirtine | |
| AH23848 (racemic) | |
| [L-Tyr<sup>8</sup>]CYN 154806 | |
| ADX88178 | |
| CI-988 | |
| MRS2179 | |
| prenalterol | An aromatic ether that has formula C12H19NO3. |
| GSK1331258 | |
| [<sup>125</sup>I]L703 606 | |
| 7-trans-OH-PIPAT | |
| tazarotene | |
| palbociclib | |
| tryptamine | An aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position. |
| verapamil | A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine. |
| [1-(hydroxycarbamoyl)-4-(3-phenoxyphenyl)butyl]phosphonate | |
| [Ile<sup>5</sup> Trp<sup>23</sup> Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human) | |
| [<sup>3</sup>H]PGF<sub>2α</sub> | |
| [<sup>3</sup>H]CNQX | |
| pizotifen | A benzocycloheptathiophene that is 9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophene 4-ylidene)-1-methylpiperidine which is joined from the 4 position to the 4 position of an N-methylpiperidine moiety by a double bond. It is a sedating antihistamine, with strong serotonin antagonist and weak antimuscarinic activity. It is generally used as the malate salt for the treatment of migraine and the prevention of headache attacks during cluster periods. |
| [<sup>125</sup>I]GIP | |
| TEI-9647 | |
| netupitant | |
| artepillin C | |
| NODAGA-[Tyr<sup>3</sup>]-octreotide | |
| 264W94 | |
| saxagliptin | |
| resolvin D1 | A very long-chain fatty acid that has formula C22H32O5. |
| azimilide | An imidazolidine-2,4-dione that has formula C23H28ClN5O3. |
| VU0238429 | |
| resolvin D2 | A very long-chain fatty acid that has formula C22H32O5. |
| M1160 | |
| NPS 2143 | |
| 17β-estradiol | The 17beta-isomer of estradiol. |
| 1 25-dihydroxyvitamin D3 | |
| (<i>S</i>)-5-iodowillardiine | |
| galanin(1-16) (rat/mouse/pig) | |
| L-arginine | An L-alpha-amino acid that is the L-isomer of arginine. |
| β-scorpion toxin Css IV | |
| 12-hydroxyheptadecatrienoic acid | |
| compound 36 (PMID: 24000170) | |
| AC-42 | |
| CP376395 | |
| F15599 | |
| 3-MATIDA | |
| TMFO1 | |
| piperidine-4-sulphonic acid | |
| VUF8507 | |
| S36539 | |
| lysophosphatidylethanolamine | A glycerophosphoethanolamine resulting from partial hydrolysis of a phosphatidylethanolamine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl. |
| [<sup>11</sup>C]pyrilamine | |
| SP600125 | |
| clonidine | |
| isradipine | |
| MK-499 | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP | |
| MK-6096 | |
| galanin(D-Trp<sup>2</sup>) (pig) | |
| [<sup>3</sup>H]CCK-8 (human mouse rat) | |
| FLTChaAR | |
| 5-fluorotryptamine | |
| fMet-Met-Tyr-Ala-Leu-Phe | |
| [<sup>3</sup>H]GR 113808 | |
| all-trans-4-oxo-retinoic acid | A retinoid that consists of all-trans-retinoic acid bearing an oxo substituent at position 4 on the cyclohexenyl ring. |
| VU0152100 | |
| dopamine | Catechol in which the hydrogen at position 4 is substituted by a 2-aminoethyl group. |
| [<sup>3</sup>H](+)-<i>cis</i>-diltiazem | |
| IRL 1620 | |
| [D-Trp<sup>2</sup>]galanin-(1–29) | |
| SM-130 686 | |
| [<sup>3</sup>H]CPP | |
| atosiban | |
| 4α-PDD | |
| (3R 5R)-7-[4-(4-fluorophenyl)-2 5-dimethyl-1-phenyl-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| E4031 | A sulfonamide that has formula C21H27N3O3S. |
| 4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide | |
| LTB<sub>4</sub> | |
| LY-465608 | |
| AGN192093 | |
| 2-[<sup>125</sup>I]MLT | |
| L-750 667 | |
| 4α-PDH | |
| [<sup>3</sup>H](+)DOB | |
| [<sup>125</sup>I]NDP-MSH | |
| JV-1-10 | |
| felodipine | The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris. |
| (-)-Ro 363 | |
| [<sup>125</sup>I]CCL8 (human) | |
| adenosine-3'-5'-bisphosphate | |
| panitumumab | |
| evatanepag | |
| [<sup>3</sup>H]OSIP339391 | |
| helodermin | |
| [<sup>125</sup>I]PD151242 | |
| [<sup>3</sup>H]N<sup>5</sup>-methylfolate | |
| lithocholic acid | A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action. |
| BIM28011 | |
| zinterol | |
| α-conotoxin PnIA | |
| apixaban | A pyrazolopyridine that is 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide substituted at position 1 by a 4-methoxyphenyl group and at position 6 by a 4-(2-oxopiperidin-1-yl)phenyl group. It is used for the prevention and treatment of thromboembolic diseases. |
| 7-OH-DPAT | |
| JMV449 | |
| zoxazolamine | A benzoxazole that has formula C7H5ClN2O. |
| galanin(1-10) | |
| FR191413 | |
| d[<small>D</small>-Phe<sup>2</sup>]AVP | |
| hypoglaucin A | |
| tasimelteon | A member of the class of 1-benzofurans that is propionamide in which one of the amide hydrogens is replaced by a [(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl group. A melatonin receptor agonist used for the treatment of non-24-hour sleep-wake disorder. |
| levallorphan | |
| thiopental | A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups. |
| Ga-NODAGA-LM3 | |
| abarelix | A polypeptide compound composed of ten natural and non-natural amino acid resiudes in a linear sequence. |
| [<sup>3</sup>H]YM298198 | |
| 2-bromo-N-[(2S 3S)-4-[2-(2 4-dichlorophenyl)ethyl-[3-(1 3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-[3-(phenoxy)phenyl]butan-2-yl]-4 5-dimethoxybenzamide | |
| dihydrocarveol | |
| neuropeptide-α | |
| 5-methyl nicotinic acid | |
| SB209712 | |
| bosentan | |
| LY303336 | |
| [<sup>125</sup>I]NPY | |
| [<sup>3</sup>H]CGS19755 | |
| azilsartan | |
| VUF 8430 | |
| P05 | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| reactive blue-2 | An anthraquinone that has formula C29H20ClN7O11S3. |
| 5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid | |
| LY320954 | |
| risedronate | |
| MRS1042 | |
| [<sup>3</sup>H]XAC | |
| SB-611812 | |
| M35 | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14</sup>]PTH-(1-14)-NH2 | |
| N/OFQ-(1-13)-NH<sub>2</sub> | |
| [<sup>3</sup>H](-)CGP 12177 | |
| PP-(13-36) (human) | |
| (+)-isradipine | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-NOC | |
| [<sup>3</sup>H]muscimol | |
| TPA023 | |
| Ap<sub>4</sub>A | |
| 11-deoxy-PGE<sub>1</sub> | |
| neomycin | A broad-spectrum highly toxic antibiotic or mixture of antibiotics produced by a streptomyces (Streptomyces fradiae) and used medically especially to treat local infections. |
| [<sup>125</sup>I]BE-2254 | |
| analog 30 | |
| YM49598 | |
| cocaine | A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca. |
| THIIC | |
| [Arg<sup>19</sup>]PTH-(1-34) (human) | |
| [Phaa<sup>1</sup> <small>D</small>-Tyr<sup>2</sup> Val<sup>4</sup> Arg<sup>6</sup> Arg-NH<sub>2</sub><sup>9</sup>]AVP | |
| (<i>R</i>)-α-methylhistamine | |
| oleoyl-thiophosphate | |
| 20-HETE | A HETE that consists of arachidonic acid bearing a hydroxy substituent at position 20. |
| UR-PG136 | |
| (3R 5R)-7-[1-cyclohexyl-4-(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| [Sar<sup>1</sup> Ala<sup>8</sup>]Ang-II | |
| rolofylline | |
| atenolol | An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent. |
| hydroxyurea | A member of the class of ureas that is urea in which one of the hydrogens is replaced by a hydroxy group. An antineoplastic used in the treatment of chronic myeloid leukaemia as well as for sickle-cell disease. |
| RB-400 | |
| Gal-B2-C<sub>8</sub> | |
| trazodone | An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group. |
| CAY10583 | |
| zibotentan | |
| VU0366058 | |
| [des-Arg<sup>11</sup>]T-kinin | |
| rho-TIA | |
| [Ala<sup>31</sup> Aib<sup>32</sup>]NPY | |
| J-113397 | |
| spirapril | |
| diltiazem | A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension. |
| [<sup>3</sup>H]banyu (I) | |
| [<sup>3</sup>H]CCPA | |
| imidaprilat | |
| fluperlapine | A benzazepine that has formula C19H20FN3. |
| GW2433 | |
| [<sup>125</sup>I]sarafotoxin S6b | |
| orciprenaline | A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis. |
| VU0240382 | |
| [<sup>3</sup>H]Ro 63-0563 | |
| ruboxistaurin | |
| tenidap | A thiophene that has formula C14H9ClN2O3S. |
| heparin | A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1->4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule. |
| SB 612111 | |
| duramycin | A 19-membered heterodetic cyclic peptide that is isolated from Streptoverticillium cinnamoneus. It exhibits antiproliferative properties and induces apoptosis in tumour cells and has been used for treatment of cystic fibrosis. |
| TIPPψ | |
| AVT | A heterodetic cyclic peptide that is homologous to oxytocin and vasopressin. It is a pituitary hormone that acts as an endocrine regulator for water balance, osmotic homoeostasis and is involved in social and sexual behavior in non-mammalian vertebrates. |
| SSR126768A | |
| BPH-742 | |
| himbacine | A piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias. |
| fenofibrate | A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring. |
| farnesol | |
| (<i>S</i>)-α-methylhistamine | |
| [<small>D</small>-Bpa<sup>5</sup> Ile<sup>13</sup>]motilin (human) | |
| geraniol | A monoterpenoid consisting of two prenyl units linked head-to-tail and functionalised with a hydroxy group at its tail end. |
| [<sup>125</sup>I]GHRH (human) | |
| L-888 607 | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup>]OVT | |
| apomorphine | |
| [tBaa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> Val<sup>4</sup> Lys<sup>6</sup> Arg-NH<sub>2</sub><sup>8</sup> des-Gly<sup>9</sup>]AVP | |
| α5IA | |
| CHIPS | |
| lidocaine | The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. |
| SB 203186 | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| α-conotoxin AuIB | |
| LY134046 | |
| TAK-385 | |
| [<sup>3</sup>H]naltrindole | |
| [Tyr<sup>36</sup>]-PTHrP-(1-36) amide (human) | |
| adapalene | An adamantane that has formula C28H28O3. |
| 5BrUTP | |
| carbachol | An ammonium salt that has formula C6H15N2O2.Cl. |
| [<sup>3</sup>H]candesartan | |
| (+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4 5-dihydro-furan-2-carboxylic acid | |
| dihydrokainate | |
| levodopa | |
| RO1138452 | |
| Des-AA<sup>1 2 5 12 13</sup>-[D-Trp<sup>8</sup>]SRIF | |
| colchicine | An alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum. |
| cerlapirdine | |
| 7α-NHMe-ginkgolide B | |
| dibutyl phthalate | |
| F180 | |
| hydrogen {2-[decyl(methyl)sulfaniumyl]-1-phosphonoethyl}phosphonate | |
| ω-agatoxin IIIA | |
| AC263093 | |
| BRL50481 | |
| cyclo apelin-12 (7-12) | |
| (3R 5R)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-(propan-2-yl)-1H 4H 5H 6H 7H 8H-pyrrolo[2 3-c]azepin-2-yl]-3 5-dihydroxyheptanoate | |
| 4-(<i>n</i>-propyl)amino-3-nitrobenzoic acid | |
| promegestone | |
| ATPA | |
| KF26777 | |
| GT2394 | |
| methiothepin | A dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively). |
| M1152 | |
| [<sup>125</sup>I]sauvagine (frog) | |
| 3-benzyl-4-(cyclopropyl-(4-(2 5-dichlorophenyl)thiazol-2-yl)amino)-4-oxobutanoic acid | |
| bufotenine | |
| cyclothiazide | |
| candoxitrilat | |
| [<sup>125</sup>I]SB-236636 | |
| isovelleral | An aldehyde that has formula C15H20O2. |
| lorazepam | |
| biperiden | |
| [<sup>3</sup>H]LXA<sub>4</sub> | |
| L-659 699 | |
| [<sup>3</sup>H]nicotinic acid | |
| analog 31 | |
| [<sup>3</sup>H]GR 125 743 | |
| enalapril | A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). |
| vofopitant | |
| ephedrine | A phenethylamine alkaloid that is 2-phenylethanamine substituted by a methyl group at the amino nitrogen and a methyl and a hydroxy group at position 2 and 1 respectively. |
| rituximab | |
| GMQ | |
| charybdotoxin | |
| docetaxel | |
| trans flupenthixol | |
| 5S-HETE | A HETE having a (5S)-hydroxy group and (6E)-, (8Z)-, (11Z)- and (14Z)-double bonds. |
| [Bpa<sup>6</sup> Tyr<sup>10</sup>]secretin-27 (rat) | |
| ATC0175 | |
| PACAP-(6-38) | |
| TBPS | |
| compound 14c [PMID:18812259] | |
| compound 17 [PMID:17125263] | |
| adenosine | A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond. |
| 2-iodo-melatonin | |
| tiospirone | |
| 17-phenyl-<i>ω</i>-trinor-PGE<sub>2</sub> | |
| LY456066 | |
| SHAAGtide | |
| medica 16 | |
| J18 (galanin analogue) | |
| 3-(2 2-Bis-phosphono-ethyl)-5-decyloxy-1-methyl-pyridinium | |
| KB-R7943 | |
| compound 8 [PMID: 22533316] | |
| zacopride | |
| bambuterol | |
| dacomitinib | |
| MK-0249 | |
| WAY-100135 | |
| fampridine | |
| suprofen | |
| PTeB | |
| ASN04421891 | |
| Lei-Dab7 | |
| GHRP-6 | |
| triamcinolone | A C21-steroid hormone that is 1,4-pregnadiene-3,20-dione carrying four hydroxy substituents at positions 11beta, 16alpha, 17alpha and 21 as well as a fluoro substituent at position 9. Used in the form of its 16,17-acetonide to treat various skin infections. |
| Ga-KE88 | |
| FPTQ | |
| GHRP-2 | |
| S26284 | |
| I-BET-762 | |
| ASN04450772 | |
| tecalcet | |
| <i>cis</i>-3-ACPBPA | |
| LY341495 | |
| D-tryptophan | The D-enantiomer of tryptophan. |
| ocaperidone | |
| RS-25344 | |
| A-317920 | |
| clemastine | 2-[(2R)-1-Methylpyrrolidin-2-yl]ethanol in which the hydrogen of the hydroxy group is substituted by a 1-(4-chlorophenyl)-1-phenylethyl group (R configuration). An antihistamine with antimuscarinic and moderate sedative properties, it is used as its fumarate salt for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin conditions. |
| (-)-EKC | |
| desvenlafaxine | |
| [<sup>3</sup>H]U69593 | |
| compound 4b | |
| P2pal18s | |
| SKF-105494 | |
| indole-3-propionic acid | |
| CP 93129 | |
| icatibant | |
| [<sup>11</sup>C]volinanserin | |
| tetronothiodin | |
| latanoprost (free acid form) | |
| istradefylline | |
| dabuzalgron | |
| FTY720-phosphate | |
| disulfiram | An organic disulfide that is 1,1'-[disulfanediylbis(carbonothioylimino)]diethane substituted by ethyl groups at the N atom. An EC 1.2.1.3 [aldehyde dehydrogenase (NAD+)] inhibitor, it is used as an alcohol deterrent. |
| lanosterol | A tetracyclic triterpenoid that is lanosta-8,24-diene substituted by a beta-hydroxy group at position 3. It is the compound from which all steroids are derived. |
| sphingosine | A sphing-4-enine in which the double bond is trans. |
| belatacept | |
| AFDX384 | A pyridobenzodiazepine that acts as a selective antagonist of the muscarinic acetylcholine receptors. |
| (+)-SKF-82526 | |
| ibudilast | |
| chloropicrin | A C-nitro compound that is nitromethane in which all three hydrogens are replaced by chlorines. It is a severe irritant, and can cause immediate, severe inflammation of the eyes, nose and throat, and significant injuries to the upper and lower respiratory tract. Formerly stockpiled as a chemical warfare agent, it has been widely used in the US as a soil fumigant, particularly for strawberry crops. It is not approved for use within the European Union. |
| SYM2081 | |
| U63640 | |
| GRI977143 | |
| [<sup>3</sup>H]CGS8216 | |
| nitrendipine | |
| SR11237 | |
| AMA | |
| MCH<sub>6-17</sub> | |
| clofibrate | A carboxylic ester that is the ethyl ester of clofibric acid. |
| 7 4'-dihydroxyisoflavone | |
| HIV-Tat | |
| St 587 | |
| mesoridazine | |
| 6-fluoromevalonate 5-diphosphate | |
| VU0364289 | |
| (5E)-octadec-5-en-7 9-diynoic acid | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-({[(11-phenoxyundecyl)oxy]carbonyl}oxy)-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| enoxaparin | |
| AG-26 | |
| cilazapril | |
| pentostatin | |
| [<sup>125</sup>I][D-Tyr<sup>6</sup>]bombesin-(6-13)-methyl ester | |
| L-703 606 | |
| [<sup>3</sup>H]d[Cha<sup>4</sup>]AVP | |
| tamoxifen | A stilbenoid that has formula C26H29NO. |
| SB452533 | |
| GR 125487 | |
| L-731120 | |
| (-)-chlorpheniramine | |
| R396 | |
| lubiprostone | |
| resolvin E1 | A leukotriene that has formula C20H30O5. |
| ω-agatoxin IVB | |
| ω-agatoxin IVA | |
| BQCA | |
| 2 2'-pyridylisatogen tosylate | |
| OSK1-K16-D20 | |
| A778317 | |
| [<sup>3</sup>H]folinic acid | |
| EPPTB | |
| SCH-23390 | A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 7 and a hydroxy substituent at position 8. |
| SHU9119 | |
| pegvisomant | |
| varenicline | |
| ω-grammotoxin SIA | |
| MGS0028 | |
| tranylcypromine | An alkylamine that has formula C9H11N. |
| clorgiline | |
| [Asu7 23']β-ANP-(7-28) | |
| AS604872 | |
| indiplon | |
| GalR3ant | |
| JWH-133 | |
| calhex 231 | |
| NS1619 | A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca). |
| [<sup>3</sup>H]JNJ 7777120 | |
| ATX-II | |
| A-317567 | |
| (-)-baclofen | A monocarboxylic acid that is butanoic acid substituted by an amino group at position 4 and a 4-chlorophenyl group at position 3. It acts as a central nervous system depressant, GABA agonist and muscle relaxant. |
| D-phenylalanine | The D-enantiomer of phenylalanine. |
| beraprost | |
| OAADPR | |
| naloxonazine | |
| rhodamine123 | An organic chloride salt that has formula C21H17ClN2O3. |
| nolpitantium | |
| nalbuphine | An organic heteropentacyclic compound that has formula C21H27NO4. |
| vitamin D3 | |
| [<sup>125</sup>I][PP<sub>1-17</sub> Ala<sup>31</sup> Aib<sup>32</sup>]NPY (human) | |
| tesamorelin | |
| [Phe<sup>3</sup>]OT | |
| T140 | |
| (3R 5S 6E)-7-[4-(4-fluorophenyl)-2-[methyl(1-methyl-1H-1 2 3 4-tetrazol-5-yl)amino]-6-(propan-2-yl)pyrimidin-5-yl]-3 5-dihydroxyhept-6-enoate | |
| urantide | |
| S-14671 | |
| (RS)-5-diphosphomevalonate | |
| buserelin | |
| [<sup>3</sup>H]pyrilamine | |
| riluzole | |
| anandamide | A fatty amide obtained by the formal condensation of arachidonic acid with ethanolamine. |
| Ava3 | |
| 10-OBn-7α-F-gingkolide B | |
| LY2811376 | |
| (3S)-3-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propanoic acid | |
| ethylestrenol | |
| nalmefene | |
| CV-3988 | |
| BQ123 | A cyclic peptide that has formula C31H42N6O7. |
| ICI 192605 | |
| RS-30199 | |
| 1-isopropylbenzotriazole-5-carboxylic acid | |
| mibolerone | An androgen that is nalandrone carrying two methyl substituents at positions 7alpha and 17. |
| MRS5151 | |
| [<sup>3</sup>H]devazepide | |
| [<sup>125</sup>I](Pyr<sup>1</sup>)apelin-13 | |
| 5β-cholestane-3α 7α 12α-triol | A 12alpha-hydroxy steroid that has formula C27H48O3. |
| moclobemide | |
| A61603 | |
| GSK Compound 34 | |
| 2-furoyl-LIGRLO-amide | |
| PSN632408 | |
| L-lysine | An L-alpha-amino acid; the L-isomer of lysine. |
| fluoxymesterone | An anabolic androgenic steroid that has formula C20H29FO3. |
| diphosphoric acid | An acyclic phosphorus acid anhydride obtained by condensation of two molecules of phosphoric acid. |
| rose bengal (photoactivated) | |
| YM44778 | |
| JNJ16259685 | |
| UDP-galactose | |
| (1S 3R 4aR 7S 8S 8aS)-3-hydroxy-8-{2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-7-methyl-1 2 3 4 4a 7 8 8a-octahydronaphthalen-1-yl (2S)-2-methylbutanoate | |
| befetupitant | |
| [<sup>111</sup>In]DOTA-NOC | |
| <i>p</i>-MPPI | |
| peginterferon alfa-2b | |
| AC-7954 | |
| palosuran | |
| Ac-DEVD-CHO | |
| JTC-801 | |
| A2P5P | |
| [Phe<sup>13</sup> Tyr<sup>19</sup>]MCH | |
| UCCF-029 | |
| ceritinib | A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonylamino)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer. |
| diclofenamide | A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma. |
| GR159897 | |
| 5-(4-phenoxybutoxy)psoralen | |
| indisulam | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14</sup> Arg<sup>19</sup>]PTH-(1-28)-NH2 (human) | |
| INS48823 | |
| NE10790 | |
| [<sup>125</sup>I]aminopotentidine | |
| terutroban | |
| S36057 | |
| 5-ethyl-4-oxo-5-phenyl-4 5-dihydro-furan-2-carboxylic acid | |
| [nLeu<sup>13</sup> Glu<sup>14</sup>]motilin (human) | |
| α-conotoxin MI | |
| [<sup>3</sup>H]histidine | |
| YIL781 | |
| BI-2536 | |
| VU0469650 | |
| PF-04457845 | |
| <i>m</i>-CPP | |
| DIOA | |
| NF546 | |
| AYPGKF-NH2 | |
| imetit | An imidothiocarbamic ester that consists of isothiourea in which the thiol hydrogen is substituted by a 2-(imidazol-4-yl)ethyl group. An extremely potent, high affinity agonist at H3 and H4 receptors (Ki values are 0.3 and 2.7 nM respectively). Induces shape change in eosinophils with an EC50 of 25 nM. Centrally active following systemic administration. |
| Y27632 | A monocarboxylic acid amide that is trans-[(1R)-1-aminoethyl]cyclohexanecarboxamide in which one of the nitrogens of the aminocarbony group is substituted by a pyridine nucleus. It has been shown to exhibit inhibitory activity against Rho-associated protein kinase (ROCK) enzyme. |
| vMCC-I | |
| (-)-pentazocine | A benzazocine that has formula C19H27NO. |
| [<sup>125</sup>I]BIM23027 | |
| pyrilamine | |
| GYKI53655 | |
| CDDO-Me | |
| methacholine | |
| topiramate | A hexose derivative that is 2,3:4,5-di-O-isopropylidene-beta-D-fructopyranose in which the hydroxy group has been converted to the corresponding sulfamate ester. It blocks voltage-dependent sodium channels and is used as an antiepileptic and for the prevention of migraine. |
| MBP7 | |
| ONO-AE-248 | |
| L-731128 | |
| M-5MPEP | |
| decitabine | |
| [1 3-bis(2 4-dichlorophenyl)-2-phosphonopropan-2-yl]phosphonic acid | |
| SDZ 64-412 | |
| 1-methylcyclopropanecarboxylic acid | |
| BMS493 | |
| UFP-101 | |
| levomilnacipran | |
| Ag<sup>+</sup> | |
| Glaxo-11p | |
| BIM 23030 | |
| 5'-iodoresiniferatoxin | |
| NDT9520492 | |
| tranexamic acid | |
| MNI-137 | |
| salmeterol | |
| methylergonovine | |
| [(3-Ph-Pr<sup>6</sup>) His<sup>7</sup> D-Ala<sup>11</sup> D-Pro<sup>13</sup> ψ13-14) Phe<sup>14</sup>]bombesin-(6-14) | |
| veratridine | A steroid that has formula C36H51NO11. |
| ivermectin | A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice. |
| EBIO | |
| [<sup>125</sup>I]PYY | |
| EC18 | |
| EP 157 | |
| 9-hydroxyoctadecadienoic acid | |
| 2-APB | |
| ICI 118551 | An indane substituted at position 7 by a methyl group and at position 4 by a 3-(isopropylamino)-2-hydroxybutoxy group (the 2R,3S-diastereomer). |
| <i>trans</i>-3-ACPBPA | |
| [<sup>125</sup>I]gastrin | |
| DM-PPP | |
| DOG | |
| [<sup>3</sup>H]ketanserin | |
| nicorandil | |
| (±)YM796 | |
| D-AP4 | |
| clomiphene | A tertiary amine that has formula C26H28ClNO. |
| [<sup>125</sup>I]CXCL5 | |
| (4R)-6-[2-(4-fluorophenyl)-4 6-bis(propan-2-yl)phenoxymethyl]-4-hydroxyoxan-2-one | |
| [<sup>125</sup>I]kisspeptin-14 (human) | |
| sumanirole | |
| dexetimide | |
| T22 | |
| chroman 28 | |
| SZ(+)-(<i>S</i>)-202-791 | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(5-36) (human) | |
| MRK-1 | |
| MSOP | |
| iloprost | |
| octyl thiophosphatidic acid | |
| compound 1 [PMID: 22533316] | |
| Rec 15/2739 | |
| PF0998425 | |
| [D-Phe<sup>6</sup>]bombesin(6-13)methyl ester | |
| 3-amino-6 6-dimethyl-2-phenyl-8H-pyrano[4 5-e]pyridazine-4-carbonitrile | |
| ramucirumab | |
| galanin(1-19) (human) | |
| PD 176252 | |
| aplaviroc | |
| (+)-norfenfluramine | |
| aspirin | |
| anacardic acid | A hydroxybenzoic acid that has formula C22H36O3. |
| AM251 | |
| L-817 818 | |
| CCL20-SEAP(His)<sub>6</sub> | |
| KN62 | |
| MZ-4-71 | |
| L-363 301 | |
| mibefradil | |
| TC-5619 | |
| S6716 | |
| NAEPA | |
| L-741 626 | |
| A-119637 | |
| AM095 | |
| (R)-5-diphosphomevalonate | |
| 25-hydroxycholesterol | A 25-hydroxy steroid that has formula C27H46O2. |
| BIIE0246 | |
| XE991 | An anthracene that has formula C26H20N2O. |
| 24(S)-hydroxycholesterol | |
| 1-benzyl-N-(4-cyclohexylphenyl)-4-hydroxy-2-oxo-2 5-dihydro-1H-pyrrole-3-carboxamide | |
| RS-102895 | |
| [<sup>125</sup>I][Sar<sup>1</sup>]Ang-II | |
| sonepiprazole | |
| GR 218 231 | |
| 2MeSATP | |
| urotensin 1 (fish) | |
| iodoaminopotentidine | |
| Ki16425 | |
| AFD(R) | |
| aripiprazole | A quinolone that has formula C23H27Cl2N3O2. |
| SB 414240 | |
| pinacidil | |
| metoprolol | A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1. |
| compound 11d [PMID: 23981898] | |
| [<sup>125</sup>I]angiotensin-(1-7) | |
| L-368 930 | |
| [<sup>3</sup>H]CI977 | |
| AMPA | |
| 24(S) 25-epoxycholesterol | |
| R R-THC | |
| FK-480 | |
| B-9958 | |
| alendronate | |
| ABT-299 | |
| JMV180 | |
| L-glutamic acid | An optically active form of glutamic acid having L-configuration. |
| mocetinostat | |
| [<sup>125</sup>I]C5a (human) | |
| [<sup>3</sup>H]eprosartan | |
| [Ile<sup>5</sup> Glu<sup>19</sup>]PTHrP-(1-34) (human) | |
| [<sup>3</sup>H]DPDPE | |
| atorvastatin | A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases. |
| [<sup>125</sup>I]chorionic gonadotropin (human) | |
| fulvestrant | |
| albiglutide | |
| dantrolene | The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. |
| RM65 | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Ala-NH<sub>2</sub><sup>9</sup>]AVP | |
| crofelemer | |
| S38151 | |
| fluticasone | |
| gemcitabine | A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. |
| NC 8-12 | |
| isoxazole azepine compound 3 | |
| 5-CT | |
| A412997 | |
| compound 9a [PMID: 22266036] | |
| benzylserine | |
| labetalol | A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure. |
| rotigotine | |
| ARC-239 | |
| cyanopindolol | |
| onapristone | |
| [<sup>125</sup>I]α-bungarotoxin | |
| Rp-8-CPT-cGMPS | |
| PL017 | |
| TEI-9063 | |
| MGS0039 | |
| anti-BrP-LPA | |
| Ava5 | |
| Ba<sup>2+</sup> | |
| [<sup>11</sup>C]xanomeline | |
| [<sup>125</sup>I]CCL16 (human) | |
| S24773 | |
| PPADS | An azo compound that has formula C14H14N3O12PS2. |
| MF 498 | |
| hydroxycitronellal | The tertiary alcohol arising from addition of water across the C=C double bond of citronellal. |
| WAY200070 | |
| [Ava<sup>9 10</sup> Ava<sup>14 15</sup>]-Ac-hMCH<sub>6-16</sub>-NH2 | |
| PD 128907 | |
| rasagiline | |
| [Lys<sup>15</sup> Arg<sup>16</sup> Leu<sup>27</sup>]VIP-(1–7)/GRF-(8–27)-NH<sub>2</sub> | |
| MEN10627 | |
| [<sup>14</sup>C]metformin | |
| AM1241 | |
| MRS3558 | |
| DPCPX | An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group. |
| UTPγS | |
| GW803430 | |
| MTEB | |
| [<sup>3</sup>H]SSR149415 | |
| WIN35428 | |
| [<sup>125</sup>I]SQ-29548 | |
| 5-oxo-1-2-4-oxadiazol biphenyl | |
| [<sup>3</sup>H]HU-243 | |
| S22153 | |
| AR-C126313 | |
| AL-8810 | |
| cyanotriphenylborate | |
| nisoxetine | A secondary amino compound that is N-methyl-3-phenylpropan-1-amine substitued at position 3 by a 2-methoxyphenoxy group. |
| TIP39-(7-39) (mouse) | |
| epipregnanolone sulphate | |
| fondaparinux | A synthetic pentasaccharide which, apart from the O-methyl group at the reducing end of the molecule, consists of monomeric sugar units which are identical to a sequence of five monomeric sugar units that can be isolated after either chemical or enzymatic cleavage of the polymeric glycosaminoglycans heparin and heparan sulfate. |
| C089 | |
| [Leu<sup>13</sup>]motilin (human) | |
| (<i>S</i>)-4C3HPG | |
| anagrelide | A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions. |
| SR2640 | |
| mianserin | |
| testosterone propionate | A steroid ester that has formula C22H32O3. |
| 5-oxo-C20:3 | |
| [<sup>3</sup>H]folic acid | |
| ATC0065 | |
| [Gln<sup>8</sup>]GnRH | |
| mesalazine | |
| WB 4101 | |
| [His<sup>5</sup> <small>D</small>-Tyr<sup>6</sup>]GnRH | |
| phyllolitorin | |
| paracetamol | A phenol which has an acetamido substituent located para to the phenolic -OH group. |
| montelukast | An aliphatic sulfide that has formula C35H36ClNO3S. |
| GW7647 | A monocarboxylic acid that is 2-(phenylsulfanyl)isobutyric acid in which the phenyl group is substituted at the para- position by a 3-aza-7-cyclohexylhept-1-yl group in which the nitrogen is acylated by a (cyclohexylamino)carbonyl group. |
| amthamine | |
| chenodeoxycholyl-N<sup>ε</sup>-nitrobenzoxadiazol-lysine | |
| [<sup>125</sup>I]Tyr<sup>3</sup> SMS 201-995 | |
| 6-fluorotryptophan | |
| SiFA-Asn(AcNH-β-Glc)-Tyr³-octreotate | |
| vinpocetine | |
| SNC80 | |
| Gal-R2-dPEG<sub>24</sub> | |
| midazolam | |
| oxaprozin | |
| M1153 | |
| galanin(1-12) | |
| pindolol | A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol. |
| (+)-sulpiride | |
| senktide | |
| [<sup>33</sup>P]H2 relaxin | |
| A438079 | |
| bezafibrate | |
| basiliximab | |
| JV-1-41 | |
| [<sup>125</sup>I]PACAP-27 | |
| FK 224 | |
| NAAG | |
| (2S)-2-(2-benzyl-3-{[(1R)-1-{[(benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl}propanamido)-3-(1H-indol-3-yl)propanoic acid | |
| BI6015 | |
| AC-178 335 | |
| AG-14 | |
| M&B 28767 | |
| exendin-(9-39) | |
| teniposide | |
| 3-chlorotyrosine | |
| MRS2905 | |
| ezetimibe | A beta-lactam that is azetidin-2-one which is substituted at 1, 3, and 4 by p-fluorophenyl, 3-(p-fluorophenyl)-3-hydroxypropyl, and 4-hydroxyphenyl groups, respectively (the 3R,3'S,4S enantiomer). |
| exenatide | |
| VU0255035 | |
| CGP 56999A | |
| nandrolone | A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17. |
| ω-conotoxin GVIA | |
| T20(DP178) | |
| methylglyoxal | A 2-oxo aldehyde derived from propanal. |
| [<sup>3</sup>H]GSK931145 | |
| 7-hydroxycholesterol | |
| 1-OH-PGE<sub>1</sub> | |
| 4-[3-(2-fluorophenoxy)phenyl]-1-phosphonatobutane-1-sulfonate | |
| SB 215505 | |
| flavone | The simplest member of the class of flavones that consists of 4H-chromen-4-one bearing a phenyl substituent at position 2. |
| [Phe<sup>13</sup>]bombesin | |
| ranitidine | A member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease. |
| CI-1015 | |
| paclitaxel | A tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name 'taxol' is now limited, as Taxol is a registered trade mark. |
| PSB-0739 | |
| dihydromorphine | A morphinane alkaloid that has formula C17H21NO3. |
| compound 10 [PMID: 15482908] | |
| [<sup>3</sup>H]dexamethasone | |
| thioperamide | A primary aliphatic amine that has formula C15H24N4S. |
| [Leu<sup>8</sup> des-Arg<sup>9</sup>]bradykinin | |
| MT-II | |
| 2-iodoacetamide | |
| diphenylboronic anhydride | |
| LY314228 | |
| (3R)-6-({3-[bis(4-fluorophenyl)methyl]-1-(propan-2-yl)naphthalen-2-yl}oxy)-3 5-dihydroxyhexanoate | |
| diprenorphine | A morphinane alkaloid that has formula C26H35NO4. |
| [<sup>3</sup>H]LTE<sub>4</sub> | |
| CID2440433 | |
| 5-butyl-1H-pyrazole-3-carboxylic acid | |
| (2S)-N-[(2S 3R)-1-cyclohexyl-4 4-difluoro-3-hydroxy-4-{[(2S)-2-methylbutyl]carbamoyl}butan-2-yl]-2-[(2S)-2-[(morpholine-4-sulfonyl)amino]-3-phenylpropanamido]pent-4-enamide | |
| pristanic acid | A branched, long-chain saturated fatty acid composed of pentadecanoic acid having methyl substituents at the 2-, 6-, 10- and 14-positions. |
| 5-oxo-12-HETE | |
| quipazine | |
| furosemide | A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure. |
| NF157 | |
| GSK 172981 | |
| putrescine | A four-carbon alkane-alpha,omega-diamine. It is obtained by the breakdown of amino acids and is responsible for the foul odour of putrefying flesh. |
| CJ-042794 | |
| CP-195543 | |
| SGC0946 | |
| 2-chloroadenosine | |
| 2-[4-(1 3-benzothiazol-2-yl)phenyl]-4-methylmorpholin-2-ol | |
| tositumomab | |
| SB 216641 | |
| ribavirin | A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. An inhibitor of HCV polymerase. |
| phenprocoumon | |
| compound (+)17a [PMID:20363624] | |
| DkTx | |
| dimethyl-W84 | |
| MRS4062 | |
| RP-69758 | |
| Ro 60-0175 | |
| [<sup>3</sup>H]RY80 | |
| teriparatide | |
| RF9 | |
| EXP3174 | |
| pravastatin | A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin. |
| olodaterol | A member of the class of benzoxazine that is 6-hydroxy-1,4-benzoxazin-3-one in which the hydrogen at position 4 is replaced by a (1R)-1-hydroxy-2-{[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino}ethyl group. Used (as its hydrochloride salt) for long-term treatment of airflow obstruction in patients with chronic obstructive pulmonary disease including chronic bronchitis and/or emphysema. |
| glycopyrrolate | |
| VU0400195 | |
| asenapine | |
| famotidine | A guanidine that has formula C8H15N7O2S3. |
| [<sup>35</sup>S]non-peptide OT antagonist | |
| L-796 778 | |
| [p-aminoPhe6]ang II | |
| CID1792197 | |
| olvanil | |
| denopamine | |
| 2-amino-uridine-5'-monophosphate | |
| CP-481 715 | |
| RO5488608 | |
| pegfilgrastim | |
| RU28362 | |
| H<sup>+</sup> | |
| aspirin-triggered resolvin D1 | |
| indacaterol | |
| D-kynurenine | |
| europium-labelled H2 relaxin | |
| senicapoc | |
| U46619 | |
| SK1-I | |
| H3 relaxin analogue 3 | |
| N-[{3-(3-trifluoromethyl-4-fluorophenyl)isoxazol-5-yl}methyl]-4-([1 8]naphthyridin-2-yl)butyramide | |
| 13 14-dihydro-15-keto-PGD<sub>2</sub> | |
| 16 16-dimethyl-PGE<sub>2</sub> | |
| AUY954 | |
| SDZ-216525 | |
| Cs<sup>+</sup> | |
| nafarelin | |
| 8-OH-DPAT | A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively |
| 6-tert-butyl-<i>m</i>-cresol | |
| (-)-cyclazocine | |
| methyl salicylate | A benzoate ester that is the methyl ester of salicylic acid. |
| MRS1066 | |
| MRS1067 | |
| MRS1065 | |
| MRS1062 | |
| [<sup>125</sup>I]kisspeptin-10 (human) | |
| VU0092273 | |
| bicuculline | Bicuculline is a light-sensitive competitive antagonist of GABAA receptors. It was originally identified in 1932 in plant alkaloid extracts and has been isolated from Dicentra cucullaria, Adlumia fungosa, Fumariaceae, and several Corydalis species. |
| SB-649868 | |
| dNPA | |
| [Mpa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> <small>D</small>-Tic<sup>7</sup> <small>D</small>-Tic<sup>9</sup>]OT | |
| oxotremorine | A N-alkylpyrrolidine that has formula C12H18N2O. |
| [<sup>125</sup>I]Tyr<sup>11</sup>-SRIF-14 | |
| tezampanel | |
| GHRH-(1-29)-NH<sub>2</sub> (human) | |
| cetrorelix | |
| CD2665 | |
| JMV3008 | |
| aniracetam | |
| Met-Met-Trp-Leu-Leu | |
| L-163 101 | |
| galantamine | |
| AD-5061 | |
| [<sup>3</sup>H]digoxin | |
| milameline | |
| mevastatin | A carboxylic ester that is pravastatin that is lacking the allylic hydroxy group and in which the lactone moiety has been hydrolysed to the corresponding delta-hydroxy-carboxylic acid. A hydroxymethylglutaryl-CoA reductase inhibitor (statin) isolated from Penicillium citrinum and from Penicillium brevicompactum, its clinical use as a lipid-regulating drug ceased following reports of toxicity in animals. |
| PSB1114 | |
| EPZ004777 | |
| calcitriol-26 23-lactone | A steroid lactone that has formula C27H40O5. |
| CRA1000 | |
| 8-deoxy-neodysiherbaine | |
| quisqualate | |
| SB 206553 | A pyrroloindole that has formula C17H16N4O. |
| gaboxadol | |
| SB399885 | |
| [<sup>125</sup>I]CCL1 (human) | |
| (+)-chlorpheniramine | |
| isopulegol | |
| T0901317 | |
| YF-476 | |
| silahexocyclium | |
| β-FNA | A morphinane alkaloid that has formula C25H30N2O6. |
| [Ga-DOTA Tyr<sup>3</sup> Thr<sup>8</sup>]octreotide | |
| CP105696 | |
| 2-thioUTP | |
| (R)-N-oleoyltyrosinol | |
| {[hydroxy({[(2E 6Z)-3 7 11-trimethyldodeca-2 6 10-trien-1-yl]oxy}methyl)phosphoryl]methyl}phosphonic acid | |
| SMP-797 | |
| 7α 27-dihydroxycholesterol | |
| bromfenac | Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure. |
| [<sup>125</sup>I]CXCL16 | |
| Pb<sup>2+</sup> | |
| esomeprazole | A 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole that has S configuration at the sulfur atom. An inhibitor of gastric acid secretion, it is used (generally as its sodium or magnesium salt) for the treatment of gastro-oesophageal reflux disease, dyspepsia, peptic ulcer disease, and Zollinger-Ellison syndrome. |
| [<sup>125</sup>I]INSL3 (human) | |
| BIM 23023 | |
| CPFPX | |
| ω-PnTx3-3 | |
| cilobradine | |
| [D-Trp<sup>11</sup>]neurotensin | |
| UDP-β-S | |
| fexofenadine | A piperidine-based anti-histamine compound. |
| mozavaptan | |
| VER-3323 | |
| TIP39-(7-39) (human/bovine) | |
| ATPγS | |
| [<sup>3</sup>H]d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP | |
| axitinib | |
| UDP | A pyrimidine ribonucleoside 5'-diphosphate that has formula C9H14N2O12P2. |
| [Leu<sup>8</sup>]-phyllolitorin | |
| VU0359516 | |
| NF449 | |
| (<i>RS</i>)-(tetrazol-5-yl)glycine | |
| histamine | A 1H-imidazol-4-yl group substituted at position C-4 by a 2-aminoethyl group. |
| RVX 208 | |
| compound 22d [PMID: 16242323] | |
| (5E 9E)-6 10 14-trimethyl-1-phosphonatopentadeca-5 9 13-triene-1-sulfonate | |
| JMV458 | |
| spiroxatrine | |
| [<sup>3</sup>H]SR49059 | |
| silodosin | |
| [D-Pro<sup>4</sup> D-Trp<sup>7 9 10</sup>]substance P (4-11) | |
| L-797 591 | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup> Val<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| N-{3-[(3R)-5-amino-3-methyl-3 6-dihydro-2H-1 4-oxazin-3-yl]-4-fluorophenyl}-5-chloro-3-methylpyridine-2-carboxamide | |
| linsitinib | |
| WWGKKYRASKLGLAR | |
| [<sup>35</sup>S]ibutamoren | |
| pyrrolopyrimidine 48 | |
| mecamylamine | |
| (+)-<i>cis</i>-H<sub>2</sub>-PAT | |
| rivaroxaban | |
| MRS1486 | |
| Sch 202596 | |
| daratumumab | |
| DC 23-60 | |
| nifedipine | A dihydropyridine that has formula C17H18N2O6. |
| Hg<sup>2+</sup> | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-OC | |
| flumazenil | A 1,4-benzodiazepine that has formula C15H14FN3O3. |
| nalfurafine | |
| K41498 | |
| chlorobenzylidene malononitrile | |
| terbutaline | A member of the class of phenylethanolamines that is catechol substuted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group. |
| irbesartan | |
| grifolic acid methyl ether | |
| tacalcitol | |
| SDF-1 1-9[P2G] dimer | |
| hyperforin | A sesquarterpenoid that has formula C35H52O4. |
| phenylglycine-01 | |
| ARP100 | |
| BMS-561392 | |
| NPY-(16-36) (pig) | |
| sumatriptan | A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). |
| CFTR<sub>inh</sub>-172 | |
| R5-HIV-1 gp120 | |
| ME67 | |
| β-scorpion toxin Cn2 | |
| [<sup>3</sup>H]alniditan | |
| AH23848 | |
| [N-Me des-Sar]Gal-B2 | |
| KRP 203-phosphate | |
| [<sup>33</sup>P]2MeSADP | |
| [<sup>125</sup>I][cPP(1-7) NPY(19-23) Ala<sup>31</sup> Aib<sup>32</sup> Gln<sup>34</sup>]hPP | |
| MZ-4-243 | |
| WAY-207024 | |
| [(pF)Phe<sup>4</sup>]N/OFQ-(1-13)-NH<sub>2</sub> | |
| WIN 62 577 | |
| piperine | A N-acylpiperidine that is piperidine substituted by a (1E,3E)-1-(1,3-benzodioxol-5-yl)-5-oxopenta-1,3-dien-5-yl group at the nitrogen atom. It is an alkaloid isolated from the plant Piper nigrum. |
| TAK-220 | |
| ML9 | |
| Trp<sup>11</sup>-neurotensin | |
| SB202190 | A member of the class of imidazoles that is 1H-imidazole in which the hydrogens at positions 2, 4, and 5 are replaced by 4-hydroxyphenyl, pyridin-4-yl, and 4-fluorophenyl groups, respectively. It is a widely used inhibitor of mitogen-activated protein kinase (MAPK) alpha and beta. |
| TUG-770 | |
| misoprostol (free acid form) | |
| SCH 37370 | |
| SB 228357 | An indolyl carboxylic acid that has formula C22H17F4N3O2. |
| DCDPC | |
| HMR-1556 | A 1-benzopyran that has formula C15H20N2O4S. |
| 1-palmitoyl-lysophosphatidylcholine | |
| Rhodei-litorin | |
| NIP-142 | |
| SB-706375 | |
| Z-WEHD-FMK | |
| MC148R | |
| L-362 855 | |
| peginesatide | |
| [<sup>125</sup>I]PP (human) | |
| [<sup>3</sup>H]SCH 58261 | |
| SR59230A | |
| [Nle<sup>8 18</sup> Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (bovine) | |
| pralatrexate | |
| F2L-[<sup>125</sup>I]Tyr | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup>]AVP | |
| MRS2365 | |
| PAT5A | |
| TC14012 | |
| GIP-(10-30) | |
| BC-254 | |
| lacosamide | |
| valsartan | |
| desipramine | A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group. |
| aflibercept | |
| Ro20-1724 | |
| ORG2058 | |
| ofatumumab | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Phe(3<sup>125</sup>I 4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT | |
| NPY-(26-36) (pig) | |
| LG100268 | |
| 2-MPP | |
| 13 14-dihydro-16-<i>m</i>-chlorophenoxy-<i>w</i>-tetranor-PGF<sub>1α</sub> | |
| AGN193109 | |
| promazine | |
| AS1907417 | |
| correolide | A hydroxy steroid that has formula C40H52O15. |
| BOC-ATE | |
| 7α-NH<sub>2</sub>-ginkgolide B | |
| [<sup>3</sup>H]4NMPB | |
| FR-181157 | |
| levocabastine | |
| visnagin | An oxacycle that has formula C13H10O4. |
| [<sup>125</sup>I][Leu<sup>31</sup> Pro<sup>34</sup>]NPY | |
| lithocholylcholine | |
| aminobenzovesamicol | |
| dioctanoy​lglycerol​ pyrophos​phate | |
| AZD6538 | |
| practolol | |
| [<small>L</small>-Bpa<sup>5</sup> Ile<sup>13</sup>]motilin (human) | |
| 4-(9-ethyl-9H-carbazol-3-yl)-1-phosphonatobutane-1-sulfonate | |
| PAMP-12 (human) | |
| cilostamide | |
| AM281 | |
| tannic acid | |
| Teijin-lead_cmp_5 | |
| monomethylfumarate | |
| (<i>R S</i>)-PHPNECA | |
| LY-510929 | |
| VU0285683 | |
| genistein | 7-Hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties. |
| AMN082 | |
| antisauvagine | |
| [<sup>14</sup>C]acetylCoA | |
| sertraline | A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder. |
| E339-3D6 | |
| [D-Ala<sup>2</sup>]deltorphin I | |
| S26131 | |
| NE10575 | |
| OL135 | |
| RO5166017 | |
| [<sup>3</sup>H]eletriptan | |
| L-367 938 | |
| compound 17 [PMID: 15300839] | |
| FL104 | |
| [<sup>125</sup>I]SHU9119 | |
| compound 27 [PMID:20346665] | |
| NCFP | |
| BCTC | |
| tacrine | |
| bromocriptine | An indole alkaloid that has formula C32H40BrN5O5. |
| [<sup>3</sup>H]R214127 | |
| Hp(2-20) | |
| GSK931145 | |
| clotrimazole | A member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to a nitrogen is replaced by a monochlorotrityl group. |
| suramin | |
| NE58043 | |
| rilonacept | |
| atomoxetine | A secondary amino compound having methyl and 3-(2-methylphenoxy)-3-phenylpropan-1-yl substituents. |
| TC-2403 | |
| FR194921 | |
| 15S-HPETE | The (S)-enantiomer of 15-HPETE. |
| [<sup>125</sup>I]thyroxine | |
| alkyl OMPT | |
| [D-Trp<sup>8</sup>]γ-MSH | |
| binodenoson | |
| A-794282 | |
| [D-Trp<sup>12</sup> Tyr<sup>34</sup>]PTH-(7-34) (bovine) | |
| [Ser<sup>8</sup>]GnRH | |
| dabigatran | An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amoino group of N-pyridin-2-yl-beta-alanine. The active metabolite of the prodrug dabigatran etexilate, it acts as an anticoagulant which is used for the prevention of stroke and systemic embolism. |
| PF-543 | |
| [<sup>125</sup>I]iodovinyl-TBZ | |
| [<sup>125</sup>I]ABOPX | |
| bromo-deaza-SAH | |
| daltroban | |
| (±)-<i>cis</i>-2-CAMP | |
| MRS2279 | |
| [<sup>3</sup>H]MRS2279 | |
| (3R 5S 6E)-7-[1-cyclohexyl-4-(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyhept-6-enoate | |
| SNAP-7941 | |
| indanidine | |
| compound 4d (PMID: 21851057) | |
| zalospirone | |
| BAY27-9955 | |
| iturelix | |
| compound 6o [PMID:19524438] | |
| compound 4a | |
| ADX-47273 | |
| [<sup>125</sup>I]XCL1 | |
| wortmannin | A delta-lactone that has formula C23H24O8. |
| [<sup>2</sup>Ala]-galparan | |
| reglitazar | |
| picrotoxin | |
| GSK575594A | |
| RS67506 | An aromatic ether that is the 3,5-dimethoxybenzyl derivative of N-(2-{4-[3-(4-amino-5-chloro-2-hydroxyphenyl)-3-oxopropyl]piperidin-1-yl}ethyl)methanesulfonamide. A potent and selective 5-HT4 antagonist, with a pKi of 9.1 at 5-HT4 receptors in guinea pig striatal membranes and greater than 1000-fold selectivity over 5-HT1A, 2C, 3 and D1, D2, M1, M2, AT1, B1 and alpha1C receptors. The ketone group gives RS 39604 a relatively long half life; it is also orally active and so suitable for in vivo studies. |
| Ac-GRP-(20-26)-methylester | |
| L-AP4 | |
| 1-arylmethylpyrrolidin-2-yl ethanol amine | |
| alemtuzumab | |
| afatinib | A quinazoline compound having a 3-chloro-4-fluoroanilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an (S)-tetrahydrofuran-3-yloxy group at the 7-position. Used (as its dimaleate salt) for the first-line treatment of patients with metastatic non-small cell lung cancer. |
| DADLE | |
| NN-dimethyl-D-erythrosphingosine | |
| N-oleoyldopamine | A fatty amide that has formula C26H43NO3. |
| S20928 | |
| decavanadate | |
| PYY-(3-36) (pig) | |
| isoguvacine | A tetrahydropyridine that has formula C6H9NO2. |
| perindoprilat | |
| 4-{dimethyl[5-(4-phenylphenyl)pentyl]azaniumyl}butane-1-sulfonate | |
| atopaxar | |
| cortisol | A C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the stress hormone as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses |
| PG 97-269 | |
| LY301875 | |
| BPH-715 | |
| leuprolide | An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty. |
| [<sup>3</sup>H]nemonapride | |
| conivaptan | |
| ponatinib | |
| HTMT | |
| difluprednate | |
| forasartan | |
| venlafaxine | A tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-methoxyphenyl group. |
| melagatran | A member of the class of azetidines that is (2S)-azetidine 2-carboxylic acid in which the carboxylic acid has been converted to the amide corresponding to formal condensation with 4-(aminomethyl)benzenecarboximidamide and in which the hydrogen attached to the azetidine nitrogen is replaced by a (2R)-2-cyclohexyl-2-[(carboxymethyl)amino]acetyl group. |
| β-phenylethylamine | |
| <i>N</i>-methylhistamine | |
| [<sup>3</sup>H]OT (human mouse rat) | |
| [Ile<sup>5</sup>]PTHrP-(1-36) (human) | |
| [Arg<sup>16</sup>]chicken secretin | |
| pazopanib | |
| [<sup>125</sup>I]ZM-241385 | |
| [<sup>3</sup>H]cytisine | |
| 7-fluorochromone-2-carboxamide | |
| peptidoglycan | A glycosaminoglycan formed by alternating residues of D-glucosamine and either muramic acid {2-amino-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose} or L-talosaminuronic acid (2-amino-2-deoxy-L-taluronic acid), which are usually N-acetylated or N-glycoloylated. The carboxyl group of the muramic acid is commonly substituted by a peptide containing residues of both L- and D-amino acids, whereas that of L-talosaminuronic acid is substituted by a peptide consisting of L-amino acids only. |
| vilazodone | |
| farglitazar | |
| reboxetine | |
| MPEP | |
| LUF5831 | |
| E55888 | |
| (1S 2S 3S 4S)-3 4-bis({butyl[(4-phenoxyphenyl)methyl]carbamoyl})cyclobutane-1 2-dicarboxylic acid | |
| ICI 169369 | |
| 2' 3'-ddATP | |
| compound 11a [PMID: 14697765] | |
| dilazep | |
| [<sup>3</sup>H]SB-674042 | |
| [<sup>125</sup>I][Tyr<sup>26</sup>]galanin (human) | |
| beclometasone dipropionate | |
| U46609 | |
| CGP37849 | |
| paroxetine | A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo. |
| alfuzosin | A tetrahydrofuranol that has formula C19H27N5O4. |
| compound 23 [PMID: 17590335] | |
| BX 667 | |
| galanin(7-29) (pig) | |
| TG-101348 | |
| VPC44116 | |
| methyl 4-[4-(2-{3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl}ethynyl)-3-(prop-2-en-1-yl)phenyl]butanoate | |
| I-BOP | |
| propanoic acid | |
| [<sup>3</sup>H]kainate | |
| NS309 | |
| L023103 | |
| [<sup>3</sup>H]S0139 | |
| moexipril | |
| sivelestat | |
| ethyl 2-[4-(2-{3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl}ethynyl)phenyl]acetate | |
| MSVIII-19 | |
| grifolic acid | |
| pemetrexed | |
| diphenhydramine | An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. |
| VU0240551 | |
| frovatriptan | |
| CGS 24012 | |
| [(2S 3aS 7aS)-2-(1 3-thiazolidine-3-carbonyl)-2 3 3a 4 5 6 7 7a-octahydroindol-1-yl]-[(1R 2R)-2-phenylcyclopropyl]methanone | |
| bevacizumab | |
| α-scorpion toxin | |
| eticlopride | |
| flecainide | |
| latanoprost (isopropyl ester) | |
| BMS compound 87b | |
| [<sup>3</sup>H]MRS1754 | |
| L-165461 | |
| barasertib-hQPA | |
| [<sup>123</sup>I]AM251 | |
| ICI 174 864 | |
| PHTPP | |
| 12S-HPETE | The (S)-enantiomer of 12-HPETE. |
| [<sup>3</sup>H]Ro154513 | |
| MPC-MECA | |
| [<sup>3</sup>H]R1881 | |
| desoximetasone | Dexamethasone in which the hydroxy group at the 17alpha position is substituted by hydrogen. A synthetic corticosteroid with glucocorticoid activity, it is used as an anti-inflammatory and anti-pruritic in the treatment of various skin disorders, including skin allergies and psoriasis. |
| BPH-628 | |
| [D-Phe<sup>6</sup> Cpa<sup>14</sup> ψ13-14]bombesin-(6-14) | |
| pioglitazone | A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity. |
| (D-Ala<sup>11</sup>]bombesin | |
| [Trp<sup>8</sup>]GnRH | |
| 19(<i>R</i>)-OH-PGE<sub>2</sub> | |
| retinol | A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraen-1-ol substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified). |
| azidopine | A benzamide that has formula C27H26F3N5O5. |
| L-369 020 | |
| 6-fluoro-noradrenaline | |
| FR173657 | |
| [<sup>125</sup>I]Tyr<sup>7</sup>-Sst3-ODN-8 | |
| GR-55562 | |
| testolactone | |
| [<sup>125</sup>I]SDF-1β (human) | |
| [<sup>3</sup>H]Lys-[des-Arg<sup>9</sup>]BK | |
| isothiourea-1t | |
| motilin-(1-13) (human) | |
| geranyl biphosphonate | |
| Ro 25-1553 | |
| IKs124 | |
| citral | |
| NaHS | |
| sildenafil | |
| saralasin | |
| L-363 409 | |
| spironolactone | A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7. |
| avagacestat | |
| PHA-543613 | |
| P'-geranyl 3 5 7-trihydroxy-3-methylheptanate 7-diphosphate | |
| BW723C86 | |
| SB-219994 | |
| SB-219993 | |
| (3R 6E)-7-[6-chloro-4-(4-fluorophenyl)-2-(propan-2-yl)quinolin-3-yl]-3 5-dihydroxyhept-6-enoate | |
| 2-({[(3-{[(2E)-3 7-dimethylocta-2 6-dien-1-yl]oxy}phenyl)methyl]carbamoyl}(hydroxy)amino)-2-methylpropanoate | |
| compound 23 [PMID:21444206] | |
| JMV594 | |
| 2-methyl-2-propanyl 1'-(3-pyridinyl)-4 4'-bipiperidine-1-carboxylate | |
| BIM 23050 | |
| sarpogrelate | |
| 3-bromo-7NI | |
| [Sar<sup>1</sup> Cha<sup>8</sup>]Ang-II | |
| XD14 | |
| fenoterol | |
| [<sup>125</sup>I][Nle<sup>8 21</sup> Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (rat) | |
| [<sup>3</sup>H]iloprost | |
| compound 27 [PMID: 20598884] | |
| dolichol phosphate | |
| antarelix | |
| 5PAM523 | |
| (3S)-4-{[(E)-2-[1-(4-fluorophenyl)-3-(propan-2-yl)-1H-indol-2-yl]ethenyl](hydroxy)phosphoryl}-3-hydroxybutanoic acid | |
| erlotinib | |
| L-aspartate | An aspartate(2-) that is the conjugate base of L-aspartate(1-). |
| tertatolol | |
| LP-403812 | |
| niflumic acid | |
| [<sup>3</sup>H]AF DX-384 | |
| GALP(1-32) (human) | |
| BMS pyrazole inhibitor 7f | |
| [<sup>3</sup>H]N/OFQ | |
| prucalopride | |
| (des 1-8) A-chain INSL3 analogue | |
| [<sup>3</sup>H]LSD | |
| X4-HIV-1 gp120 | |
| MK 0354 | |
| compound 29 [PMID:17064898] | |
| infliximab | |
| P'-geranyl 2-fluoromevalonate 5-diphosphate | |
| 3 5-dimethyl PPP | |
| 2-pyridylethylamine | An aminoalkylpyridine that is pyridine substituted by a ethanamino group at position 2. |
| linoleic acid | An octadecadienoic acid in which the two double bonds are at positions 9 and 12 and have Z (cis) steeochemistry. |
| [<sup>3</sup>H]S-145 | |
| [<sup>3</sup>H]zolpidem | |
| super cinnamaldehyde | |
| [<sup>125</sup>I]TSH | |
| DMCM | |
| ML204 | |
| 4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-1-(1 3-dihydroisoindol-2-yl)butane-1 4-dione | |
| i-Boc-Met-Leu-Phe | |
| MCCG | |
| CL82198 | |
| chlorothiazide | 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension. |
| UTP | A pyrimidine ribonucleoside 5'-triphosphate having uracil as the nucleobase. |
| L-CCG-I | |
| (R)-PIA | |
| diflorasone diacetate | The 17,21-diacetate derivative of diflorasone. It is used topically for its anti-inflammatory and antipruritic properties in the treatment of various skin disorders. |
| [<sup>3</sup>H]SQ-29548 | |
| eflornithine | |
| TFLLR-NH<sub>2</sub> | |
| iloperidone | |
| α-conotoxin TxIA | |
| RWJ-56110 | |
| compound 4b [PMID:16099654] | |
| glibenclamide | |
| t-Boc-Met-Leu-Phe | |
| T21/DP107 | |
| GSK2606414 | |
| KOS1326 | |
| Ro64-6198 | |
| sphingosine kinase inhibitor | |
| B-9858 | |
| YSFKPMPLaR | |
| F peptide | |
| (4S 6S)-6-{2-[1-benzyl-5-(4-fluorophenyl)-3-(propan-2-yl)-1H-pyrazol-4-yl]ethyl}-4-hydroxyoxan-2-one | |
| [<sup>125</sup>I]ET-1 | |
| <i>S</i>-OOPP | |
| SEAP-XCL1 | |
| NS-220 | |
| MRS1088 | |
| escitalopram | |
| [<sup>125</sup>I]APNEA | |
| BTP2 | |
| Ip<sub>5</sub>I | |
| NAD | |
| L-366 682 | |
| [Bpa<sup>1</sup> Ile<sup>13</sup>]motilin (human) | |
| L-citrulline | The L-enantiomer of citrulline. |
| gemtuzumab ozogamicin | |
| compound 3 [PMID:21310611] | |
| GW1100 | |
| formoterol | |
| [<sup>3</sup>H]alanine | |
| A-794278 | |
| fasidotrilat | |
| (D-Thr<sup>6</sup> D-Trp<sup>8 9</sup>)galanin(1-15)ol | |
| ketamine | A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. |
| 3-hydroxy-3-methyl-6-phosphohexanoic acid | |
| I-SAP | |
| TRV120027 | |
| L838417 | |
| SKF 89748 | |
| [des-Gly<sup>10</sup> <small>D</small>-Ala<sup>6</sup>]GnRH <i>N</i>-ethylamide | |
| VU0029767 | |
| WAY170523 | |
| imidapril | |
| RU 24969 | |
| Abbott 14c | |
| d-AP5 | |
| aclidinium | |
| SF-01 | |
| AC262970 | |
| PNU-282987 | |
| (+)-SCH-23390 | A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 7 and a hydroxy substituent at position 8. |
| R214127 | |
| aconitine | A diterpenoid that is 20-ethyl-3alpha,13,15alpha-trihydroxy-1alpha,6alpha,16beta-trimethoxy-4-(methoxymethyl)aconitane-8,14alpha-diol having acetate and benzoate groups at the 8- and 14-positions respectively. |
| NPY-(18-36) (human pig) | |
| flunisolide | A cyclic ketal that has formula C24H31FO6. |
| IIK7 | |
| 2-(3-iodophenyl)histamine | |
| pseudechetoxin | |
| 12R-HETE | A HETE having a (12R)-hydroxy group and (5Z)-, (8Z)-, (10E)- and (14Z)-double bonds. |
| 2-(3-bromophenyl)histamine | |
| buspirone | An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the nitrogen atom. |
| alpha1-proteinase inhibitor | |
| osanetant | |
| [<sup>125</sup>I][Glp<sup>65</sup>Nle<sup>75</sup> Tyr<sup>77</sup>]apelin-13 | |
| PPTN | |
| BrP-LPA | |
| W54011 | |
| [Sar<sup>1</sup> Cha<sup>4</sup>]Ang-II | |
| compound 19 [PMID:18812259] | |
| erythromycin-A | An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively. |
| [<sup>3</sup>H]BSP | |
| [<sup>3</sup>H]ZM 241385 | |
| 2-oleoyl-LPA | |
| scriptaid | |
| H<sub>2</sub>O<sub>2</sub> | |
| Ro19-4603 | An organosulfur heterocyclic compound that has formula C15H17N3O3S. |
| 3 5-DHPG | |
| [<sup>14</sup>C]GlySar | |
| maurotoxin | |
| enadoline | |
| fluparoxan | |
| GW9578 | |
| PA451 | |
| drotrecogin alfa | |
| quinine | A cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. |
| CGEN-856 | |
| SKF-75670 | |
| 6-n-octylaminouracil | |
| [<sup>3</sup>H]SP (human mouse rat) | |
| BAYK 8644 | A dihydropyridine that has formula C16H15F3N2O4. |
| flufenamate | |
| MK-5435 | |
| LY503430 | |
| MRE-269 | |
| WRWWWW | |
| 1 6-hexamethylene diisocyanate | |
| spiramide | An azaspiro compound that consists of 1,3,8-triazaspiro[4.5]decan-4-one having a phenyl group attached to N-1 and a 3-(4-fluorophenoxy)propyl attached to N-8. Selective 5-HT antagonist, which binds to 5-HT2 sites as potently as spiperone but has lower affinity for 5-HT2C receptors. Also a high affinity D2 receptor antagonist (Ki = 3 nM). Lacks the disruptive effect of spiperone on animal behaviour. |
| THG213.29 | |
| (3R 5S 6E)-7-[1-(4-fluorophenyl)-2-phenyl-4-(propan-2-yl)-1H-imidazol-5-yl]-3 5-dihydroxyhept-6-enoate | |
| ibuprofen | A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. |
| CP-339818 | An aminoquinoline that has formula C21H24N2. |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-(tetradecyloxy)-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| Des-AA<sup>1 5</sup>-[Tyr<sup>2</sup> D-Trp<sup>8</sup> IAmp<sup>9</sup>]SRIF | |
| UCL1684 | An aminoquinoline that has formula C34H30N4. |
| miglitol | |
| acipimox | |
| DFGYVAE | |
| remogliflozin | |
| <i>cis</i>-10 [PMID: 15771457] | |
| MF266-1 | |
| IP<sub>3</sub> | |
| 5-Cl-5-deoxy-(±)-ENBA | |
| all-<i>trans</i>-retinal | |
| [<sup>3</sup>H]LY341495 | |
| 13 14-dihydro-PGE<sub>1</sub> | |
| Gal-B2-C<sub>14</sub> | |
| N-[(1R)-1-(N'-cyano-N N'-dimethylhydrazinecarbonyl)-2-(2-methylpropanesulfonyl)ethyl]benzamide | |
| ONO-AE1-259 | |
| SCH 40338 | |
| MPDT | |
| α-helical CRF | |
| propylthiouracil | |
| alniditan | |
| AFT-II | |
| kallstroemin D | |
| GR 196429 | |
| RO116-4875/608 | |
| BMS compound 4c | |
| (3R 5R)-7-[5-(3-fluorophenyl)-1-(4-fluorophenyl)-4-oxo-3-(propan-2-yl)-3H 4H 5H-pyrrolo[2 3-c]quinolin-2-yl]-3 5-dihydroxyheptanoate | |
| foropafant | |
| acifran | |
| MHC binding peptide | |
| CL316243 | |
| tropicamide | |
| org 12962 | |
| [<sup>18</sup>F]altanserin | |
| ASN04885796 | |
| RS 116 0086 | |
| SB 204070 | |
| denufosol | |
| mifepristone | |
| Pfizer compound 11 [PMID:18445527] | |
| NMDA | |
| JMV1431 | |
| sarafotoxin S6b | |
| sarafotoxin S6c | |
| muromonab-CD3 | |
| carboxyatractyloside | |
| bivalirudin | |
| NS1643 | |
| [<sup>125</sup>I]LTT-SRIF-28 | |
| Bc-III | |
| GSK126 | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(2-36) (human) | |
| ulipristal acetate | A 20-oxo steroid obtained by acetylation of the 17-hydroxy group of (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-ol (ulipristal). A selective progesterone receptor modulator, which is employed as an emergency contraceptive. |
| [(3E 7E)-4 8 12-trimethyl-1-phosphonatotrideca-3 7 11-trien-1-yl]phosphonate | |
| SC-51322 | |
| ketoprofen | An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2. |
| FR139317 | |
| A-71623 | |
| PF-04418948 | |
| NPC 18565 | |
| AC187 | |
| SNAP 37889 | |
| ifetroban | |
| 2-hexynyl-NECA | |
| 2-[4-(4-bromophenyl)phenyl]-4-methyl-octahydro-2H-1 4-benzoxazin-2-ol | |
| [<sup>125</sup>I]CGP 71872 | |
| 7α-F-ginkgolide B | |
| JNJ17203212 | |
| tacrolimus | |
| [D-Cys(<sup><i>t</sup></i>Bu)<sup>5</sup>]NPS | |
| [<sup>125</sup>I]PYY (pig) | |
| PG01037 | |
| drospirenone | |
| ricolinostat | |
| morin | A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5. |
| BP-CCL3 | |
| [<sup>3</sup>H]WAY100635 | |
| UR-PG55B | |
| (-)-SKF-82526 | |
| NPY-(3-36) (pig) | |
| [<sup>3</sup>H](-)devapamil | |
| W-84 | |
| dihydroergocryptine | |
| reserpine | An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. |
| compound 58 [PMID:21273063] | |
| GYKI53784 | |
| AC262620 | |
| [Pro<sup>3</sup>]GIP | |
| [<sup>3</sup>H]Tyr<sup>14</sup>-N/OFQ | |
| aza-THIP | |
| [<sup>3</sup>H]hemicholinium-3 | |
| NIHP | |
| UCL1848 | |
| piroxicam | A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine. |
| 3-[2-(4-phenylphenyl)ethyl]-1-azabicyclo[2.2.2]octane | |
| [<sup>3</sup>H]NPVF | |
| N-methyl scopolamine | |
| CFMMC | |
| dasatinib | |
| [Ile<sup>5</sup>]PTHrP-(1-34) (human) | |
| 1-[17-(1 5-dimethyl-hexyl)-3-hydroxy-4 4 10 13-tetramethyl-1 2 3 4 5 6 9 10 11 12 13 15 16 17-tetradecahydro-cyclopenta[a]phenanthren-14-yl]-ethanone | |
| LY255283 | |
| L-365260 | A benzodiazepine that has formula C24H22N4O2. |
| MK-212 | |
| compound 24 [PMID: 23374867] | |
| (3S)-4-({2-[2-(4-fluoro-3-methylphenyl)-4-methyl-6-(propan-2-yl)phenyl]ethyl}(hydroxy)phosphoryl)-3-hydroxybutanoic acid | |
| RO4868443 | |
| SB328437 | |
| CGP 47656 | |
| compound 10i [PMID: 23084894] | |
| OSIP339391 | |
| golimumab | |
| [<sup>3</sup>H]L158809 | |
| compound 20f [PMID:21536438] | |
| [Ile<sup>5</sup>]PTHrP-(1-36) | |
| BX 471 | |
| BN-81 674 | |
| Ro 04-6790 | |
| (3R 5S 6E)-7-[2 3-bis(4-fluorophenyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3 5-dihydroxyhept-6-enoic acid | |
| brucine | A monoterpenoid indole alkaloid that has formula C23H26N2O4. |
| SR48527 | |
| [<sup>125</sup>I]PTA-OH | |
| aminoglutethimide | |
| nadolol | Nadolol is a diastereoisomeric mixture consisting of equimolar amounts of the four possible 2,3-cis-isomers of 5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol. |
| AR231453 | |
| EMDT | |
| doxorubicin | An anthracycline antibiotic that has formula C27H29NO11. |
| (2-{4-[(E)-2-phenylethenyl]phenoxy}ethyl)(2-phenylpropyl)amine | |
| AF353 | |
| JMV2004 | |
| loxapine | A dibenzoxazepine that has formula C18H18ClN3O. |
| NS5818 | |
| α-conotoxin RgIA | |
| methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1 2 4-triazole-3-carboxylate | |
| 7β 27-dihydroxycholesterol | |
| dithiipin-1 1 4 4-tetroxide analogue 7 | |
| GLP-2-(1-29) (rat) | |
| haloperidol | A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety. |
| theophylline | A dimethylxanthine having the two methyl groups located at positions 1 and 3. It is structurally similar to caffeine and is found in green and black tea. |
| A-841720 | |
| otenzepad | |
| MRS1220 | |
| V3 peptide | |
| PSB603 | |
| canakinumab | |
| GW1929 | A benzophenone that has formula C30H29N3O4. |
| MK-678 | |
| L742791 | |
| maltotriose-[<sup>125</sup>I][Tyr<sup>3</sup> Thr<sup>8</sup>]octreotide | |
| KW-3635 | |
| [<sup>3</sup>H]52770 RP | |
| PD-135158 | |
| melatonin | A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. |
| PIK-93 | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-6-(dodecyloxy)-4 7-dihydroxy-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| maxadilan | |
| (pyridin-3-ylmethyl)[(2E 6E)-3 7 11-trimethyldodeca-2 6 10-trien-1-yl]amine | |
| oleanolic acid | A pentacyclic triterpenoid that is olean-12-en-28-oic acid substituted by a beta-hydroxy group at position 3. |
| S-5751 | |
| PSB36 | |
| [<sup>3</sup>H]UBP310 | |
| cANF<sup>4-23</sup> | |
| trifluoperazine | A member of the class of phenothiazines that is phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position. |
| (+)-adrenaline | A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen. |
| pregnenolone-16α-carbonitrile | A nitrile that has formula C22H31NO2. |
| LY86057 | |
| anatibant | |
| [<sup>3</sup>H]resiniferatoxin | |
| GSK-264220A | |
| empagliflozin | A C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
| tertiapin | |
| ramelteon | |
| atropine | A racemate composed of equimolar concentrations of (S)- and (R)-atropine . It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. |
| [<sup>125</sup>I][Tyr<sup>4</sup>]bombesin | |
| α.β-methylene-2-thio-UDP | |
| metergoline | |
| MRS1132 | |
| substance P-(4-11) | |
| d-CCPene | |
| M871 | |
| Gal-B2 | |
| [<sup>3</sup>H]aldosterone | |
| 4-hydroxy​tamoxifen | |
| 5-(nonyloxy)-tryptamine | A tryptamine derivative that consists of serotonin bearing an additional O-nonyl substituent. 5-HT1B selective agonist, several times more potent than sumatriptan and inactive as a 5-HT1A agonist (Ki at 5-HT1B = 1 nM, selectivity over 5-HT1A > 300-fold). |
| acrolein | An enal that is prop-2-ene with an oxo group at position 1. |
| digoxin | Digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small. |
| LY2886721 | |
| alprenolol | |
| 4-APPES | |
| (-)-aceclidine | |
| N1-(2-Phenylethyl)-2R)-2-{[4-chorobenzoyl)-hydrazino] carboxamido}3-(1H-3-indolyl)propanamide | |
| AMP-PNP | An adenosine 5'-phosphate that has formula C10H17N6O12P3. |
| AHPN | |
| [<sup>3</sup>H]RP62203 | |
| [<sup>125</sup>I][Tyr<sup>26</sup>]galanin (pig) | |
| (4R)-6-{2-[chloro(cyclohexyl)methyl]-4 6-dimethylphenoxymethyl}-4-hydroxyoxan-2-one | |
| saclofen | |
| GW409544 | A monocarboxylic acid that has formula C31H30N2O5. |
| Gal-B5 | |
| MRS1084 | |
| bexarotene | |
| xestospongin C | |
| Z-VEID-FMK | |
| LY2087101 | |
| compound 21 [PMID:21185185] | |
| lumiracoxib | An amino acid that is phenylacetic acid which is substituted at position 2 by the nitrogen of 2-chloro-6-fluoroaniline and at position 5 by a methyl group. A highly selective cyclooxygenase 2 inhibitor, it was briefly used for the treatment of osteoarthritis, but was withdrawn due to concersns of hepatotoxicity. |
| spermidine | A triamine that is the 1,5,10-triaza derivative of decane. |
| [<sup>3</sup>H]MCH (human mouse rat) | |
| [(6E)-7 11-dimethyl-1-phosphonododeca-6 10-dien-1-yl]phosphonic acid | |
| romidepsin | |
| T0070907 | |
| muscimol | A member of the class of isoxazoles that is 1,2-oxazol-3(2H)-one substituted by an aminomethyl group at position 5. It has been isolated from mushrooms of the genus Amanita. |
| salicylic acid | A monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves. |
| cyclohexylmethyl-(1-p-tolyl-1H-indol-3-ylmethyl)-amine | |
| AMTB | |
| α-methylnoradrenaline | A catecholamine that has formula C9H13NO3. |
| [<sup>3</sup>H]dDAVP | |
| iodoproxyfan | |
| omalizumab | |
| oxybutynin | An acetylenic compound that has formula C22H31NO3. |
| [Pro<sup>34</sup>]NPY | |
| plumbagin | A naphthoquinone that is 1,4-naphthoquinone in which the hydrogens at positions 2 and 5 are substituted by methyl and hydroxy groups, respectively. |
| ML233 | |
| PTHrP-(1-21)/PTH-(22-34) (human) | |
| (3S)-4-({[2-(4-fluoro-3-methylphenyl)-4-methyl-6-(propan-2-yl)phenyl]methoxy}(hydroxy)phosphoryl)-3-hydroxybutanoic acid | |
| NBI-59159 | |
| vilanterol | An dichlorobenzene derivative that is used in the form of its trifenate salt for treatment of chronic obstructive pulmonary disease. |
| [Mpa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> <small>D</small>-Tic<sup>7</sup>]OT | |
| 6-aminocaproic acid | |
| MPPG | |
| BIM 23313 | |
| LSN2463359 | |
| [<sup>125</sup>I]GLP-1-(7-36)-amide | |
| methylfurmethide | |
| CGP 23996 | |
| PG 99-465 | |
| ibrutinib | A member of the class of acrylamides that is (3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine in which the piperidine nitrogen is replaced by an acryloyl group. A selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase, it is used for treatment of B-cell malignancies. |
| plerixafor | |
| benzoquinone | |
| apratastat | |
| [D-Tpi<sup>6</sup> Leu<sup>13</sup> ψ(CH<sub>2</sub>NH)-Leu<sup>14</sup>]bombesin-(6-14) | |
| 5-MeOT | |
| [<sup>125</sup>I]GRP (human) | |
| compound 7d (PMID:19111466) | |
| bosutinib | |
| XD25 | |
| EP<sub>4</sub>A | |
| ZK118182 | |
| linaclotide | |
| metyrapone | |
| [1-fluoro-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid | |
| CGP 35348 | |
| Ro 48-8071 | |
| A-71915 | |
| 4-methyl-2-[4-(thiophen-2-yl)phenyl]morpholin-2-ol | |
| terguride | |
| GB88 | |
| [Met<sup>5</sup>]dynorphin-(1-17) | |
| 5-HEAT | |
| rilapladib | |
| motilin-(1-12) (human) | |
| heme | A heme is any tetrapyrrolic chelate of iron. |
| (3R 5S 6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3 5-dihydroxyhept-6-enoic acid | |
| SC-51089 | |
| undecanoic acid | A straight-chain, eleven-carbon saturated medium-chain fatty acid found in body fluids; the most fungitoxic of the C7:0 - C18:0 fatty acid series. |
| [Bz-Phe6]U-II (human) | |
| myristic acid | A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat. |
| pegaptanib | |
| [<sup>125</sup>I][Tyr<sup>11</sup>]des-Br-NPB-23 | |
| LY215840 | |
| FK-788 | |
| E7 | |
| chelerythrine | A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae. |
| dromostanolone propionate | A steroid ester that has formula C23H36O3. |
| cyclo(7-12) Des-AA<sup>1 2 5</sup>-[Glu<sup>7</sup> D-Trp<sup>8</sup> IAmp<sup>9</sup> m-I-Tyr<sup>11</sup> hhLys<sup>12</sup>]SRIF | |
| 27-hydroxycholesterol | |
| 3-[2-(4-phenylphenyl)ethynyl]-1-azabicyclo[2.2.2]octan-3-ol | |
| SC-19220 | |
| NPA | |
| terazosin | A piperazine that has formula C19H25N5O4. |
| BN 50739 | |
| progesterone | A C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species. |
| clozapine | A benzodiazepine that is 5H-dibenzo[b,e][1,4]diazepine substituted by a chloro group at position 8 and a 4-methylpiperazin-1-yl group at position 11. It is a second generation antipsychotic used in the treatment of psychiatric disorders like schizophrenia. |
| mallotoxin | |
| ivacaftor | |
| ecopipam | |
| prochlorperazine | A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position. |
| SF-11 | |
| 15-deoxy-Δ-12 14-prostaglandin J2 | A prostaglandin J derivative comprising prostaglandin J2 lacking the 15-hydroxy group and having C=C double bonds at the 12- and 14-positions. |
| rifamycin SV | |
| MBP10 | |
| israpafant | |
| luzindole | |
| imiloxan | |
| compound 18 [PMID: 17723296] | |
| JV-1-37 | |
| vildagliptin | |
| panobinostat | |
| [Tyr<sup>34</sup>]PTH-(1-34) (human) | |
| thioguanine | |
| nivolumab | |
| SB 243213 | An indolyl carboxylic acid that has formula C22H19F3N4O2. |
| [<sup>125</sup>I]AB-MECA | |
| PGJ<sub>2</sub> | |
| WX-UK1 | |
| PRL-2970 | |
| BAY 367620 | |
| ocinaplon | |
| [<sup>18</sup>F]FPIT | |
| SR120819A | |
| casopitant | |
| μ-conotoxin GIIIA | |
| org 37684 | |
| [<sup>3</sup>H]naloxone | |
| SB 207710 | |
| caffeine | A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. |
| SC-41930 | |
| GR 113808 | An indolyl carboxylate ester obtained by formal condensation between the carboxy group of 1-methylindole-3-carboxylic acid with the hydroxy group of N-{2-[4-(hydroxymethyl)piperidin-1-yl]ethyl}methanesulfonamide. |
| garcinol | A monoterpenoid that has formula C38H50O6. |
| YM44781 | |
| NKY80 | |
| FD-1 | |
| wFw-Isn-NH<sub>2</sub> | |
| OPC-21268 | |
| gG-2p20 | |
| eledoisin | |
| isothiourea-1a | |
| BMY 45778 | A bisoxazole that has formula C26H18N2O5. |
| 2 4-epi-neodysiherbaine | |
| 4 9-anhydro-tetrodotoxin | |
| 3-pyridine-acetic acid | |
| pamoic acid | A dicarboxylic acid that has formula C23H16O6. |
| borneol | |
| CYM-5442 | |
| zinc pyrithione | A zinc coordination entity that has formula C10H8N2O2S2Zn. |
| compound 8 [PMID: 20598884] | |
| muscarine | A monosaccharide that has formula C9H20NO2. |
| compound 3a [PMID:16099654] | |
| ACTH-(1-24) | |
| S-EMCA | |
| joro toxin | |
| Ro 40-6055 | |
| etalocib | |
| CTEP | |
| ALX 1393 | |
| frescolat ML | |
| compound 4 [PMID:22984835] | |
| Ac-RYYRWK-NH<sub>2</sub> | |
| suvorexant | An aromatic amide obtained by formal condensation of the carboxy group of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid with the secondary amino group of 5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole. An orexin receptor antagonist used for the management of insomnia. |
| PD 165929 | |
| belinostat | A hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. |
| WAY-213613 | |
| <i>N</i>-1-isopropyl-5-MeOT | |
| (+)-SK&F10047 | |
| phosphatidyl (3 5) inositol biphosphate | |
| cyproheptadine | The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia. |
| tiratricol | |
| [<sup>3</sup>H]mazindol | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Tyr(3<sup>125</sup>I)-NH<sub>2</sub><sup>9</sup>]OVT | |
| BzATP | |
| CGP 64213 | |
| NBTGR | |
| J-104123 | |
| HCl | |
| [<sup>3</sup>H]ETB-TBOA | |
| meperidine | |
| MRS2298 | |
| L-735021 | |
| agomelatine | |
| [<sup>125</sup>I][His<sup>9</sup>]ghrelin (human) | |
| SM-32504 | |
| EKC | |
| clofarabine | |
| compound 53 [PMID: 23434029] | |
| (2S 4R 5S 6S)-2-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-2-carbamoyl-4-({[(2E 4S 6S)-4 6-dimethyloct-2-enoyl]oxy}methyl)-5-hydroxy-1 3-dioxane-4 5 6-tricarboxylic acid | |
| BILL 260 | |
| Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH<sub>2</sub> | |
| (3R 5S 6E)-7-[2-(4-fluorophenyl)-7-[(4-phenylphenyl)methyl]-4 5 6 7-tetrahydro-2H-indazol-3-yl]-3 5-dihydroxyhept-6-enoate | |
| [<sup>125</sup>I]Tyr-Ala-hexarelin | |
| [<sup>3</sup>H]tiagabine | |
| [<sup>3</sup>H]quisqualate | |
| GSK0660 | |
| triprolidine | |
| [<sup>3</sup>H]methoxy-PEPy | |
| benazeprilat | |
| motilin-(1-19) (human) | |
| Gal-B2-MPEG<sub>4</sub> | |
| I-ABOPX | |
| TIP39-(9-39) (human/bovine) | |
| K185 | |
| T1117 | |
| rolapitant | |
| waixenicin A | |
| sertindole | |
| (3R)-6-[2-(4-fluorophenyl)-4-[(4-fluorophenyl)sulfanyl]-6-(propan-2-yl)phenoxy]-3 5-dihydroxyhexanoate | |
| flagellin | |
| T-226296 | |
| XCT790 | A cinnamamide that has formula C23H13F9N4O3S. |
| Li<sup>+</sup> | |
| [<sup>3</sup>H]SR48692 | |
| NE58027 | |
| BC11-38 | |
| dexamethasone | A fluorinated steroid that is 9-fluoropregna-1,4-diene substituted by hydroxy groups at positions 11, 17 and 21, a methyl group at position 16 and oxo groups at positions 3 and 20. It is a synthetic member of the class of glucocorticoids. |
| compound 2 [PMID:11375253] | |
| vMIP-III | |
| obinutuzumab | |
| Ro 25-1392 | |
| ZM-241385 | |
| sitaxsentan | |
| AZ11645373 | |
| GR138676 | |
| LSP4-2022 | |
| [PP<sub>1-17</sub> Ala<sup>31</sup> Aib<sup>32</sup>]NPY (human) | |
| L-SOP | |
| [Phe(Me)<sup>7</sup>]neurokinin B | |
| NBI-42902 | |
| gisadenafil | |
| RO116-9132/238 | |
| FMH | |
| iberiotoxin | |
| G15 | |
| H87/07 | |
| oleocanthal | |
| [<sup>3</sup>H]senktide | |
| daminozide | A straight-chain fatty acid that has formula C6H12N2O3. |
| [<sup>3</sup>H]BK (human mouse rat) | |
| ibandronic acid | |
| L-372662 | |
| R116031 | |
| Gal-(K)4 | |
| GlaxoSmithKline compound 6i [PMID:18926700] | |
| indocyanine Green | A benzoindole that has formula C43H47N2NaO6S2. |
| WIN55212-2 | A organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole substituted at position 6 by a 1-naphthylcarbonyl group. |
| LXA<sub>4</sub> | |
| 3-[4-(4-bromophenyl)phenyl]-octahydropyrido[2 1-c]morpholin-3-ol | |
| SB 224289 | A member of the class of benzamides obtained by formal condensation of the carboxy group of 2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid with the secondary amino group of 1'-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4'-piperidine]. Selective 5-HT1B receptor antagonist (pKi = 8.2). Displays >60-fold selectivity over 5-HT1D, 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A and 5-HT2C receptors in radioligand binding and functional assays. Centrally active following oral administration in vivo. |
| farnesylthiosalicylic acid | |
| DCG-IV | |
| SLV320 | |
| mirtazapine | A tetracyclic antidepressant that has formula C17H19N3. |
| ω-conotoxin MVIIC | |
| 10-OBn-epi-ginkgolide C | |
| ω-conotoxin MVIIA | |
| JB 98064 | |
| sulukast | |
| [Ac-Tyr<sup>1</sup> D-Arg<sup>2</sup>]GHRH-(1-29)-NH<sub>2</sub> (human) | |
| Ro01-6128 | |
| ganirelix | |
| trichostatin A | A trichostatin that has formula C17H22N2O3. |
| xylazine | |
| threo-3-methylglutamate | |
| AMG-837 | |
| cimetidine | A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach. |
| L-156 602 | |
| charybdotoxin-GLU32 analog | |
| BN-81 644 | |
| CX516 | A N-acylpiperidine that has formula C14H15N3O. |
| S(+)-niguldipine | |
| phytanic acid | A branched-chain saturated fatty acid consisting of hexadecanoic acid carrying methyl substituents at positions 3, 7, 11 and 15. |
| AS70 | |
| enantio PAF C-16 | |
| tolazoline | |
| AS74 | |
| enprostil | |
| [<sup>3</sup>H]gastrin | |
| dioscin | A spirostanyl glycoside that consists of the trisaccharide alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc attached to position 3 of diosgenin via a glycosidic linkage. |
| CV-1674 | |
| (3R 5S 6E)-7-[2-(4-fluorophenyl)-4-(3-phenylpentan-3-yl)phenyl]-3 5-dihydroxyhept-6-enoate | |
| [<sup>3</sup>H]strychnine | |
| VU-1545 | |
| BX 048 | |
| PCPA | |
| JV-1-42 | |
| MRS1523 | |
| [<sup>3</sup>H](+)-isradipine | |
| A839977 | |
| butaprost (free acid form) | |
| [<sup>3</sup>H]7-OH-DPAT | |
| fluvastatin | |
| exemestane | A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer. |
| proxyfan | |
| diphosphoglycolyl proline | |
| (2S)-3-methyl-2-[12-(5-methylfuran-2-yl)-8-oxatricyclo[7.4.0.0]trideca-1(9) 2(7) 3 5 10 12-hexaene-5-sulfonamido]butanoic acid | |
| 5-oxo-20-HETE | |
| exendin-3 | A 39-membered polypeptide consisting of His, Ser, Asp, Gly, Thr, Phe, Thr, Ser, Asp, Leu, Ser, Lys, Gln, Met, Glu, Glu, Glu, Ala, Val, Arg, Leu, Phe, Ile, Glu, Trp, Leu, Lys, Asn, Gly, Gly, Pro, Ser, Ser, Gly, Ala, Pro, Pro, Pro and Ser-NH2 residues joined in sequence. It is isolated from venom of the Gila monster lizard Heloderma horridum. |
| roflumilast | |
| 2-{4-[5-(3-Chloro-4-trifluoromethoxyphenyl)-[1 3 4]oxadiazol-2-yl]butyl}-[1 8]naphthyridine | |
| maprotiline | |
| EC 5-21 | |
| compound 4 [PMID: 22533316] | |
| compound 2g [PMID:19309152] | |
| certolizumab pegol | |
| UR-PG146 | |
| 4-AMBA | |
| MRS1041 | |
| [<sup>3</sup>H]SR 121463A | |
| 3-[4-(5-bromothiophen-2-yl)phenyl]-octahydropyrido[2 1-c]morpholin-3-ol | |
| bepafant | |
| morphine | A morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). |
| NBQX | A sulfonic acid derivative that has formula C12H8N4O6S. |
| compound 1 [CID 44270471] | |
| [<sup>3</sup>H]CGP39653 | |
| [<sup>3</sup>H]8-OH-DPAT | |
| 2-(2-thiazolyl)ethanamine | |
| 1-(diphosphenyloxy)-3 4-dimethylpentan-3-ol | |
| bethanechol | The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention. |
| K31440 | |
| clobetasol propionate | The 17-O-propionate ester of clobetasol. A potent corticosteroid, it is used to treat various skin disorders, including exzema and psoriasis. |
| RY024 | |
| methadone | A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4. |
| GC-1 | A diarylmethane that has formula C20H24O4. |
| vesamicol | |
| 15S-HETE | An optically active form of 15-HETE having 15(S)-configuration.. |
| cADPR | |
| IRL 2500 | |
| SB 258719 | |
| BMS compound 16 [PMID:23368907] | |
| CTA<sub>2</sub> | |
| JNJ-26070109 | |
| Na<sup>+</sup> | |
| fingolimod | |
| 3570-0208 [PMID:19807662] | |
| [<sup>125</sup>I]CGP42112 | |
| 4-thio-UTP | |
| WDuo3 | |
| 15-deoxy-Δ<sup>12 14</sup>-PGJ<sub>2</sub> | |
| [<sup>3</sup>H]AD5075 | |
| [Mpa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> <small>D</small>-Tic<sup>7</sup> Aib<sup>9</sup>]OT | |
| (2<i>R</i> 3<i>R</i>)-APDC | |
| lisinopril | A dipeptide that has formula C21H31N3O5. |
| SB203580 | |
| pobilukast | |
| fMet-Ile-Val-Thr-Leu-Phe | |
| compound 9 [PMID: 22533316] | |
| [Hyp<sup>3</sup> Tyr(Me)<sup>8</sup>]BK | |
| ACET | |
| [<sup>3</sup>H]SB269970 | |
| HC-056456 | |
| KGP94 | |
| SN-1 | |
| SN-2 | |
| yohimbine | An indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina. |
| PrP<sub>106-126</sub> | |
| verlukast | |
| phenoxybenzamine | |
| sufentanil | An anilide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid. |
| VU0463841 | |
| amitriptyline | An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5. |
| naloxone benzoylhydrazone | |
| romiplostim | |
| raltitrexed | |
| HHSiD | |
| loratadine | |
| lasofoxifene | |
| [<sup>3</sup>H]A-585539 | |
| neratinib | A quinoline compound having a cyano group at the 3-position, a 3-chloro-4-(2-pyridylmethoxy)anilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an ethoxy group at the 7-position. |
| (S)-PIA | |
| AS1269574 | |
| (6E)-8-[(9Z)-3 6-difluoro-9H-fluoren-9-ylidene]-3 5-dihydroxy-8-(1-methyl-1H-1 2 3 4-tetrazol-5-yl)oct-6-enoate | |
| [<sup>125</sup>I]DOI | |
| Ro67-4853 | |
| [<sup>125</sup>I]PrRP-20 (human) | |
| compound 26c [PMID: 16242323] | |
| MRS1191 | |
| L748328 | |
| LY262691 | |
| labradimil | |
| AZ-4217 | |
| MRE 3008F20 | |
| L745870 | |
| MRS2698 | |
| umeclidinium | A quaternary ammonium ion that is quinuclidine substituted at positions 1 and 4 by 2-(benzyloxy)ethyl and hydroxy(diphenyl)methyl groups respectively. |
| APNEA | Lack of breathing with no movement of the respiratory muscles and no exchange of air in the lungs. This term refers to a disposition to have recurrent episodes of apnea rather than to a single event. |
| lergotrile | |
| compound 4 [PMID: 9003518] | |
| [<sup>125</sup>I]INSL5 (human) | |
| VU0463597 | |
| L-β-BA | |
| Ga-DOTA-TOC | |
| JNJ 7777120 | |
| [Ala<sup>31</sup> Aib<sup>32</sup>]NPY (pig) | |
| CP-226269 | |
| Bay60-6583 | |
| S36077 | |
| EVP-6124 | |
| methysergide | |
| iralukast | |
| AM630 | |
| [(CH<sub>2</sub>NH)<sup>4 5</sup>]secretin | |
| nicotine | An N-alkylpyrrolidine that consists of N-methylpyrrolidine bearing a pyridin-3-yl substituent at position 2. It has been isolated from Nicotiana tabacum. |
| minodronic acid | |
| repinotan | |
| MRE 2029F20 | |
| vapreotide | |
| galangin | A 7-hydroxyflavonol with additional hydroxy groups at positions 3 and 5 respectively. |
| 2-thio-UDP | |
| (3R)-7-[(1S 2S 6R 8S 8aR)-2 6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1 2 6 7 8 8a-hexahydronaphthalen-1-yl]-3 5-dihydroxyheptanoate | |
| lixisenatide | |
| NNC 11-1585 | |
| CPCCOEt | |
| (+)-<i>trans</i>-H<sub>2</sub>-PAT | |
| 3-hydroxy lauric acid | A medium-chain fatty acid that is the 3-hydroxylated derivative of lauric acid; associated with fatty acid metabolic disorders. |
| AZ10417808 | |
| GR94800 | |
| (+)-WAY 100135 | |
| BC-264 | |
| [<sup>3</sup>H]methoxymethyl-MTEP | |
| europium-labelled INSL3 | |
| [<sup>3</sup>H]MDL105519 | |
| BIBP3226 | |
| digitoxin | |
| mefenamic acid | An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis. |
| L-798 106 | |
| 5-hydroxy-L-tryptophan | The L-enantiomer of 5-hydroxytryptophan. |
| isoprenaline | A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders. |
| TIP39-(3-39) (human/bovine) | |
| AVE 0991 | |
| GSK962040 | |
| propranolol | A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. |
| M1151 | |
| EM-TBPC | |
| SF-21 | |
| M372049 | |
| 2-amino-4-methylpyridine | |
| NPC-567 | A ten-membered oligopeptide comprising D-arginyl, L-arginyl, L-prolyl, (4R)-4-hydroxy-L-prolyl, glycyl, L-phenylalanyl, L-seryl, D-phenylalanyl, L-phenylalanyl and L-arginine residues joined in sequence. |
| (S)-EF-1520 | |
| bithionol | Diphenyl sulfide in which each phenyl group is substituted at position 2 by hydroxy and at positions 3 and 5 by chlorine. A fungicide and anthelmintic, it was used in various topical drug products for the treatment of liver flukes, but withdrawn after being shown to be a potent photosensitizer with the potential to cause serious skin disorders. |
| [<sup>125</sup>I]resiniferatoxin | |
| milnacipran | |
| {2-[4-(benzyloxy)phenoxy]ethyl}(2-phenylpropyl)amine | |
| bicalutamide | A sulfone that is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism. |
| tasosartan | |
| SB209670 | |
| [<sup>3</sup>H]GR100679 | |
| [<sup>3</sup>H]LY334370 | |
| carbenoxolone | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-{[(11-phenoxyundecyl)carbamoyl]oxy}-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| [<sup>125</sup>I]neurotensin (human mouse rat) | |
| etanercept | |
| BBL-454 | |
| nilotinib | |
| olaparib | A member of the class of N-acylpiperazines obtained by formal condensation of the carboxy group of 2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoic acid with the free amino group of N-(cyclpropylcarbonyl)piperazine. |
| QX-314 | A monocarboxylic acid amide that has formula C16H27N2O. |
| candesartan | A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension. |
| 3-{2-[(3R 5S)-7-chloro-5-(2 3-dimethoxyphenyl)-1-(3-hydroxy-2 2-dimethylpropyl)-2-oxo-1 2 3 5-tetrahydro-4 1-benzoxazepin-3-yl]acetamido}propanoic acid | |
| PTHrP-(1-34) | |
| BW-A1433 | |
| SQ-27986 | |
| EGIS-7625 | |
| losartan | A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position |
| ketorolac | |
| DPDPE | A heterodetic cyclic peptide that is a cyclic enkephalin analogue, having D-penicillaminyl residues located at positions 2 and 5, which form the heterocycle via a disulfide bond. |
| pentylthio-TZTP | |
| TG4-155 | |
| 4BP-TQS | |
| TPMPA | |
| corticotropin zinc hydroxide | |
| 2-Br-LSD | |
| L-694 247 | |
| pirenperone | |
| SDZ 205557 | |
| N-stearyl-[Nle<sup>17</sup>] neurotensin-(6-11)/VIP-(7-28) | |
| masitinib | A member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor. |
| MS05 | |
| mosapride | |
| [<sup>125</sup>I]apelin-13 | |
| [<sup>125</sup>I]SCH23982 | |
| bupropion | A propanone that is propan-1-one substituted by a tert-butylamino group at position 2 and a 3-chlorophenyl group at position 1. |
| [Ala<sup>1 3 11 15</sup>]ET-1 | |
| CGEN-855A | |
| compound 12 [PMID:19800804] | |
| [<sup>3</sup>H]L365260 | |
| oxiglutatione | |
| 2-<i>O</i>-ethyl-PAF C-16 | |
| ML 10375 | |
| [<sup>125</sup>I]CCL4 (human) | |
| 2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH<sub>2 </sub> | |
| dabrafenib | An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma. |
| [<sup>125</sup>I]-BDZ<sub>2</sub> | |
| compound 2f [PMID:17532216] | |
| LG190178 | |
| (2S)-2-[[(1R)-1-(4-bromophenyl)ethyl]carbamoylamino]-5-(carbamoylamino)-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1 3-thiazol-2-yl)pentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]pentanamide | |
| compound 18b [PMID: 16242323] | |
| thymol | A phenol that is a natural monoterpene derivative of cymene. |
| gastrin releasing peptide (14-27) (human) | |
| [<sup>3</sup>H]NBTI | |
| B-10356 | |
| nepicastat | |
| (-)-<i>trans</i>-H<sub>2</sub>-PAT | |
| etoricoxib | |
| VU0155041 | |
| (<i>R</i>)-cetirizine | |
| alogliptin | A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes. |
| 3-azageranylgeranyl diphosphate | |
| SB-410220 | |
| myriocin | An amino acid-based antibiotic derived from certain thermophilic fungi; acts as a potent inhibitor of serine palmitoyltransferase, the first step in sphingosine biosynthesis. Myriocin also possesses immunosuppressant activity. |
| pimecrolimus | |
| R(-)amphetamine | An amphetamine that has formula C9H13N. |
| sANP | |
| vigabatrin | |
| ASN02563583 | |
| galanin(3-29) (pig) | |
| nelivaptan | |
| [<sup>3</sup>H]2-deoxyglucose | |
| MRS2603 | |
| [<sup>3</sup>H]BQ123 | |
| galanin(2-11) | |
| MDIP | |
| CGS 15943 | |
| valdecoxib | |
| J-104118 | |
| αβ-methyleneADP | |
| CD666 | |
| APPA | |
| amidephrine | |
| GV150013 | |
| arcaine | |
| tapentadol | |
| ICI 204448 | |
| pramipexole | A member of the class of benzothiazoles that is 4,5,6,7-tetrahydro-1,3-benzothiazole in which the hydrogens at the 2 and 6-pro-S-positions are substituted by amino and propylamino groups, respectively. |
| 7-methoxy-1-naphthylpiperazine | |
| dicumarol | |
| levonorgestrel | A 17beta-hydroxy steroid that has formula C21H28O2. |
| ONO-8713 | |
| danazol | A 17beta-hydroxy steroid that has formula C22H27NO2. |
| salbutamol | |
| [<sup>125</sup>I]St<sub>a</sub> | |
| VPC12249 | |
| cosyntropin | A synthetic peptide that is identical to the 24-amino acid segment at the N-terminal of adrenocorticotropic hormone (corticotropin). A segment similar in all species, it contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. It is used diagnostically to investigate adrenocortical insufficiency. |
| [<sup>3</sup>H]AMPA | |
| <i>E. coli</i> heat-stable enterotoxin (ST<sub>a</sub>) | |
| Z-360 | |
| lapatinib | |
| tinzaparin | |
| SGC‑CBP30 | |
| [<sup>123</sup>I]iodoproxyfan | |
| kuwanon H | |
| PSB-11 | |
| HS024 | |
| [<sup>125</sup>I][D-Tyr<sup>6</sup> β-Ala<sup>11</sup> Phe<sup>13</sup> Nle<sup>14</sup>]bombesin-(6-14) | |
| thiothixene | |
| grayanotoxin | |
| tolcapone | |
| desGlyNH<sub>2</sub>-d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Orn<sup>8</sup>]OT | |
| GNTI | |
| YM 471 | |
| JCF 109 | |
| ALX 1405 | |
| d[Val<sup>4</sup> DArg<sup>8</sup>]VP | |
| JMV310 | |
| vinblastine | |
| cCMP | |
| lorglumide | |
| L-366 875 | |
| cediranib | |
| nisoldipine | |
| [<sup>11</sup>C]WAY100635 | |
| ONO-4817 | |
| CID1172084 | |
| zileuton | |
| spiraprilat | |
| A-123189 | |
| bradyzide | |
| 2-methyl-3-phenethyl-3H-pyrimidin-4-one | |
| tretinoin | |
| N(6)-cyclohexyladenosine | |
| RO3 | |
| HAMI3379 | |
| candoxatril | The 2,3-dihydro-1H-inden-5-yl ester of the active enantiomer of candoxatrilat. Candoxatril is an orally active prodrug of candoxatrilat, a potent neutral endopeptidase (NEP, neprilysin) inhibitor used in the treatment of chronic heart failure. |
| FR260010 | |
| CV-6209 | |
| methyl p-hydroxybenzoate | |
| cooling agent 10 | |
| [Pen5]-U (4-11) (human) | |
| LY233053 | |
| JP1302 | |
| GW0072 | |
| YM-75440 | |
| VU0152099 | |
| d[Leu<sup>4</sup>]LVP | |
| LK 204-545 | |
| crizotinib | |
| BMS 181 101 | |
| glycyrrhizin | |
| (1-methyl-1-{[3-(3-phenoxyphenyl)propyl]carbamoyl}ethyl)phosphonate | |
| ingenol mebutate | |
| 3-phenacyl-UDP | |
| raclopride | |
| α-conotoxin PIA | |
| α-methyl-5-HT | |
| tolbutamide | An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position. |
| [4-(4-phenylphenyl)-1-phosphonatobutyl]phosphonate | |
| ABC294640 | |
| compound 22c [PMID: 16242323] | |
| α-dendrotoxin | |
| SB 235375 | |
| PSB1115 | |
| 1-naphthylpiperazine | |
| satavaptan | |
| protriptyline | An organic tricyclic compound that has formula C19H21N. |
| FK888 | |
| AC-90179 | |
| BIBO3304 | |
| ramatroban | |
| CGEN-857 | |
| hexamethonium | A quaternary ammonium salt that has formula C12H30N2. |
| RWJ-351647 | |
| <i>N</i>-[<sup>3</sup>H]α-methylhistamine | |
| decanoic acid | |
| R-PSOP | |
| ONO-8711 | |
| dequalinium | |
| compound 4 [PMID: 21105727] | |
| M617 | |
| Ga-DOTA-NOC | |
| CJ-023423 | |
| indomethacin | |
| pentanoic acid | A straight-chain saturated fatty acid containing five carbon atoms. |
| [<sup>125</sup>I]secretin (pig) | |
| OMPT | |
| CBiPES | |
| BIMU 8 | |
| methoxamine | |
| eplerenone | A steroid acid ester that has formula C24H30O6. |
| BIMU 1 | |
| [<sup>3</sup>H]2 2 2-TEMPS | |
| Y-RFRP-3 | |
| repaglinide | |
| 11-deoxy-PGE<sub>2</sub> | |
| compound 4 [PMID:23083103] | |
| Ro 41-5253 | |
| TTNPB | |
| BeKm-1 | |
| A317491 | |
| sabcomeline | |
| 2-[3-(5-carbamimidoyl-2 3-dihydro-1H-1 3-benzodiazol-2-ylidene)-5-{5-[(carbamoylamino)methyl]-2-hydroxyphenyl}-4-oxocyclohexa-1 5-dien-1-yl]butanedioic acid | |
| UR-PG153 | |
| NVP-AAM077 | |
| [<sup>3</sup>H]DPCPX | |
| ICI198615 | |
| regorafenib | |
| 7α-Cl-ginkgolide B | |
| Ca<sup>2+</sup> | |
| tripitramine | |
| 5-(4-cyano-3-methylphenyl)-2-(4-(3-isopropyl-1 2 4-oxadiazol-5-yl)piperidin-1-yl)nicotinitrile | |
| [<sup>125</sup>I]GTI | |
| IB-MECA | |
| L-759 656 | |
| [Phaa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> Val<sup>4</sup> Lys<sup>6</sup> Tyr-NH<sub>2</sub><sup>8</sup> des-Gly<sup>9</sup>]AVP | |
| GW-5823 | |
| [Ser<sup>11</sup>](N-CNP C-ANP)pBNP<sup>2-15</sup> | |
| galanin(1-19) (rat/mouse) | |
| vardenafil | The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine. |
| compound 21 [PMID: 22802221] | |
| 2-phenylethylyl-adenosine derivative | |
| bromocresol green | |
| NNC55-0396 | |
| GSK1614343 | |
| tubocurarine | |
| A-304121 | |
| etonitazene | |
| [<sup>125</sup>I]cetrorelix | |
| kainate | |
| [<sup>125</sup>I]CCL27 | |
| [<sup>125</sup>I]CCL25 | |
| ME36 | |
| [<sup>125</sup>I]CCL20 | |
| [<sup>125</sup>I]psalmotoxin 1 | |
| DMP696 | |
| oxymetazoline | |
| [Pro<sup>34</sup>]PYY (human) | |
| Des-Ala<sup>1 2 5</sup>-[D-Trp<sup>8</sup> IAmp<sup>9</sup>]SRIF | |
| triazine compound 1 | |
| [<sup>125</sup>I](3-iodo-Tyr<sup>13</sup>)-MCH | |
| PBP10 | |
| octanol | A fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of eight carbon atoms. |
| dodecyl-thiophosphate | |
| dalteparin | |
| oleoyl-lysophosphatidylcholine | A lysophosphatidylcholine 18:1 in which the acyl group is specified as oleoyl and is located at either position 1 or 2. |
| THIQ | |
| bardoxolone | |
| PGE<sub>2</sub> | |
| compound 11s [PMID:19433355] | |
| Z-DQMD-FMK | |
| carprofen | Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs. |
| fMet-Met-Trp-Leu-Leu | |
| UDP-glucuronic acid | |
| BIM 23058 | |
| sergolexole | |
| U-II-(4-11) (human) | |
| apafant | |
| JMV431 | |
| minoxidil | A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6. |
| MTEP | |
| [<sup>35</sup>S]TBPS | |
| NGD 94-1 | |
| ketanserin | |
| JMV1116 | |
| [Sar<sup>1</sup> Gly<sup>4</sup> Gly<sup>8</sup>]Ang-II | |
| PSB-0788 | |
| cangrelor | |
| 4-fluorobenzoyl-FGLRW-NH2 | |
| talnetant | |
| CTAP | |
| pyrazolone 1 | |
| PMBA | |
| azelastine | A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position. |
| [<sup>14</sup>C]alanine | |
| XMT-1191 | |
| compound 24 [PMID:20346665] | |
| tripelennamine | |
| JNJ-42153605 | |
| BMS270394 | |
| PNU-120596 | |
| tafluprost acid | |
| muramyl dipeptide | Muramyl dipeptide is a peptidoglycan constituent of both Gram positive and Gram negative bacteria. It is composed of N-acetylmuramic acid linked by its lactic acid moiety to the N-terminus of the dipeptide L-alanyl-D-isoglutamine. |
| SR58611A | |
| L-363 377 | |
| RN1747 | |
| leflunomide | A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide. |
| [<sup>14</sup>C]glutamine | |
| [<sup>3</sup>H]EM-TBPC | |
| hexahydrodifenidol | |
| cilostazol | A lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substiuted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group. |
| ketotifen | |
| BzT‑7 | |
| β-D-hydroxybutyric acid | |
| TZD18 | |
| phentolamine | |
| L-644 698 | |
| bimatoprost (free acid form) | |
| CXCL12-(1-9) | |
| [Pro<sup>7</sup>]neurokinin B | |
| [<sup>3</sup>H]AVP | |
| L-(cis)-diltiazem | |
| compound 9n [PMID:18752940] | |
| gabazine | |
| RO320-2947/001 | |
| biphenylindanone A | |
| septide | |
| nafamostat | |
| PENECA | |
| GnRH III | |
| T-98475 | |
| GR-127935 | A member of the class of benzamides obtained by formal condensation of the carboxy group of 2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid and the anilino group of 4-methoxy-3-(4-methylpiperazin-1-yl)aniline. Potent and selective 5-HT1B/1D receptor antagonist (pKi values are 8.5 for both guinea pig 5-HT1D and rat 5-HT1B receptors). Displays > 100-fold selectivity over 5HT1A, 5-HT2A, 5-HT2C receptors and other receptor types. Centrally active following oral administration. |
| ipratropium | A propanoate ester that has formula C20H30NO3. |
| lenvatinib | |
| L-783483 | |
| TRAM-34 | An organochlorine compound that has formula C22H17ClN2. |
| MK-0767 | |
| CBIQ | |
| tiotidine | |
| trimethylamine | A tertiary amine that is ammonia in which each hydrogen atom is substituted by an methyl group. |
| piracetam | |
| dimethylallyl diphosphate | |
| nahuoic acid A | |
| carazolol | |
| Lys[Z(NO<sub>2</sub>)]-Pro | |
| [<sup>3</sup>H]WIN35428 | |
| TCPOBOP | |
| [Val<sup>4</sup>]AVP | |
| hexestrol | A stilbenoid that has formula C18H22O2. |
| CGP42112 | |
| BMY-7378 | |
| [<sup>125</sup>I]exendin-(9-39) | |
| JNJ1661010 | |
| leiurotoxin I | |
| JV-1-43 | |
| [Sar <small>D</small>-Phe<sup>8</sup> des-Arg<sup>9</sup>]bradykinin | |
| DG-051 | |
| NADA | |
| astemizole | |
| <i>N N</i>-dimethylhistamine | |
| [<sup>3</sup>H]diprenorphine | |
| dihydroergocristine | |
| Cpd B [PMID:18477808] | |
| anantin | |
| agmatine | A primary amino compound that has formula C5H14N4. |
| SKA-31 | |
| octreotide | A homodetic cyclic peptide that has formula C49H66N10O10S2. |
| pentoxifylline | |
| imiquimod | An imidazoquinoline that has formula C14H16N4. |
| tecadenoson | |
| phorbol 12-myristate 13-acetate | |
| (5-{[4-(benzenesulfonyl)-1 2 5-oxadiazol-3-yl]oxy}-1-hydroxy-1-phosphonopentyl)phosphonic acid | |
| 7α-OCOCH<sub>2</sub>Ph-ginkgolide B | |
| [<sup>125</sup>I]Tyr<sup>0</sup>-CRF (human rat mouse) | |
| SSR-103800 | |
| NPC 17731 | |
| [<sup>3</sup>H]tyramine | |
| europium-labelled INSL5 | |
| rolipram | |
| ω-conotoxin CVIB | |
| ω-conotoxin CVIC | |
| ω-conotoxin CVIA | |
| tiotropium | |
| [<sup>3</sup>H]N-methyl scopolamine | |
| ω-conotoxin CVID | |
| SB-568849 | |
| α3IA | |
| (1<i>S</i> 3<i>R</i>)-ACPD | |
| 5 6-epoxyeicosatrienoic acid | |
| PD 168368 | |
| (+)-cyclazosin | A monocarboxylic acid amide obtained by formal condensation of the carboxy group of furoic acid with the secondary amino group of 6,7-dimethoxy-2-[(4aR,8aS)-octahydroquinoxalin-1-yl]quinazolin-4-amine. |
| ABT-229 | |
| [<sup>14</sup>C]glycine | |
| mexiletine | An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol. |
| bongkrek acid | |
| litorin | |
| orlistat | |
| 2-(3-phenoxyphenyl)-1-phosphonatoethane-1-sulfonate | |
| taurocholic acid | A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals. |
| DFB | |
| phenindione | |
| YM-022 | |
| loxiglumide | |
| <i>N</i>-α-Ac-PYY-(25-36) (rat) | |
| amlodipine | A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina. |
| methimepip | |
| [<sup>14</sup>C]ascorbic acid | |
| antalarmin | |
| C5a hexapeptide analogue | |
| fluorometholone | A member of the class of glucocorticoids that is Delta(1)-progesterone substituted at positions 11beta and 17 by hydroxy groups, at position 6alpha by a methyl group and at position 9 by a fluoro group. Used for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. |
| 7α-hydroxycholesterol | The 7alpha-hydroxy derivative of cholesterol. |
| asoprisnil | |
| 1-(2-bromo-phenyl)-3-((4S 5S)-2 2-dimethyl-4-phenyl-[1 3]dioxan-5-yl)-urea | |
| [Phe<sup>3</sup> Leu<sup>13</sup>]motilin (human) | |
| INCB3344 | |
| [[(3-methylpyridin-2-yl)amino]methyl]phosphonic acid | |
| ONO-3708 | |
| LTD<sub>4</sub> | |
| GR 128107 | |
| [<sup>125</sup>I]SAP | |
| sulfasalazine | An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position. |
| diazoxide | A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. |
| CP55 667 | |
| 3-keto-lithocholic acid | |
| PD-140548 | |
| GR 89696 | |
| androstanol | A 3-hydroxy steroid that has formula C19H32O. |
| (±)-adrenaline | |
| SB 714786 | |
| [<sup>125</sup>I][Tyr<sup>4</sup>]ghrelin (human) | |
| [<sup>3</sup>H]MK-801 | |
| [D-Trp<sup>12</sup>]PTH-(7-34) (bovine) | |
| tetralin_urea analogue (7o) | |
| KT 5823 | |
| [<sup>11</sup>C]MMTP | |
| teriflunomide | |
| sst<sub>3</sub>-ODN-8 | |
| danaparoid | |
| JTE-013 | |
| R-(-)-6-methyl-2 4-disubstituted pyridazin-3(2H)-one | |
| galanin(10-29) (pig) | |
| hydrocodone | An organic heteropentacyclic compound that has formula C18H21NO3. |
| EHNA | A purine derivative having an adenine skeleton substituted at N-9 with a erythro-2-hydroxynonan-3-yl group; relative configuration. |
| ritanserin | A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action. |
| dATPαS | |
| promethazine | A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. |
| hydromorphone | A morphinane alkaloid that has formula C17H19NO3. |
| [<sup>125</sup>I]H3 relaxin | |
| [Thr<sup>4</sup> Gly<sup>7</sup>]OT | |
| endomorphin-2 | |
| endomorphin-1 | |
| AR234960 | |
| BIX-01294 | |
| JV-1-63 | |
| 5 7-dihydroxy-4'-methoxyisoflavone | |
| mogamulizumab | |
| JNJ-17156516 | |
| amesergide | |
| Gd<sup>3+</sup> | |
| [<sup>3</sup>H]CGS 21680 | |
| ZK159222 | |
| ONO-AE3-208 | |
| RX821002 | |
| triamcinolone acetonide | A synthetic glucocorticoid that is the 16,17-acetonide of triamcinolone. Used to treat various skin infections. |
| RY764 | |
| heteropodatoxin-2 | |
| L735821 | A N-acyl-amino acid that has formula C25H19Cl2N3O2. |
| brinzolamide | |
| BIM 28163 | |
| (-)-YM796 | |
| 9-phenanthrol | A phenanthrol that has formula C14H10O. |
| [<sup>3</sup>H]PD128907 | |
| N/OFQ-NH<sub>2</sub> | |
| dextrothyroxine | |
| G36 | |
| budesonide | A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis. |
| dysiherbaine | |
| [<sup>125</sup>I]urocortin 1 (mouse rat) | |
| BIM 23034 | |
| [<sup>3</sup>H]fenobam | |
| PSMα3 | |
| flurbiprofen | A fluorobiphenyl that has formula C15H13FO2. |
| (S)-4-CMTB | |
| citric acid | A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms. |
| amiodarone | A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias. |
| compound 2 (PMID:22911925) | |
| [<sup>3</sup>H]U46619 | |
| compound 15b [PMID: 16242323] | |
| [<sup>3</sup>H]5-CT | |
| tetrodotoxin | A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. |
| [<sup>125</sup>I]CCL1 (mouse) | |
| thiorphan | A N-acyl-amino acid that has formula C12H15NO3S. |
| [His<sup>5</sup>]PTH-(1-34) (human) | |
| (-)-(S)-BayK8644 | |
| EI1 | |
| malic acid | A 2-hydroxydicarboxylic acid that is succinic acid in which one of the hydrogens attached to a carbon is replaced by a hydroxy group. |
| alvocidib | |
| zolmitriptan | |
| (3R 6E)-7-[5-(4-fluorophenyl)-3-(propan-2-yl)-1-(pyrazin-2-yl)-1H-pyrazol-4-yl]-3 5-dihydroxyhept-6-enoate | |
| memantine | |
| codeine | A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties. |
| [<sup>3</sup>H]methotrexate | |
| [<sup>3</sup>H]BIBP3226 | |
| quinoprilat | |
| SR12813 | An organic phosphonate that is the tetraethyl ester of [2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethene-1,1-diyl]bis(phosphonic acid). |
| [<sup>3</sup>H]LTD<sub>4</sub> | |
| ASN06917370 | |
| L-168 049 | |
| hongotoxin-1 | |
| pirenzepine | |
| olanzapine | A benzodiazepine that has formula C17H20N4S. |
| AcPhe-Orn-Pro-D-Cha-Trp-Arg | |
| fluticasone propionate | A trifluorinated corticosteroid that consits of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a propionyl substituent at position 17; has anti-inflammatory, anti-asthmatic and anti-allergic activity. |
| FR190997 | |
| OAG | |
| WIN 51 708 | |
| cyclizine | |
| I-ABA | |
| [<sup>125</sup>I]SB258585 | |
| α-conotoxin-GIC | |
| <i>p</i>-F-HHSiD | |
| hydroxyflutamide | An anilide that has formula C11H11F3N2O4. |
| UBP302 | |
| DOI | |
| resiquimod | An imidazoquinoline that has formula C17H22N4O2. |
| compound 36j [PMID:21536438] | |
| NH-3 | |
| sapropterin | |
| natalizumab | |
| MS417 | A member of the class of thienotriazolodiazepines that is the methyl ester of [(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid. A bromodomain and extra-terminal domain (BET)-specific inhibitor that belongs to a group of thienodiazepine-based compounds |
| [Lys<sup>5</sup> Me-Leu<sup>9</sup> Nle<sup>10</sup>]NKA-(4-10) | |
| dorzolamide | 5,6-Dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide in which hydrogens at the 4 and 6 positions are substituted by ethylamino and methyl groups, respectively (4S, trans-configuration). A carbonic anhydrase inhibitor, it is used as the hydrochloride in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension. |
| fenobam | |
| S9947 | A biphenyl that has formula C29H27N3O3. |
| tolvaptan | |
| α-conotoxin GI | |
| AS99 | |
| [Trp<sup>23</sup> Tyr<sup>36</sup>]PTHrP-(1-36)-NH<sub>2</sub> (human) | |
| AS96 | |
| AS95 | |
| fentanyl | The carboxamide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid. |
| NOC-ATE | |
| apadenoson | |
| fosinopril | A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite. |
| medroxyprogesterone | A 3-oxo Delta(4)-steroid that is pregn-4-ene-3,20-dione substituted by an alpha-hydroxy group at position 17 and a methyl group at position 6. |
| dihydrotestosterone | |
| NE97220 | |
| cis-flupentixol | |
| vipadenant | |
| 2-oleoyl glycerol | A 2-monoglyceride where the acyl group is (9Z)-octadecenoyl. |
| JV-1-62 | |
| W146 | |
| SR144528 | |
| capecitabine | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]OVT | |
| cipralisant | |
| (S)-TBPG | |
| [<sup>3</sup>H]PSB-11 | |
| MeTRH | |
| ACPT-I | |
| sulprostone | |
| CGP7930 | |
| RBI257 | |
| tetraethylammonium | A quaternary ammonium ion that has formula C8H20N. |
| etoposide | A furonaphthodioxole that has formula C29H32O13. |
| SB-436811 | |
| (3R 5R)-7-[4-(4-fluorophenyl)-2-methyl-1-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| (-)-tertatolol | |
| {2-[dodecyl(methyl)amino]-1-phosphonoethyl}phosphonic acid | |
| deoxycorticosterone | |
| substance P-OMe | |
| compound 1 [PMID:20080612] | |
| GlaxoSmithKline compound 5h [PMID:20542694] | |
| [Trp<sup>23</sup>]PTHrP-(1-36) (human) | |
| α-latrotoxin | |
| AC-260584 | |
| rizatriptan | A tryptamine that has formula C15H19N5. |
| UCB35625 | |
| probucol | |
| 2R 3R 4R 5S)-N 3 4 5-tetrahydroxy-1-[4-(phenoxy)phenyl]sulfonylpiperidine-2-carboxamide | |
| [<sup>125</sup>I]neuromedin U-23 (rat) | |
| etazolate | |
| pirlindole | |
| 1DMe | |
| (<i>S</i>)-3 4-DCPG | |
| YM298198 | |
| d[Leu<sup>4</sup> Dap<sup>8</sup>]VP | |
| 13 14-dihydro-15-keto-PGF<sub>2α</sub> | |
| MK-5046 | |
| tetrabenazine | |
| ABS212 | |
| N36 | |
| BIM 23627 | |
| L689560 | |
| L-796449 | |
| triazine compound PC7 | |
| ethinyl estradiol | |
| KF 17837S | |
| PYY-(13-36) (mouse rat pig) | |
| N-Me-aminopyrimidinone 9 | |
| 2MeSAMP | |
| ZM 253270 | |
| oxotremorine-M | A quaternary ammonium ion that has formula C11H19N2O. |
| β-alanine | |
| 5-iodoUDP | |
| diclofenac | A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. |
| (3R 5S 6E)-7-[4-(4-fluorophenyl)-2-methyl-1-phenyl-1H-pyrrol-3-yl]-3 5-dihydroxyhept-6-enoate | |
| [<sup>18</sup>F]FITM | |
| MZ-4-169 | |
| [des-Phe<sup>9</sup> des-Arg<sup>10</sup>]kallidin | |
| molindone | |
| ACTH-(11-24) | |
| (8S 11R)-N-[(4-carbamimidoylphenyl)methyl]-10-oxo-11-phenylmethanesulfonamido-3 4 5 9 14 15 16-heptaazatetracyclo[16.3.1.1.1]tetracosa-1(21) 4 6(24) 13(23) 14 18(22) 19-heptaene-8-carboxamide | |
| SB 272183 | |
| NS8593 | |
| (<i>S</i>)-4-AHCP | |
| [<sup>3</sup>H]EYF | |
| ONO-1301 | |
| ciglitazone | An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist. |
| ramiprilat | A dipeptide that is the active metabolite of ramipril. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. |
| rofecoxib | |
| cyproterone acetate | A chlorinated steroid that has formula C24H29ClO4. |
| BPH-830 | |
| CP-775146 | |
| emricasan | |
| psalmotoxin 1 | |
| p-nitrophenyl glutamyl anilide | |
| raloxifene | A benzothiophene that has formula C28H27NO4S. |
| [<sup>3</sup>H]A778317 | |
| pasireotide | |
| methyltestosterone | A 17beta-hydroxy steroid that is testosterone bearing a methyl group at the 17alpha position. |
| U50488 | A monocarboxylic acid amide obtained by formal condensation between the carboxy group of 3,4-dichlorophenylacetic acid and the secondary amino group of (1R,2R)-N-methyl-2-(pyrrolidin-1-yl)cyclohexanamine |
| SCH 206272 | |
| INSL3 B-chain analogue | |
| VU0090157 | |
| oleic acid | An octadec-9-enoic acid in which the double bond at C-9 has Z (cis) stereochemistry. |
| fenoprofen | Propanoic acid in which one of the hydrogens at position 2 is substituted by a 3-phenoxyphenyl group. A non-steroidal anti-inflammatory drug, the dihydrate form of the calcium salt is used for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding. |
| arformoterol | |
| (3R 5S 6E)-7-[4-(4-fluorophenyl)-1 2-bis(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyhept-6-enoate | |
| SB 649915 | |
| geranylgeranyl diphosphate | A polyprenol diphosphate having geranylgeranyl as the polyprenyl component. |
| 4-[({5-[(3R 5R)-6-carboxylato-3 5-dihydroxyhexyl]-1-ethyl-4-(4-fluorophenyl)-3-methyl-1H-pyrrol-2-yl}formamido)methyl]benzoate | |
| desmosterol | A cholestanoid that is cholesta-5,24-diene substituted by a beta-hydroxy group at position 3. It is an intermediate metabolite obtained during the synthesis of cholesterol. |
| ginkgolide J | A diterpene lactone that has formula C20H24O10. |
| UNC0642 | |
| [<sup>35</sup>S]ACPPB | |
| IDRA-21 | |
| [<sup>3</sup>H]WIN55212-2 | |
| INS49266 | |
| L-serine | The L-enantiomer of serine. |
| AM3 | |
| RGFP109 | |
| PIBTU | |
| [<sup>125</sup>I]SP (human mouse rat) | |
| compound 12 [PMID:12723943] | |
| galanin(3-29) (rat/mouse) | |
| MK-886 | |
| [<sup>3</sup>H]glutamine | |
| everolimus | |
| JZL184 | |
| GYPGQV-NH<sub>2</sub> | |
| [<sup>125</sup>I]astressin | |
| bepridil | |
| bimatoprost | |
| [<sup>3</sup>H]raclopride | |
| apigenin | A trihydroxyflavone that is flavone substituted by hydroxy groups at positions 4', 5 and 7. |
| arachidonylcyclopropylamide | |
| isopropyl-4-(3-cyano-5-(quinoxalin-6-yl)pyridine-2-yl)piperazine-1-carboxylate | |
| mitoxantrone | A hydroxyanthraquinone that has formula C22H28N4O6. |
| YM-355179 | |
| scopolamine | A tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol. |
| [<sup>125</sup>I][Tyr<sup>3</sup> Thr<sup>8</sup>]octreotide | |
| A331440 | |
| (2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]propanamido]pentanedioic acid | |
| [<sup>3</sup>H]nicotine | |
| trandolapril | |
| anisindione | |
| RP67580 | |
| DY131 | |
| Met-Ckβ7 | |
| etorphine | An alcohol that has formula C25H33NO4. |
| apraclonidine | An imidazoline compound having a 4-amino-2,6-dichloroanilino group at the 2-position. |
| compound 17f (PMID:19632837) | |
| LTX<sup>(N4C)</sup> | |
| EMPA | |
| almorexant | |
| nortriptyline | An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline. |
| 3-(prop-2-en-1-yl)-4-{3-[(propan-2-yl)amino]propoxy}phenyl propanoate | |
| E-6801 | |
| STA<sub>2</sub> | |
| BIM 23454 | |
| novokinin | |
| CGP 12177 | A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group. |
| [<sup>125</sup>I]CCL3 (human) | |
| T2328 | |
| JNJ-479655 | |
| [<sup>14</sup>C]histidine | |
| [<sup>125</sup>I]C3a (human) | |
| 22-oxacal​citriol | |
| TCS-OX2-29 | |
| itriglumide | |
| (2-guanidino-1-hydroxy-1-phosphono-ethyl)phosphonic acid | |
| compound 14a [PMID:18812259] | |
| JNJ-5207787 | |
| ragaglitazar | |
| ABS-201 | |
| FSH deglycosylated α/β | |
| GR148672X | |
| FLPLAR | |
| (3R 5R)-7-[4-(4-fluorophenyl)-5-methyl-1-phenyl-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| (6R 7R)-1-[(4S 5R)-4-(acetyloxy)-5-benzyl-3-methylidenehexyl]-4 7-dihydroxy-6-[(11-phenoxyundecanoyl)oxy]-2 8-dioxabicyclo[3.2.1]octane-3 4 5-tricarboxylic acid | |
| [<sup>3</sup>H]pirenzepine | |
| lixivaptan | |
| 5-MeO-DMT | |
| homo-AMPA | |
| α-methyl-D L-tryptophan | |
| Ac-hMCH-(6-16)-NH2 | |
| SB 221284 | An indolyl carboxylic acid that has formula C16H14F3N3OS. |
| tamapin | |
| compound 5 [PMID: 22533316] | |
| MRS2567 | |
| S18986 | |
| (3R)-4-{[6-(4-fluorophenyl)-4-(propan-2-yl)-3-azatricyclo[9.4.0.0^{2 7}]pentadeca-1(15) 2(7) 3 5 11 13-hexaen-5-yl]methyl phosphonato}-3-hydroxybutanoate | |
| capromab | |
| draflazine | |
| flesinoxan | |
| {3-[4-butoxy-2-(prop-2-en-1-yl)phenoxy]propyl}(propan-2-yl)amine | |
| exendin-4 | A bioactive polypeptide of 39 amino acid residues isolated from the saliva of the Gila monster (Heloderma suspectum). High-affinity glucagon-like peptide 1 (GLP-1) receptor agonist (Kd = 136 pM); potently induces cAMP formation without stimulating amylase release in pancreatic acini; potentiates glucose-induced insulin secretion in isolated rat islets; protects against glutamate-induced neurotoxicity. A synthetic version is called exenatide. |
| EPZ-5676 | |
| YM-202074 | |
| d[<small>D</small>-Pal<sup>2</sup>]AVP | |
| CGP 71683A | |
| corticosterone | A 21-hydroxy steroid that is consists of pregn-4-ene substituted by hydroxy groups at positions 11 and 21 and oxo groups at positions 3 and 20. Corticosterone is a 21-carbon steroid hormone of the corticosteroid type produced in the cortex of the adrenal glands. |
| L701324 | |
| odanacatib | |
| capsazepine | A benzazepine that is 2,3,4,5-tetrahydro-1H-2-benzazepine which is substituted by hydroxy groups at positions 7 and 8 and on the nitrogen atom by a 2-(p-chlorophenyl)ethylaminothiocarbonyl group. A synthetic analogue of capsaicin, it was the first reported capsaicin receptor antagonist. |
| (-)-methadone | A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4. |
| cholesterol sulphate | |
| vemurafenib | |
| [<sup>125</sup>I]triptorelin | |
| LY334370 | |
| carvacrol | A phenol that is a natural monoterpene derivative of cymene. An inhibitor of bacterial growth, it is used as a food additive. Potent activator of the human ion channels transient receptor potential V3 (TRPV3) and A1 (TRPA1). |
| L-368 228 | |
| (-)-norfenfluramine | |
| E2078 | |
| Zn<sup>2+</sup> | |
| compound 3 [PMID: 22533316] | |
| (E)-ethylidene({[3-(prop-2-en-1-yl)-4-{3-[(propan-2-yl)amino]propoxy}phenyl]methoxy})amine | |
| GDP | A purine ribonucleoside 5'-diphosphate that has formula C10H15N5O11P2. |
| norfluoxetine | |
| flavanone | The simplest member of the class of flavanones that consists of flavan bearing an oxo substituent at position 4. |
| MK 6892 | |
| LUF5981 | |
| noradrenaline | A catecholamine in which C-1 of the aminoethyl side-chain is hydroxy-substituted. |
| UK-356618 | |
| [<sup>125</sup>I]CCL2 | |
| 4-hydroxynonenal | |
| [Tyr<sup>8</sup>]GnRH | |
| [<sup>3</sup>H]HEMADO | |
| LY456236 | |
| zatebradine | |
| ARL-15849 | |
| fMet-Leu-Phe-Ile-Ile-Lys-FITC | |
| ABT-239 | |
| difluorophenyl-dihydro-indenyl isobutyl-dioxopiperazinyl-isopropylethanamide | |
| N-(S)-MPEPAamide | |
| VPC03090-P | |
| UFP-102 | |
| benzquinamide | |
| ShK Toxin | |
| ST-1535 | |
| ASIP [90-132 (L89Y)] | |
| L-152 804 | |
| anastrozole | A 1,2,4-triazole compound having a 3,5-bis(2-cyano-2-propyl)benzyl group at the 1-position. |
| guanylpirenzepine | |
| PF-06463922 | |
| ibutilide | |
| chlordane | A cyclodiene organochlorine insecticide that has formula C10H6Cl8. |
| compound 14 [PMID: 21155570] | |
| DRF 2519 | |
| NAADP | |
| dofetilide | |
| motilin-(1-11) (human) | |
| thioridazine | A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position. |
| BAYu9773 | |
| DAMGO | |
| PGF<sub>1α</sub> | |
| triazine compound PC10 | |
| CP-294838 | |
| VNA932 | |
| [<sup>111</sup>In]DOTA-BOC-ATE | |
| rebamipide | |
| 1400W | |
| AR-C118925XX | |
| T<sub>4</sub> | |
| thiochrome | |
| GSK2193874 | |
| (S)-UH 301 | |
| zofenoprilat | A proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-2-methyl-3-sulfanylpropanoyl group. The active metabolite of zofenopril. |
| lisuride | |
| JNJ-38431055 | |
| entacapone | |
| NE-100 | |
| pilocarpine | |
| Lys-CoA | |
| CP608 039 | |
| dodecane-1-hydroxy-1 1-bisphosphonate | |
| (-)-devapamil | A nitrile that acts as an L-type calcium channel blocker. |
| secretin-(5-27) (pig) | |
| N-arachidonoylglycine | Biologically active derivative of anandamide |
| [<sup>3</sup>H]TBZOH | |
| donitriptan | |
| Ni<sup>2+</sup> | |
| YM976 | |
| methylhistaprodifen | |
| fludrocortisone | A mineralocorticoid that has formula C21H29FO5. |
| mirabegron | |
| [<sup>3</sup>H]A81988 | |
| azithromycin | A macrolide antibiotic useful for the treatment of bacterial infections. |
| [<sup>3</sup>H](R)-NPTS | |
| MRS923 | |
| EPZ-6438 | |
| [Ile<sup>5</sup> Val<sup>21</sup>]PTHrP-(1-34) (human) | |
| cirazoline | |
| compound 42 [PMID: 17189691] | |
| bombesin | |
| HJC 0350 | |
| (4S 6S)-6-{2-[1 5-bis(4-fluorophenyl)-3-(propan-2-yl)-1H-pyrazol-4-yl]ethyl}-4-hydroxyoxan-2-one | |
| BMY-14802 | |
| L-glutamine | An optically active form of glutamine having L-configuration. |
| (+)-HA966 | |
| SNAP5089 | |
| methoprene acid | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Thr<sup>4</sup> Phe(3I 4N<sub>3</sub>)-NH<sub>2</sub><sup>9</sup>]OVT | |
| compound 3j [PMID:21444206] | |
| dapiprazole | |
| palmitic acid | A straight-chain, sixteen-carbon, saturated long-chain fatty acid. |
| PGI<sub>2</sub> | |
| MRS2950 | |
| MRS2957 | |
| SKF 105854 | |
| 1-(diphosphenyloxy)-3-methylpentan-3-ol | |
| domperidone | |
| compound 1q [PMID:18029181] | |
| ONO-4057 | |
| cicaprost | |
| Gal-B2-C<sub>10</sub> | |
| 7α-N<sub>3</sub>-ginkgolide B | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup> Val<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| adenophostin A | A disaccharide phosphate that has formula C16H26N5O18P3. |
| compound 3 [PMID: 21105727] | |
| CGP53353 | |
| CPPHA | |
| compound 23i [PMID: 17929793] | |
| 4-[dimethyl(9-phenylnonyl)azaniumyl]butane-1-sulfonate | |
| ROMe | |
| cerivastatin | (3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cholesterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity. |
| p-[<sup>18</sup>F]MPPF | |
| [<sup>3</sup>H]pentazocine | |
| bufexamac | |
| CPT | |
| ciproxifan | |
| BMS204352 | An indole that has formula C16H10ClF4NO2. |
| sea anemone toxin BDS-I | |
| Thr<sup>10</sup>contulakin-G | |
| zotepine | |
| Ro0711401 | |
| AP18 | |
| ABT702 | |
| 2-[(2-carbamimidoyl-1-benzothiophen-4-yl)oxy]-2-phenylethyl N-(2-{[(2-methylpropyl)amino]methyl}phenyl)carbamate | |
| furmethide | |
| dacinostat | |
| JNJ 10397049 | |
| α-bungarotoxin | |
| GSK1016790A | |
| LY063518 | |
| selegiline | |
| nTzDpa | |
| [4-[(4-tert-butylcyclohexanecarbonyl)amino]phenyl] N-morpholin-4-ylcarbamate | |
| Gal-B2-C<sub>18</sub> | |
| 4-(3-piperdin-1-yl-propoxy)benzonitrile | |
| [des-Pro<sup>8</sup> des-Phe<sup>9</sup> des-Arg<sup>10</sup>]kallidin | |
| A-850002 | |
| guanfacine | |
| CP 154 526 | |
| GSK4112 | |
| SKF-81297 | |
| Z-Arg-Leu-Val-Agly-Ile-Val-OMe | |
| 5α-pregnan-3α-ol-20-one | |
| KF24345 | |
| JI-38 | |
| fluoxetine | A aromatic ether consisting of 4-trifluoromethylphenol substituted on oxygen by a 3-(methylamino)-1-phenylpropyl group. |
| arecaidine propargyl ester | |
| RPR121154 | |
| N<sup>1</sup>-dansyl-spermine | |
| LY293284 | |
| auranofin | |
| abiraterone | |
| VU0080241 | |
| SB 204741 | |
| phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide | |
| 3-iodothyronamine | |
| APETx-1 | |
| compound 29b [PMID: 20809633] | |
| (3R 5R)-7-[1-(4-fluorophenyl)-3-{methyl[(1R)-1-phenylethyl]carbamoyl}-4-(propan-2-yl)-1H-pyrazol-5-yl]-3 5-dihydroxyheptanoate | |
| (S)-(+)-CBPG | |
| UBP310 | |
| bestatin | A peptide that has formula C16H24N2O4. |
| galanin(1-11) | |
| Met-Lys-bradykinin | |
| VUF 8328 | |
| LY466195 | |
| [<sup>123</sup>I]iodobenzovesamicol | |
| fexaramine | A biphenyl that has formula C32H36N2O3. |
| 5-methoxy-luzindole | |
| PAC1 | |
| methimazole | A member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen. |
| SB234551 | |
| R-486 | |
| vapiprost | |
| PD 161182 | |
| A127722 | |
| alitretinoin | |
| [<sup>3</sup>H]resolvin D1 | |
| 2-methyl-5-HT | |
| cisapride | The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere. |
| 9-OH-risperidone | |
| [<sup>125</sup>I]EXP985 | |
| 52770 RP | |
| teduglutide | A 33-membered polypeptide consisting of His, Gly, Asp, Gly, Ser, Phe, Ser, Asp, Glu, Met, Asn, Thr, Ile, Leu, Asp, Asn, Leu, Ala, Ala, Arg, Asp, Phe, Ile, Asn, Trp, Leu, Ile, Gln, Thr, Lys, Ile, Thr and Asp residues joined in sequence. A glucagon-like peptide-2 receptor agonist used for the treatment of short-bowel syndrome. |
| tofacitinib | |
| SSR240612 | |
| impromidine | |
| CFMTI | |
| NB-598 | |
| ramipril | A dipeptide that is the prodrug for ramiprilat, the active metabolite obtained by hydrolysis of the ethyl ester group. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. |
| robalzotan | |
| TAK-779 | |
| [His<sup>5</sup> Arg<sup>19</sup>]PTH-(1-34) (human) | |
| epigallocatechin-3-gallate | A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. |
| L655708 | |
| [<sup>125</sup>I](Tyr<sup>10</sup>)secretin | |
| ZD7288 | |
| SC46275 | |
| UK-356202 | |
| SB366791 | |
| MK 1903 | |
| (S)-flurocarazolol | |
| rauwolscine | A methyl 17-hydroxy-20xi-yohimban-16-carboxylate that has formula C21H26N2O3. |
| dicyclomine | The ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularly that associated with irritable bowel syndrome. |
| carvedilol | A member of the class of carbazoles that is an adrenergic antagonist with non-selective beta- and alpha-1 receptor blocking properties which helps in the management of congestive heart failure. |
| staurosporine | An indolocarbazole alkaloid that has formula C28H26N4O3. |
| cholic acid | A bile acid that is 5beta-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12. |
| docosahexaenoic acid | Any C22 polyunsaturated fatty acid containing six double bonds. |
| [<sup>125</sup>I]CCL5 (human) | |
| MRS1177 | |
| β<sup>3</sup>-tetrapeptide | |
| NBI27914 | |
| (4R)-6-[(1E)-4 4-bis(4-fluorophenyl)-3-(1-methyl-1H-1 2 3 4-tetrazol-5-yl)buta-1 3-dien-1-yl]-4-hydroxyoxan-2-one | |
| T0156 | |
| A8<sup>Δ71-73</sup> | |
| alprazolam | A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug. |
| galanin(3-30) (human) | |
| GR 175737 | |
| 3-[4-(1 3-benzothiazol-2-yl)phenyl]-octahydropyrido[2 1-c]morpholin-3-ol | |
| compound 1 (PMID: 22795084) | |
| AMG7703 | |
| arachidonic acid | A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14. |
| LY 156735 | |
| solifenacin | |
| [<sup>125</sup>I]mini-TyrRS | |
| MSOPPE | |
| concanavalin A | |
| N-methyl LTC<sub>4</sub> | |
| sphingosylphosphorylcholine | |
| NBTI | |
| trandolaprilat | |
| Lys[Z(NO<sub>2</sub>)]-Lys[Z(NO<sub>2</sub>)] | |
| (2S)-2-benzyl-3-{[(2S)-1-[(2S)-2-acetamido-4-methylpentanoyl]pyrrolidin-2-yl](hydroxy)phosphoryl}propanoic acid | |
| ixabepilone | |
| dibenzoxazepine | |
| PrRP-(24-31) (human) | |
| betamethasone | A glucocorticoid that has formula C22H29FO5. |
| L-826266 | |
| (2E 6E)-farnesylbisphosphonate | |
| (-)-propranolol | A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. |
| 1-[4-(3-piperidin-1-ylpropoxy)benzyl]piperidine | |
| MNI-135 | |
| LY392098 | |
| p-guanidinobenzoyl-MCH-(7-17) | |
| [D-Arg<sup>1</sup> D-Phe<sup>5</sup> D-Trp<sup>7 9</sup> Leu<sup>11</sup>]substance P | |
| [<sup>3</sup>H]PGD<sub>2</sub> | |
| lazabemide | |
| nafadotride | A naphthalenecarboxamide resulting from the formal condensation of the carboxylic acid group of 4-cyano-1-methoxynaphthalene-2-carboxylic acid with the primary amino group of 1-(1-butylpyrrolidin-2-yl]methanamine. It is a highly potent, competitive, preferential dopamine D3 receptor antagonist, centrally active upon systemic administration. |
| 1'-acetoxychavicol acetate | An acetate ester that is chavicol acetate substituted by an acetoxy group at position 1'. |
| T-0509 | |
| [<sup>125</sup>I]cathepsin G (human) | |
| calindol | |
| dapagliflozin | |
| brilliant blue G | |
| d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Ile<sup>4</sup> Ala-NH<sub>2</sub>]AVP | |
| retigabine | |
| VU0360172 | |
| sulpiride | |
| vorinostat | |
| RS 93520 | |
| [<sup>3</sup>H]thiamine | |
| LY320135 | |
| misoprostol (methyl ester) | |
| (+)-DOI | |
| tideglusib | |
| Pyr3 | |
| [<sup>3</sup>H](<i>R</i>)-α-methylhistamine | |
| [<sup>125</sup>I]GLP-1-(7-37) | |
| γ-hydroxybutyric acid | |
| NECA | A derivative of adenosine in which the 5'-hydroxymethyl group is replaced by an N-ethylcarboxamido group. |
| BIM 23197 | |
| CTOP | |
| PBC-264 | |
| CGP 54626A | |
| compound 48 [PMID: 22364337] | |
| conantokin-G | |
| [<sup>3</sup>H]L689560 | |
| compound R-(-)-5f [PMID: 22607879] | |
| HS014 | |
| 3-iodotyrosine | |
| vismodegib | |
| [<sup>3</sup>H]AP4 | |
| spiradoline | |
| PMX53 | |
| CP55940 | |
| compound 19a (PMID: 24359159) | |
| eugenol | |
| VL-0395 | |
| BQ788 | |
| sakuranetin | A flavonoid phytoalexin that is (S)-naringenin in which the hydroxy group at position 7 is replaced by a methoxy group. |
| alpha-methyltyrosine | |
| trans trans-farnesyl diphosphate | |
| [D-Phe<sup>12</sup>]bombesin | |
| nimodipine | A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm. |
| NNC052090 | |
| chloroquine | An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis. |
| acetyl-podocarpic dimer | |
| hydroxychloroquine | |
| [<sup>3</sup>H]PGE<sub>2</sub> | |
| NVP ACQ090 | |
| [<sup>125</sup>I]CXCL7 | |
| 4-methylhistamine | An aralkylamino compound that is histamine bearing a methyl substituent at the 5 position on the ring. |
| Z-LEHD-FMK | |
| SB 271046 | |
| BU-E 47 | |
| galparan | |
| lovastatin | A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as a antilipemic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). |
| [D-Lys<sup>6</sup>]GnRH-II | |
| [<sup>125</sup>I]GnRH I (human mouse rat) | |
| PMX205 | |
| FTIDC | |
| EISAI-2 | |
| SITS | |
| isoflurane | An organofluorine compound that has formula C3H2ClF5O. |
| compound 36 [PMID:21273063] | |
| BRL-15572 | |
| RS-102221 | |
| ticagrelor | |
| [<sup>125</sup>I]CCL19 | |
| alloxazine | A benzo[g]pteridine-2,4-dione that has formula C10H6N4O2. |
| LG100754 | |
| SB-408124 | |
| FPL64176 | 1H-Pyrrole substituted at C-2 and -5 by methyl groups, at C-3 by methoxycarbonyl and at C-4 by a 2-benzylbenzoyl group. |
| [Ala<sup>11</sup> D-Leu<sup>15</sup>]orexin-B | |
| [<sup>125</sup>I]CXCL1 | |
| atorvastatin lactone | |
| [Phaa<sup>1</sup> <small>D</small>-Tyr(Me)<sup>2</sup> Arg<sup>6</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| [<sup>125</sup>I]HEAT | |
| tamibarotene | A tetralin that has formula C22H25NO3. |
| Ac-Lys-[MeAla<sup>6</sup> Leu<sup>8</sup> des-Arg<sup>9</sup>]bradykinin | |
| RO4929097 | |
| [<sup>3</sup>H]haTRAP | |
| (-)-sulpiride | |
| [<sup>3</sup>H]citalopram | |
| ruthenium red | A ruthenium coordination entity that has formula H42N14O2Ru3.6Cl. |
| ipsapirone | |
| LGR7-truncate | |
| bazedoxifene | |
| tolrestat | |
| KB-141 | |
| SC-435 | |
| pamidronic acid | |
| L-371 257 | |
| amoxapine | A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position. |
| N-[3-cyano-6-(1 1-dimethylpropyl)-4 5 6 7-tetrahydro-1-benzothien-2-yl]-2-ethylbutanamide | |
| (+)-UH232 | |
| AMG 9810 | |
| L-365 209 | |
| [<sup>14</sup>C]methylamine | |
| A192621 | |
| [<sup>125</sup>I]MCH (human mouse rat) | |
| allicin | A sulfoxide that has formula C6H10OS2. |
| WKYMVm | |
| PRE-084 | |
| [D-Ala<sup>2</sup>]deltorphin II | |
| S-15535 | |
| 5-[(2S)-2-(phenoxymethyl)pyrrolidin-1-yl]sulfonyl-1-(phenylmethyl)indole-2 3-dione | |
| M1145 | |
| NH<sub>4</sub>Cl | |
| [<sup>3</sup>H]glycine | |
| bretazenil | |
| [<sup>14</sup>C]MTEP | |
| BPH-252 | |
| [<sup>3</sup>H]CP55940 | |
| (S)-4CPG | |
| LY53857 | |
| resiniferatoxin | A diterpenoid that has formula C37H40O9. |
| [<sup>125</sup>I-Tyr]Ac2-26 | |
| [<sup>125</sup>I]CGP 64213 | |
| α-methylphenylalanine | |
| [<sup>3</sup>H]NAD 299 | |
| xanomeline | A tetrahydropyridine that has formula C14H23N3OS. |
| N' 2-diphenylquinoline-4-carbohydrazide 8m | |
| rT<sub>3</sub> | |
| 1-stearoyl-lysophosphatidylcholine | |
| A-71378 | |
| milrinone | A member of the class of bipyridines that is 2-pyridone which is substituted at positions 3, 5, and 6 by cyano, pyrid-4-yl, and methyl groups, respectively. It is used (particularly intravenously, as the lactate) for the short-term management of severe heart failure. |
| benazepril | A benzazepine that has formula C24H28N2O5. |
| fenofibric acid | A monocarboxylic acid that is 2-methylpropanoic acid substituted by a 4-(4-chlorobenzoyl)phenoxy group at position 2. It is a metabolite of the drug fenofibrate. |
| estrone | A 17-oxo steroid that is estra-1,3,5(10)-triene substituted by an hydroxy group at position 3 and an oxo group at position 17. |
| alefacept | |
| SCH442416 | |
| imiglitazar | |
| tiagabine | |
| galanin(1-13)amide | |
| AR305352 | |
| BW 245C | |
| Co<sup>2+</sup> | |
| 5-methylurapidil | |
| SiFA-Asn(AcNH-β-Glc)-PEG-Tyr³-octreotate | |
| NVP 231 | |
| [<sup>3</sup>H]paroxetine | |
| [<sup>3</sup>H]apafant | |
| AP811 | |
| 7α-OAc-ginkgolide B | |
| LY97241 | |
| L-97-1 | |
| sorafenib | |
| toxaphene | A highly complex mixture of several hundred polychlorinated compounds obtained by chlorination of camphene to an overall chlorine content of 67-69% by weight and having an overall empirical formula of C10H10Cl8 (including optical isomers, it could theoretically contain over 32,000 congeners). Toxaphene was used from the mid-1940s as an agricultural insecticide (mostly in the USA, particularly on corn and soybeans). Usage increased with the phasing out of DDT in the 1970s and it became the most heavily manufactured pesticide in the US, but it is now banned as a result of concerns over its toxicity and carcinogenicity. It is estimated that total production since its first use was around half a million tons. In the environment, most of the components of toxaphene get metabolised, but from 10 to >100 resist biodegradation, depending on the medium and the specialisation of the enzyme system. Breathing, drinking or eating high levels of toxaphene can damage the lungs, kidneys, and nervous system. |
| darapladib | |
| diquafosol | A pyrimidine ribonucleoside 5'-tetraphosphate compound having 5'-uridinyl residues at the P(1)- and P(4)-positions. |
| GHRH-(1-29)-NH<sub>2</sub> (rat) | |
| MA-2029 | |
| (4R)-6-[(E)-2-[4-(4-fluorophenyl)-2 6-bis(propan-2-yl)pyrimidin-5-yl]ethenyl]-4-hydroxyoxan-2-one | |
| dexloxiglumide | |
| PHCCC | |
| befloxatone | |
| WS-12 | |
| [<sup>3</sup>H]dihydrotestosterone | |
| [<sup>3</sup>H]α-bungarotoxin | |
| cyamemazine | |
| rimonabant | |
| clopidogrel (active metabolite) | |
| compound 22a [PMID: 21688779] | |
| donepezil | Donepezil is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine. |
| NS-49 | |
| treprostinil | |
| [<sup>3</sup>H]<i>p</i>-MPPF | |
| [<sup>3</sup>H]MeTRH | |
| In-NODAGATOC | |
| SB251023 | |
| Z-DEVD-FMK | |
| bisandrographolide | |
| levetimide | |
| [Nphe<sup>1</sup>]N/OFQ-(1-13)-NH<sub>2</sub> | |
| NPC-349 | |
| AMG628 | |
| (3R)-6-[2-(4-fluorophenyl)-4 6-bis(propan-2-yl)phenoxy]-3 5-dihydroxyhexanoate | |
| 3-(4-phenylphenyl)-1-azabicyclo[2.2.2]octan-3-ol | |
| MRS2496 | |
| ranibizumab | |
| NAN 190 | An N-alkylpiperazine that consists of (2-methoxyphenyl)piperazine in which the amine hydrogen is substituted by a 4-(2-phthalimido)butyl group. |
| NC 4-28B | |
| eglumegad | |
| D-23487 | |
| methotrexate | A pteridine that has formula C20H22N8O5. |
| ADP ribose | |
| (<i>S</i>)-5-fluorowillardiine | |
| phenylacetyl-Ala DTrp-phenthylamide | |
| [<sup>125</sup>I]BH-[Sar<sup>9</sup> Met(O<sub>2</sub>)<sup>11</sup>]SP | |
| fMet-Ile-Phe-Leu | |
| N-chloromethyl-brucine | |
| IPDX | |
| [<sup>3</sup>H]MK-912 | |
| peptide III-BTD | |
| LY303870 | |
| vanillotoxin-1 | |
| vanillotoxin-2 | |
| vanillotoxin-3 | |
| [Ile<sup>5</sup> Glu<sup>19</sup> Val<sup>21</sup>]PTHrP-(1-34) (human) | |
| [Phe<sup>23</sup>]PTH-(1-34) (human) | |
| fasiglifam | |
| ACDPP | |
| methyl 4-[4-chloro-3-(trifluoromethyl)phenyl]-6-methyl-3-oxo-1 4 7-tetrahydroisobenzofuran-5-carboxylate | |
| PD-156707 | |
| ketoconazole | A N-carbonylpiperazine that has formula C26H28Cl2N4O4. |
| betulinic acid | A pentacyclic triterpenoid that is lupane having a double bond at position 20(29) as well as 3beta-hydroxy and 28-carboxy substituents. It is found in the bark and other plant parts of several species of plants including Syzygium claviflorum. It exhibits anti-HIV, antimalarial, antineoplastic and anti-inflammatory properties. |
| clofilium | An organic amino compound that has formula C21H37ClN. |
| B-R13/17K H2 relaxin | |
| <i>S</i>-(-)CPB | |
| compound 42 [PMID:22420767] | |
| [Ac-D-2Nal<sup>1</sup> D4CPA<sup>2</sup> D-3Pal<sup>3 6</sup> Leu<sup>8</sup> D-Ala<sup>10</sup>]GnRH-II | |
| ZK112993 | |
| [<sup>125</sup>I]PYY-(3-36) (human) | |
| [<sup>125</sup>I][Ala<sup>1 3 11 15</sup>]ET-1 | |
| [Sar<sup>1</sup> Ile<sup>8</sup>]Ang-II | |
| <i>S</i>-(-)CPP | |
| lasmiditan | |
| compound 20 [PMID: 16439120] | |
| UBP141 | |
| kaliotoxin | |
| sitagliptin | A triazolopyrazine that exhibits hypoglycemic activity. |
| [<sup>125</sup>I]neuromedin U-8 (pig) | |
| tifluadom | A benzodiazepine that has formula C22H20FN3OS. |
| CVT-6883 | |
| dextromethorphan | An organic heterotetracyclic compound that is morphinan substituted by a methoxy group at position 3 and a methyl group at position 7. It is used as an antitussive drug for suppressing cough. |
| Cd<sup>2+</sup> | |
| flunitrazepam | |
| JNJ-40068782 | |
| calciseptine | |
| [<sup>125</sup>I]BOP | |
| SC 53116 | |
| [<sup>3</sup>H]GBR12935 | |
| [<sup>3</sup>H]estrone-3-sulphate | |
| [<sup>67</sup>Ga]NODAGA-[Tyr<sup>3</sup>]octreotide | |
| 4-[2-fluoro-5-(4-fluorophenoxy)phenyl]-1-phosphonatobutane-1-sulfonate | |
| compound 1 (PMID: 15724976) | |
| ADX71743 | |
| naloxone | A morphinane alkaloid that has formula C19H21NO4. |
| SR142948A | |
| amantidine | |
| NPY-(20-36) (pig) | |
| IQM-97423 | |
| [Nle<sup>8 18</sup> Tyr<sup>34</sup>]PTH-(3-34)-NH<sub>2</sub> (bovine) | |
| dipraglurant | |
| tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide | |
| AZ12216052 | |
| SHA 68 | |
| trans-cinnamoyl-LIGRLO [N-[<sup>3</sup>H]propionyl]-NH<sub>2</sub> | |
| Cl<sup>-</sup> | |
| 10-OBn-ginkgolide B | |
| 10-OBn-ginkgolide C | |
| proglumide | |
| compound 6 [PMID: 22533316] | |
| norfenfluramine | |
| devazepide | An indolecarboxamide obtained by formal condensation of the carboxy group of indole-2-carboxylic acid with the exocyclic amino group of (3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one. A cholecystokinin antagonist used for treatment of gastrointestinal disorders. |
| omega-chloroacetophenone | |
| NIBR-0213 | |
| [<sup>125</sup>I]ACTH-(1–24) | |
| [<sup>3</sup>H]valsartan | |
| S33084 | |
| R 914 | |
| triazolam | A triazolobenzodiazepine that has formula C17H12Cl2N4. |
| [<sup>3</sup>H]D-aspartic acid | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Tyr(Et)<sup>2</sup> Ile<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| nicotinic acid | A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group. |
| [<sup>3</sup>H]irbesartan | |
| [<sup>125</sup>I]PD164333 | |
| tetrahydrocannabivarin | |
| αβ-meATP | |
| D-24710 | |
| 4P-PDOT | |
| degarelix | |
| procaterol | |
| 1-benzyl-APDC | |
| 12S-HETE | A HETE having a (12S)-hydroxy group and (5Z)-, (8Z)-, (10E)- and (14Z)-double bonds. |
| <i>R</i>-(+)-methanandamide | |
| [<small>D</small>-Lys<sup>1</sup> des-Arg<sup>10</sup>]kallidin | |
| UFP-112 | |
| BIC1 | |
| α-conotoxin ImI | |
| L-692 429 | |
| <i>N</i>-benzyl brucine | |
| deltorphin II | A peptide that has formula C38H54N8O10. |
| MRS1093 | |
| BRL-54443 | |
| benzyl bromide | A member of the class of benzyl bromides that is toluene substituted on the alpha-carbon with bromine. |
| [<sup>125</sup>I]NPFF | |
| MRS1097 | |
| CSC | |
| PGE<sub>1</sub> | |
| PCCG-4 | |
| arpromidine | |
| cyclopentyladenosine | |
| GBR12935 | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(1-36) (human) | |
| 5-oxo-15-HETE | |
| prazosin | A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively. |
| (3R 5R)-7-[4-(4-fluorophenyl)-1-phenyl-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyheptanoate | |
| GALP(3-32) (human) | |
| eltrombopag | |
| compound 2 [PMID:19230660] | |
| waglerin-1 | |
| bupranolol | |
| LY108742 | |
| PD 154740 | |
| volinanserin | |
| DG-041 | |
| ER819762 | |
| BASS antagonist | |
| PGD<sub>2</sub> | |
| SSR 146977 | |
| AS1535907 | |
| TFMPP | |
| AH13205 | |
| dimethylhistaprodifen | |
| [<sup>3</sup>H]CTEP | |
| [<sup>3</sup>H]naltriben | |
| RS 116 1148 | |
| [Ala<sup>11 22 28</sup>]VIP | |
| [<sup>3</sup>H]MRE 3008F20 | |
| AC55649 | |
| AG-09/1 | |
| vandetanib | A quinazoline that is 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline bearing additional methoxy and 4-bromo-2-fluorophenylamino substituents at positions 6 and 4 respectively. Used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. |
| (3S)-4-{[(E)-2-[3'-(4-fluorophenyl)spiro[cyclopentane-1 1'-indene]-2'-yl]ethenyl](hydroxy)phosphoryl}-3-hydroxybutanoic acid | |
| compound 16m [PMID: 19931453] | |
| BIM 23052 | |
| [<sup>3</sup>H]F13640 | |
| [Sar<sup>1</sup> Ile<sup>4</sup> Ile<sup>8</sup>]Ang-II | |
| vanillin | A member of the class of benzaldehydes carrying methoxy and hydroxy substituents at positions 3 and 4 respectively. |
| galanin(1-15) | |
| KE 108 | |
| [<sup>125</sup>I]CCL17 | |
| crotylaldehyde | |
| dobutamine | A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure. |
| tubacin | |
| dihydro-D-erythrosphingosine | |
| domitroban | |
| Gö 7874 | |
| LSN2814617 | |
| pentagastrin | |
| FMOC-L-Leucine | |
| O-1812 | |
| 1 3-bis(phenylmethyl)-1 3-diazetidine-2 4-dione | |
| improgan | |
| NS9283 | |
| kynurenic acid | A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4. |
| pranlukast | |
| [<sup>18</sup>F]FP-TZTP | |
| FTI 276 | |
| VU0092145 | |
| CPS125 | |
| URB597 | |
| [<sup>11</sup>C]GlySar | |
| NBI-74330 | |
| [<sup>11</sup>C]doxepin | |
| 5-butyl-methyl immidazole carboxylate 30 | |
| brentuximab vedotin | |
| galnon | |
| [<sup>125</sup>I]Y-RFRP-3 | |
| AR244555 | |
| [<sup>125</sup>I]QRFP (human) | |
| S-14506 | |
| zolpidem | An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position. |
| PPAHV | |
| phloretin | A member of the class of dihydrochalcones that is dihydrochalcone substituted by hydroxy groups at positions 4, 2', 4' and 6'. |
| vorapaxar | A carbamate ester that is the ethyl ester of [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethynyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamic acid. A protease-activated receptor-1 antagonist used (as its sulfate salt) for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease. It has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke and urgent coronary revascularisation. |
| [<sup>125</sup>I]PrRP31 | |
| [<sup>125</sup>I]FSH (human) | |
| (S)-N-oleoyltyrosinol | |
| O-arachidonoyl ethanolamine | |
| GR79236 | |
| BVT173187 | |
| [<sup>3</sup>H]BH-[Sar<sup>9</sup> Met(O<sub>2</sub>)<sup>11</sup>]SP | |
| ZK 756326 | |
| NPS2390 | |
| benzylcysteine | |
| L-772 405 | |
| MSX-2 | |
| schisandrin A | |
| O-1602 | |
| L-366 948 | |
| BGC201531 | |
| SB 218795 | |
| dexmedetomidine | |
| Y-KE88 | |
| SB 277011-A | |
| compound 2 [PMID: 21105727] | |
| (+)-menthol | |
| BIM 23295 | |
| CHF-5074 | |
| mini-TyrRS | |
| SB-282241 | |
| compound 8f [PMID:20615702] | |
| fluocinolone acetonide | A fluorinated steroid that is flunisolide in which the hydrogen at position 9 is replaced by fluorine. A corticosteroid with glucocorticoid activity, it is used (both as the anhydrous form and as the dihydrate) in creams, gels and ointments for the treatment of various skin disorders. |
| CXCL12-(1-9) dimer | |
| CGS-12066 | |
| BMS614 | |
| meclofenamic acid | An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis. |
| 1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole | |
| SB656104 | |
| GS9667 | |
| 7NI | |
| PG-901 | |
| Up<sub>3</sub>U | |
| α-propyldopacetamide | |
| lanreotide | |
| kisspeptin-15 | |
| [<sup>3</sup>H]desGly-NH<sub>2</sub>[D-Ile<sup>2</sup> Ile<sup>4</sup>]VP | |
| guggulsterone | |
| [<sup>3</sup>H]<i>N</i>-methylspiperone | |
| compound 16a [PMID: 14697765] | |
| 7β-hydroxycholesterol | A 7beta-hydroxy steroid that has formula C27H46O2. |
| MZ-5-156 | |
| diazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. |
| MMK-1 | |
| CATPB | |
| AL12180 | |
| I-BET151 | |
| (N)methanocarba-UTP | |
| VU0361747 | |
| N-oleoylethanolamide | |
| A-967079 | |
| SB357134 | |
| PD 157672 | |
| WS-5 | |
| MRS 2219 | |
| aldosterone | A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney. |
| N′ 2-diphenylquinoline-4-carbohydrazide | |
| [<sup>125</sup>I]IRL1620 | |
| JYL1421 | |
| etodolac | A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active. |
| prednisone | A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid. |
| AC265347 | |
| GYPGKF-NH2 | |
| compound 11 [PMID: 20638279] | |
| PTBE | |
| L902688 | |
| VU-29 | |
| troglitazone | |
| cloprostenol | |
| XEN907 | |
| NPY-(2-36) (pig) | |
| MTSEA | |
| acarbose | A tetrasaccharide derivative consisting of a dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl C7 cyclitol moiety [called valienol (or valienamine)] linked via nitrogen to isomaltotriose. |
| PD-149164 | |
| homoquinolinic acid | |
| [<sup>125</sup>I]GR231118 | |
| [<sup>3</sup>H]PL017 | |
| domoic acid | A L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,4-dien-2-yl group at position 4. It is an analog of kainic acid and is the neurotoxin associated with the amnesic shellfish poisoning (ASP). |
| vortioxetine | An N-arylpiperazine in which the aryl group is specified as 2-[(2,4-dimethylphenyl)sulfanyl]phenyl. Used (as its hydrobromide salt) for treatment of major depressive disorder. |
| D-serine | The R-enantiomer of serine. |
| 6-iodo-nordihydrocapsaicin | |
| cyclosporin A | A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. |
| L-162 313 | |
| BayCysLT<sub>2</sub> | |
| NCG21 | |
| CAY 10471 | |
| semagacestat | |
| Ro 63-0563 | |
| cyclosporin H | |
| UCPH-101 | |
| galanin(1-20) (human) | |
| MRS2802 | |
| motesanib | A pyridinecarboxamide that has formula C22H23N5O. |
| GR231118 | |
| cannabidiol | An organic molecular entity that has formula C21H30O2. |
| α-conotoxin ArIB | |
| monobenzone | |
| GSK494581A | |
| eletriptan | |
| vicriviroc | |
| Ro 10-4548 | |
| diamide 7 | |
| (3R)-7-[(1S 2S 4aR 6S 8S)-2 6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1 2 4a 5 6 7 8 8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid | |
| cetuximab | |
| foretinib | |
| [<sup>125</sup>I]d(CH<sub>2</sub>)<sub>5</sub>[<small>D</small>-Ile<sup>2</sup> Val<sup>4</sup> Tyr-NH<sub>2</sub><sup>9</sup>]AVP | |
| [<sup>125</sup>I]NPW-23 (human) | |
| O<sub>3</sub> | |
| trametinib | A pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment. |
| peptide 234 | |
| enzalutamide | |
| [<sup>3</sup>H]N-methyl-AZ10419369 | |
| JPE1375 | |
| des-His<sup>1</sup>-[Glu<sup>9</sup>]glucagon-NH<sub>2</sub> | |
| motilin-(2-22) (human) | |
| [<sup>3</sup>H]ancriviroc | |
| tolterodine | A tertiary amine that has formula C22H31NO. |
| L-740093 | |
| PD157672 | |
| H-8 | |
| HPTE | |
| MNI-136 | |
| {3-[4-phenyl-2-(prop-2-en-1-yl)phenoxy]propyl}(propan-2-yl)amine | |
| LY344864 | |
| [<sup>3</sup>H]mibolerone | |
| (+)-naloxone | A morphinane alkaloid that has formula C19H21NO4. |
| [<sup>125</sup>I]α-conotoxin MII | |
| cannabinol | |
| (RS)-PPCC | |
| DSLET | |
| contulakin-G | |
| 5-OH-DPAT | |
| [<sup>3</sup>H]ORG2058 | |
| linalool | A monoterpenoid that is octa-1,6-diene substituted by methyl groups at positions 3 and 7 and a hydroxy group at position 3. It has been isolated from plants like Ocimum canum. |
| C646 | |
| CJ13610 | |
| DEPX | |
| EM-523 | |
| XD1 | |
| 4-[3-(1-benzofuran-5-yloxy)phenyl]-1-phosphonatobutane-1-sulfonate | |
| AC261066 | |
| physostigmine | An indole alkaloid that has formula C15H21N3O2. |
| AG-11/03 | |
| RS-100329 | |
| MRS2578 | |
| saredutant | |
| JWH015 | |
| PBIT | |
| dydrogesterone | |
| agatoxin 489 | |
| AQW051 | |
| [<sup>125</sup>I]Hpp-desArg<sup>10</sup>HOE140 | |
| DABCO | |
| kisspeptin-9 | |
| [<sup>125</sup>I]S36057 | |
| [<sup>125</sup>I]BAY 55-9837 | |
| HU-308 | |
| 2-ClATP | |
| [<sup>125</sup>I]kisspeptin-54 (human) | |
| JNJ-16567083 | |
| [<sup>3</sup>H]Lys-[Leu<sup>8</sup>][des-Arg<sup>9</sup>]BK | |
| NIL | |
| [<sup>3</sup>H]NBI-49202 | |
| YM 218 | |
| [<sup>111</sup>In]DOTA-dLVT | |
| TP-680 | |
| compound 23e [PMID: 17929793] | |
| SB 222200 | |
| GW9662 | A benzamide that has formula C13H9ClN2O3. |
| cyclourea apelin-12 (1-7) | |
| U69593 | A monocarboxylic acid amide obtained by formal condensation between the carboxy group of phenylacetic acid and the secodary amino group of (5R,7S,8S)-N-methyl-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-amine. |
| GB 110 | |
| inamrinone | |
| 20-hydroxy-LTB<sub>4</sub> | |
| APETx2 | |
| loxoribine | |
| sunitinib | A pyrrole that has formula C22H27FN4O2. |
| CGP 62349 | |
| [D-Phe<sup>6</sup>]bombesin(6-13)propylamide | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Et)<sup>2</sup> Val<sup>4</sup> des-Gly<sup>9</sup>]AVP | |
| CX546 | |
| [<sup>3</sup>H]ramatroban | |
| [<sup>125</sup>I](-)ICYP | |
| AS100 | |
| methylprednisolone | |
| α-linolenic acid | A linolenic acid with cis-double bonds at positions 9, 12 and 15. Shown to have an antithrombotic effect. |
| [<sup>3</sup>H]N-methyl-SSR504734 | |
| galanin (10-29) (rat/mouse) | |
| HC030031 | |
| CI-966 | |
| PTHrP-(7-34) (human rat mouse) | |
| <i>trans</i>-2-methylcrotonic acid | |
| U92016A | |
| finasteride | An aza-steroid that is a synthetic drug for the treatment of benign prostatic hyperplasia. |
| [<sup>3</sup>H]estradiol-17β-glucuronide | |
| guanabenz | |
| (3R 6E)-9 9-bis(4-fluorophenyl)-3 5-dihydroxy-8-(1-methyl-1H-1 2 3 4-tetrazol-5-yl)nona-6 8-dienoate | |
| geranyl diphosphate | The diphosphate of the polyprenol compound geraniol. |
| naltriben | |
| [<sup>3</sup>H]L-aspartic acid | |
| [<sup>3</sup>H]epibatidine | |
| 1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one | |
| chromanol 293B | A 1-benzopyran that has formula C15H20N2O4S. |
| Cu<sup>2+</sup> | |
| canagliflozin | A C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. |
| quisinostat | |
| doxepin | A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug. |
| BmP09 | |
| trastuzumab | |
| nimesulide | |
| ethyl 4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzoate | |
| L-736380 | |
| piboserod | |
| CMPD-1 | |
| 2-[4-(5-bromothiophen-2-yl)phenyl]-4-methyl-octahydro-2H-1 4-benzoxazin-2-ol | |
| hydrochlorothiazide | |
| incensole acetate | |
| dynorphin-(1-11) | |
| hemicholinium-3 | |
| ARL66096 | |
| LY367385 | |
| [<sup>125</sup>I]neuromedin U-25 (human) | |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(4-36) (human) | |
| [<sup>125</sup>I][Tyr<sup>26</sup>]galanin (rat/mouse) | |
| (+)-S-14297 | |
| 2-hydroxy lauric acid | A monohydroxy fatty acid with a lauric acid core substituted at position 2 by a hydroxy group, which confers chirality; a component of cellular lipids in Pseudomonas strains. |
| DM-1451 | |
| [<sup>3</sup>H]17β-estradiol | |
| KC-12615 | |
| (<i>S</i>)-3HPG | |
| K-252a | A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a |
| JV-1-36 | |
| taltirelin | |
| galanin(2-29) (pig) | |
| ALRT 1550 | |
| SM19712 | |
| phyllomedusin | |
| vitamin K2 | |
| JV-1-39 | |
| JV-1-38 | |
| [<sup>111</sup>In <sup>90</sup>Y]DOTA-TOC | |
| [<sup>125</sup>I]BQ3020 | |
| compound 9n [PMID: 23084894] | |
| [<sup>125</sup>I]U-II (human) | |
| [<sup>125</sup>I]CX<sub>3</sub>CL1 (human) | |
| (<i>R</i>)-DOI | |
| [<sup>125</sup>I]GDNF (rat) | |
| [<sup>3</sup>H]deltorphin II | |
| [<sup>3</sup>H]5-HT | |
| preladenant | |
| 2-furoyl-LIGRL[N[<sup>3</sup>H]propionyl]-O-NH<sub>2</sub> | |
| brimonidine | A quinoxaline derivative that has formula C11H10BrN5. |
| (3R 5R 6E)-7-[4 5-bis(4-fluorophenyl)-2-(propan-2-yl)-1H-imidazol-1-yl]-3 5-dihydroxyhept-6-enoic acid | |
| eprosartan | |
| timolol | 1,2,5-Thiadiazole substituted at the 3 position by a 3-(tert-butylamino)-2-hydroxypropoxy group and at the 4 position by a morpholin-4-yl group. The (S)-(-) enantiomer, also known as timolol, is a beta-adrenergic antagonist and is used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine. |
| FUB 465 | |
| DSTBULET | |
| [<sup>3</sup>H]fMet-Leu-Phe | |
| propantheline | |
| [<sup>125</sup>I]OH-LVA | |
| MRS1086 | |
| LY339434 | |
| doxycycline | Tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis. |
| CDPPB | |
| N-acetyl-4-benzoquinoneimine | |
| nicardipine | |
| rosiglitazone | |
| (<i>R S</i>)-4-PPG | |
| 3-(4-phenylphenyl)-1-azabicyclo[2.2.2]octane | |
| Org 25543 | |
| lysophosphatidylcholine | A compound resulting from partial hydrolysis of a phosphatidylcholine which removes one of the fatty acid groups. |
| jingzhaotoxin-III | |
| mazindol | |
| [D-Val<sup>5</sup>]NPS | |
| bortezomib | |
| UDP N-acetyl-glucosamine | |
| naltrexone | An organic heteropentacyclic compound that is 4,5-epoxymorphinan-6-one substituted by a cyclopropylmethyl group at position 17 and hydroxy groups at positions 3 and 14. A mu-opioid receptor antagonist, it is used to treat alcohol dependence. |
| Ac-RYYRIK-NH<sub>2</sub> | |
| compound 26 [PMID: 16439120] | |
| flufenamic acid | |
| [<sup>3</sup>H]SB-733993 | |
| zonisamide | A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position. |
| [Ile<sup>5</sup> Trp<sup>23</sup>]PTHrP-(5-36) | |
| cipemastat | |
| [<sup>3</sup>H]sumatriptan | |
| NF023 | |
| levetiracetam | |
| androstenol | |
| α-ketoglutaric acid | |
| MRS928 | |
| pertuzumab | |
| E5700 | |
| L-775 606 | |
| SRA880 | |
| LU32-176B | |
| compound 15a [PMID:16242323] | |
| ZD6021 | |
| ONO-AP-324 | |
| cromakalim | A 1-benzopyran that has formula C16H18N2O3. |
| nemonapride | A racemate composed of (2S,3S)- and (2R,3R)-enantiomers of nemonapride. Highly potent dopamine D2-like receptor antagonist; selective over D1-like receptors (Ki values are 0.1 and 740 nM for D2-like and D1-like receptors respectively). Also potent 5-HT1A receptor agonist (IC50 = 34 nM) and has affinity for sigma receptors. |
| [<sup>3</sup>H]JNJ-40068782 | |
| MRL24 | |
| <small>D</small>-Lys<sup>0</sup>-[des-Arg<sup>10</sup>]kallidin | |
| NS004 | |
| MRL20 | |
| linagliptin | |
| [<sup>125</sup>I]ET-2 | |
| tamatinib | |
| [Ala<sup>1 12</sup> Aib<sup>3</sup> Gln<sup>10</sup> hArg<sup>11</sup> Trp<sup>14</sup> Arg<sup>19</sup>]PTH-(1-34)-NH2 | |
| regadenoson | |
| [dY]<sup>1</sup>KP-10 | |
| BADGE | |
| [<sup>125</sup>I]ICYP | |
| ibritumomab tiuxetan | |
| sphingosine 1-phosphate | A phosphosphingolipid that consists of sphingosine having a phospho group attached at position 1 |
| variant MCH | |
| [<sup>3</sup>H]PSB603 | |
| 7α 25-dihydroxycholesterol | A 25-hydroxy steroid that has formula C27H46O3. |
| fluprostenol | An organofluorine compound that is racemic prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of its isopropyl ester prodrug, travoprost, are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. The isopropyl ester group of travoprost is hydrolysed to the biologically active free acid by esterases in the cornea. |
| spermine | A polyazaalkane that is tetradecane in which the carbons at positions 1, 5, 10 and 14 are replaced by nitrogens. Spermine has broad actions on cellular metabolism. |
| ethyl 3-[4-(2-{3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl}ethynyl)-3-(prop-2-en-1-yl)phenyl]propanoate | |
| WAY-181187 | |
| BQ 3020 | |
| compound 18a [PMID:22901672] | |
| nepadutant | |
| begacestat | |
| quinelorane | |
| ropinirole | An indolone that has formula C16H24N2O. |
| dihydrosp​hingosine​-1-phosph​ate | |
| D-aspartate | An aspartate(2-) that is the conjugate base of D-aspartate(1-). |
| CP-122288 | |
| carbacyclin | |
| [<sup>3</sup>H](2S 4R)-4-methylglutamate | |
| fluspirilene | |
| [<sup>125</sup>I]L750667 | |
| AGN 191976 | |
| ergotamine | A peptide ergot alkaloid that is dihydroergotamine in which a double bond replaces the single bond between positions 9 and 10. |
| sergliflozin | |
| FR122047 | |
| [<sup>125</sup>I][Sar<sup>1</sup> Ile<sup>8</sup>]Ang-II | |
| AG-041R | |
| pregnanedione | |
| spiperone | An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively. |
| GRN-529 | |
| nilutamide | |
| mesulergine | A member of the class of ergot alkaloids that is known to act on serotonin and dopamine receptors. |
| LY382884 | An alpha-amino acid that has formula C18H23NO4. |
| ancriviroc | |
| mast cell degranulating peptide | |
| clobenpropit | An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM. |
| MZ-6-55 | |
| compound 11 [PMID:12812482] | |
| A-867744 | |
| bunolol | |
| [<sup>11</sup>C]AZ10419369 | |
| tadalafil | |
| [<sup>3</sup>H]losartan | |
| [<sup>125</sup>I]motilin (human) | |
| ADPβS | |
| MT2 | |
| MT1 | |
| MT7 | |
| RS 116 2617 | |
| benzamil | A pyrazine that has formula C13H14ClN7O. |
| mycophenolate mofetil | |
| [Tyr<sup>34</sup>]PTH-(1-34)-NH<sub>2</sub> (human) | |
| [<sup>125</sup>I]MK-678 | |
| [<sup>3</sup>H]DAMGO | |
| GSK690693 | |
| YM348 | |
| 2-fluoromevalonate 5-diphosphate | |
| cGMP | |
| disopyramide | A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug. |
| cabazitaxel | |
| dexniguldipine | |
| 2-<i>O</i>-methyl-PAF C-18 | |
| La<sup>3+</sup> | |
| K<sup>+</sup> | |
| compound 38 (PMID: 24000170) | |
| hydroxyzine | A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively. |
| JMV641 | |
| RS-136270 | |
| isopropylureido-FLFLF | |
| isopentenyl diphosphate | A prenol phosphate comprising 3-methylbut-3-en-1-ol having an O-diphosphate substituent. |
| BIM 23268 | |
| gallamine | |
| piribedil | |
| NNC 11-1314 | |
| tandospirone | |
| α-fluoromethylenephosphonate | |
| decyl dihydrogen phosphate | |
| CP55 244 | |
| L-366 509 | |
| [<sup>125</sup>I][MePhe<sup>7</sup>]NKB | |
| hexarelin | |
| (4R)-6-[(1 3-dichloro-6-fluoro-9H-fluoren-9-yl)methyl]-4-hydroxyoxan-2-one | |
| [D-Tyr<sup>6</sup> (R)-APA<sup>11</sup> Phe<sup>13</sup> Nle<sup>14</sup>]bombesin-(6-14) | |
| L-803 087 | |
| lysergic acid | An ergoline alkaloid comprising 6-methylergoline having additional unsaturation at the 9,10-position and a carboxy group at the 8-position. |
| quin-C7 | |
| glucagon-(1-6) | |
| naratriptan | A heteroarylpiperidine that has formula C17H25N3O2S. |
| H-c[DCys-Phe-LAgl(N<sup>β</sup>Me benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH | |
| darusentan | |
| quin-C1 | |
| AMG517 | |
| (R/S) EF-1500 | |
| nexturastat A | |
| A68930 | |
| [D-Tyr<sup>6</sup> Apa-4Cl<sup>11</sup> Phe<sup>13</sup> Nle<sup>14</sup>]bombesin-(6-14) | |
| camphor | A cyclic monoterpene ketone that is bornane bearing an oxo substituent at position 2. A naturally occurring monoterpenoid. |
| BMS753 | |
| alvimopan | |
| B-9430 | |
| GABA | |
| nintedanib | |
| GW3965 | A diarylmethane that has formula C33H31ClF3NO3. |
| fluocinonide | |
| MM 11253 | |
| methyllycaconitine | A diterpenoid that has formula C37H50N2O10. |
| glycine | The simplest (and the only achiral) proteinogenic amino acid, with a hydrogen atom as its side chain. |
| LY2033298 | |
| lasso D | |
| 5-HT | |
| ONO-DI-004 | |
| zafirlukast | A carbamate ester that has formula C31H33N3O6S. |
| spinorphin | |
| AFP-07 | |
| [<sup>125</sup>I]3-N<sub>3</sub>-Phpa-LVA | |
| cyPPTS | |
| loperamide | A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease. |
| isocarbacyclin | |
| dNal-<i>cyc</i>(Cys-Tyr-dTrp-Orn-Val)-Nal-NH<sub>2</sub> | |
| GsMTx-4 | |
| ciclesonide | |
| beclometasone | |
| [<sup>3</sup>H]vesamicol | |
| zaragozic acid C | A polyketide isolated from fungi that is a potent inhibitor of fungal and mammalian squalene synthase. |
| zaragozic acid B | |
| zaragozic acid A | A polyketide isolated from fungi that is a potent inhibitor of fungal and mammalian squalene synthase. |
| SKF89976A | |
| argiotoxin | |
| PD123177 | A diarylmethane that has formula C29H28N4O3. |
| GW7845 | |
| compound 3a [PMID:21444206] | |
| cabozantinib | |
| TP003 | |
| (+)-AJ76 | |
| L741742 | |
| [<sup>3</sup>H]NFPS | |
| fenfluramine | |
| [<sup>125</sup>I]SDF-1α (human) | |
| [Pro<sup>9</sup>]SP | |
| 4-[3-(2-benzylphenoxy)phenyl]-1-phosphonatobutane-1-sulfonate | |
| (R)-UH 301 | |
| CCK-8 (desulphated) | |
| MRS2782 | |
| phytosphingosine 1-phosphate | A phosphosphingolipid that is phytosphingosine bearing a phospho group at position 1. |
| ShK(L5) | |
| AGN193836 | |
| prednisolone | A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone. |
| D-lactic ​acid | |
| GW9508 | |
| trihexyphenidyl | |
| [F/G]N/OFQ-(1-13)-NH<sub>2</sub> | |
| ({[({4-[(1E)-2 6-dimethylhepta-1 5-dien-1-yl]phenyl}methoxy)methyl](hydroxy)phosphoryl}methyl)phosphonic acid | |
| [<sup>18</sup>F]SPA-RQ | |
| abatacept | |
| [<sup>125</sup>I]7-azido-8-iodoketanserine | |
| BNTX | |
| JNJ1930942 | |
| Gal-B2-dPEG<sub>24</sub> | |
| XAC | |
| H3 relaxin/INSL5 chimera | |
| LY334362 | |
| VU0001171 | |
| Ro64-5229 | |
| deslanoside | |
| β-scorpion toxin TiTXγ | |
| [<sup>3</sup>H]dimethyl-W84 | |
| FP0429 | |
| JNJ-10191584 | |
| Δ<sup>12</sup>-PGJ<sub>2</sub> | |
| tanomastat | |
| renzapride | |
| (-)-adrenaline | A catecholamine in which the aminoethyl side-chain is hydroxy-substituted at C-1 and methylated on nitrogen. |
| RS 39604 | An aromatic ether that is the 3,5-dimethoxybenzyl derivative of N-(2-{4-[3-(4-amino-5-chloro-2-hydroxyphenyl)-3-oxopropyl]piperidin-1-yl}ethyl)methanesulfonamide. A potent and selective 5-HT4 antagonist, with a pKi of 9.1 at 5-HT4 receptors in guinea pig striatal membranes and greater than 1000-fold selectivity over 5-HT1A, 2C, 3 and D1, D2, M1, M2, AT1, B1 and alpha1C receptors. The ketone group gives RS 39604 a relatively long half life; it is also orally active and so suitable for in vivo studies. |
| <i>N</i>-methyl-Phe-Lys-Pro-<small>D</small>-Cha-Trp-<small>D</small>-Arg-CO<sub>2</sub>H | |
| [<sup>125</sup>I]PD142308 | |
| [<sup>125</sup>I]BgK (W5Y / Y26F) | |
| 29-methylidene-2 3-oxidosqualene | |
| RO3244794 | |
| [<sup>3</sup>H]histamine | |
| DH97 | |
| maraviroc | |
| BD-1047 | |
| Z-IETD-FMK | |
| vCCL4 | |
| syn-BrP-LPA | |
| VUF 4904 | |
| cabergoline | An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia. |
| imatinib | |
| L-tryptophan | The L-enantiomer of tryptophan. |
| NVP-SAA164 | |
| acebutolol | An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol. |
| G-1 | |
| GW 627368 | |
| oleamide | A fatty amide derived from oleic acid. |
| MG149 | |
| Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH<sub>2</sub> | |
| AB-MECA | |
| compound (S)-3h [PMID:15686947] | |
| [Phaa<sup>1</sup> <small>D</small>-Tyr(Et)<sup>2</sup> Lys<sup>6</sup> des-Gly<sup>9</sup>]AVP | |
| propofol | A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group. |
| (3R 5R)-7-(3-{[3-(carbamoylmethyl)phenyl]sulfamoyl}-4 5-bis(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-1-yl)-3 5-dihydroxyheptanoate | |
| PGF<sub>2α</sub> | |
| benzyl(2-{4-[(E)-2-phenylethenyl]phenoxy}ethyl)amine | |
| daclizumab | |
| SCH 50911 | |
| (3α 5β 12α 17xi)-3-hydroxy-21-[(2R 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]pregnan-12-yl (2S)-2-methylbutanoate | |
| 3-deazaadenosine | |
| compound 10 [PMID: 15482906] | |
| KH064 | |
| lysergol | An alkaloid of the ergoline family that occurs as a minor constituent in some species of fungi and in the morning glory family of plants. Its structure is that of ergoline with a methyl group at N-6 and a beta-hydroxymethyl substituent at C-8. |
| physalaemin | |
| lysophosphatidylinositol | A glycerophosphoinositol resulting from partial hydrolysis of a phosphatidyl-1D-myo-inositol, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl. |
| CZC 24832 | |
| [(7E)-8 12-dimethyl-1-phosphonotrideca-7 11-dien-1-yl]phosphonic acid | |
| cholesten | |
| chembridge-5861528 | |
| nalorphine | A morphinane alkaloid that has formula C19H21NO3. |
| AZD3839 | |
| SR8278 | |
| RP73870 | |
| α-conotoxin MII [H9A L15A] | |
| compound 18a [PMID: 16242323] | |
| prinaberel | |
| [<sup>125</sup>I][Nle<sup>75</sup> Tyr<sup>77</sup>]apelin-36 (human) | |
| UCCF-339 | |
| Ro-26-9228 | |
| AM966 | |
| dimethyltryptamine | |
| (4R)-6-[(E)-2-[6-tert-butyl-4-(4-fluorophenyl)-2-(propan-2-yl)pyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one | |
| testosterone | An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.. |
| olmesartan | A biphenylyltetrazole that has formula C24H26N6O3. |
| NNC269100 | |
| [<sup>125</sup>I]CCL21 | |
| pyrimethamine | |
| ipilimumab | |
| [<sup>125</sup>I]NKA (human mouse rat) | |
| substance P-(6-11) | |
| LTC<sub>4</sub> | |
| R121919 | |
| chlordiazepoxide | A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2. |
| bromoacetone | An alpha-bromoketone that is acetone in which one of the hydrogens is replaced by a bromine atom. A poweful lachrymator, it was formerly used as a chemical weapon. |
| compound 13 [PMID: 15686941] | |
| Z-YVAD-FMK | |
| duloxetine | |
| NE11808 | |
| RU28318 | |
| SKF-38393 | |
| octopamine | Octopamine is a biogenic phenylethanolamine, which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates. |
| dipyridamole | A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots. |
| RS-127445 | |
| 2 3-dihydro-1 4-dithiin-1 1 4 4-tetroxide | |
| SB290157 | |
| androstenedione | |
| [<sup>3</sup>H]JB-93182 | |
| HQL-79 | |
| NS3763 | |
| MRS2211 | |
| 2-{2-[(3R 5S)-7-chloro-5-(2 3-dimethoxyphenyl)-1-(3-hydroxy-2 2-dimethylpropyl)-2-oxo-1 2 3 5-tetrahydro-4 1-benzoxazepin-3-yl]acetamido}acetic acid | |
| VU-71 | |
| 2 2-difluoromevalonate 5-diphosphate | |
| aprepitant | |
| frescolat MGA | |
| [Sar<sup>9</sup> Met(O<sub>2</sub>)<sup>11</sup>]SP | |
| ibutamoren | |
| icilin | |
| ZK110841 | |
| GW6471 | An amphetamine that has formula C35H36F3N3O5. |
| KH28 | |
| GEA 3162 | |
| dizocilpine | An organic tricyclic compound that has formula C16H15N. |
| acetazolamide | A thiadiazole that has formula C4H6N4O3S2. |
| flutamide | A (trifluoromethyl)benzene that has formula C11H11F3N2O3. |
| 2-[4-(4-bromophenyl)phenyl]-4-methylmorpholin-2-ol | |
| [<sup>125</sup>I]H2 relaxin | |
| deoxycholic acid | A dihydroxy-5beta-cholanic acid that has formula C24H40O4. |
| margatoxin | |
| NPY-(13-36) (pig) | |
| AZD1480 | |
| MRS1754 | |
| SKF96365 | |
| neuromedin B (1-30) (human) | |
| dextroamphetamine | |
| terfenadine | |
| ruxolitinib | |
| S36541 | |
| S36540 | |
| [<sup>125</sup>I]LSD | |
| ryanodine | An insecticide alkaloid isolated from South American plant Ryania speciosa. |
| DL-TBOA | |
| desirudin | |
| NNC 92-1687 | |
| arvanil | |
| neuropeptide head activator | |
| bupivacaine | A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic. |
| SCH51866 | |
| methionine benzimidazole 6 | |
| fluphenazine | A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position. |
| NK2301 | |
| N-methyl-SSR504734 | |
| DABCO-C<sub>16</sub> | |
| compound 29a [PMID:21444206] | |
| AS101 | |
| GW501516 | An aromatic ether that is phenoxyacetic acid in which the phenyl group is substituted at position 2 by a methyl group and at position 4 by a (1,3-thiazol-5-ylmethyl)sulfanediyl group, and in which the 1,3-thiazolyl group is substituted at positions 2 and 4 by p-trifluoromethylphenyl and methyl groups, respectively. |
| CGS 21680 | A derivative of adenosine in which the 5'-hydroxymethyl group is replaced by N-ethylcarboxamido and the hydrogen at position 2 on the adenine is replaced by a 4-(2-carboxyethyl)phenethylamino group. |
| phenylbutazone | A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. |
| (S)-FTY720-phosphate | |
| ethoxzolamide | 1,3-Benzothiazole substituted a sulfonamide and an ethoxy group at positions 2 and 6, respectively. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic. |
| oleoyl-CoA | An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of oleic acid. |
| compound 47 [PMID: 21295468] | |
| GLP-1-(9-36) | |
| mycophenolic acid | |
| (3R 5S 6E)-7-[4-(4-fluorophenyl)-1-phenyl-2-(propan-2-yl)-1H-pyrrol-3-yl]-3 5-dihydroxyhept-6-enoate | |
| valproic acid | A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. |
| NE21650 | |
| [<sup>3</sup>H]LY354740 | |
| [D-Ala<sup>2</sup> F<sub>5</sub> Phe<sup>4</sup>]dynorphin-(1-17)-NH<sub>2</sub> | |
| epinastine | A benzazepine that is 6,11-dihydro-5H-dibenzo[b,e]azepine in which the azepine ring is fused to the e side of 4,5-dihydro-1H-imidazol-2-amine. |
| PMD38 | |
| NF340 | |
| MRS1186 | |
| compound 32 [PMID: 19289283] | |
| BW284C51 | |
| fasidotril | |
| UNC0638 | |
| picrotoxinin | A furopyran that has formula C15H16O6. |
| [<sup>3</sup>H]nisoxetine | |
| PG-106 | |
| nor-binaltorphimine | An isoquinoline that has formula C40H43N3O6. |
| dinaciclib | |
| SB 225002 | |
| (-)-bremazocine | A benzazocine that has formula C20H29NO2. |
| doxazosin | A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure. |
| SK&F 83589 | |
| P'-geranyl 3 5 9-trihydroxy-3-methylnonanate 9-diphosphate | |
| (-)-noradrenaline | A catecholamine in which C-1 of the aminoethyl side-chain is hydroxy-substituted. |
| [<sup>3</sup>H]RX821002 | |
| metiamide | An imidazole that has formula C9H16N4S2. |
| pandinotoxin-K α | |
| propargylglycine | |
| PP-(2-36) (human) | |
| arachidonyl-2-chloroethylamide | |
| [<sup>125</sup>I]epibatidine | |
| ziprasidone | A piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms. |
| simvastatin | A fatty acid ester comprising a dihydroxyheptanoic acid unit condensed into a lactone; a partially reduced naphthalene structure; and a 2,2-dimethylbutyric acyl substituent at C17. It is used as a cholesterol-lowering and anti-cardiovascular disease drug. |
| DAX | |
| [<sup>125</sup>I]CXCL8 (human) | |
| isobutyric acid | A branched fatty acid comprising propanoic acid carrying a methyl branch at C-2. |
| GSK 256471 | |
| (±)-<i>cis</i>-H<sub>2</sub>-PAT | |
| M65 | |
| diarylpropionitril | |
| [<sup>125</sup>I][des-Gly<sup>10</sup> <small>D</small>-Ala<sup>6</sup>]GnRH <i>N</i>-ethylamide | |
| nomifensine | |
| [<sup>3</sup>H]L655708 | |
| 2-(3-chlorophenyl)histamine | |
| [<sup>125</sup>I]Tyr<sup>45</sup>-kisspeptin-15 | |
| SL65.0155 | |
| [<sup>125</sup>I]LH | |
| ScTx1 | |
| temsirolimus | |
| LY 165 163 | |
| cimadronate | |
| α-KTx 13.2 | |
| GIP-(7-30) | |
| normorphine | A morphinane alkaloid that has formula C16H17NO3. |
| tamsulosin | A sulfonamide that has formula C20H28N2O5S. |
| lurasidone | |
| A-582941 | |
| PF750 | |
| MS436 | |
| [<sup>125</sup>I]BH-NMB | |
| calcipotriol | A seco-cholestane that has formula C27H40O3. |
| dovitinib | |
| [<sup>3</sup>H]NPY | |
| phrixotoxin 1 | |
| d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup> Arg<sup>8</sup>]VP | |
| phrixotoxin 2 | |
| estriol |
